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Abstract 
Natural products remain a source of new drugs.  Many plant-derived drugs have been 
introduced to the market and used as medicine in today’s society.  However, only a small 
percentage of plants have been investigated for their chemical constituents and medicinal 
properties.   
 
This study aimed to determine the phytochemical constituents of species belonging to genera 
that have historical medicinal uses or known biological activities.  Five species belonging to 
three families were investigated in this study: Croton dichogamus Pax (Euphorbiaceae 
family), Crinum sp. 6538, Crinum hardyi Lehmiller and of Crinum sp. 5629 (Amaryllidaceae 
family), and Toona sinensis M. Roem (Meliaceae family).  The families and genera which 
were chosen for this study have been reported to possess various classes of compounds with 
different biological activities including anti-cancer activity.  
A total of thirty-three compounds were isolated in this study, of which five compounds were 
new and one was a new isomer.  The roots of Croton dichogamus yielded fifteen compounds 
including four known sesquiterpenoids (CD.1-CD.4), one new enantiomer of a known 
sesquiterpenoid (CD.5), four known ent-clerodane diterpenoids (CD.6-CD.9), two new ent-
halimane diterpenoids (CD.10-CD.11), one known crotofolane (CD.12), two new crotofolane 
diterpenoids (CD.13-CD.14) and one known triterpenoid (CD.15).  The bulbs of Crinum sp. 
6538, Crinum hardyi and of Crinum sp. 5629 gave nine compounds: one new alkaloid 
(CF.2), seven known alkaloids (CF.1, CF.3, CF.4, CF.5, CF.6, CH.1 and CS.3) along with 
an alkaloid salt (CF.7).  The stem bark of Toona sinensis yielded nine compounds: five 
known triterpenoids (TS.1-TS.5), two known flavonoids (TS.6-TS.7) and two common 
phytosterols (TS.8-TS.9).  The structures of these compounds were determined using nuclear 
magnetic resonance spectroscopy, infrared spectroscopy, mass spectrometry, electronic 
circular dichroism and optical rotation measurements.  Some of the isolated compounds were 
screened in vitro for cell viability against Caco-2 (Human Colorectal Adenocarcinoma) cell 
lines by using the neutral red assay.  CD.5 showed some activity with an IC50 of 24.1 µM.  
Selected compounds were submitted to the National Cancer Institute (NCI) in the USA for 
testing at one dose of 15 µg/ml NCI60 cell line panel.  The mean values of growth inhibition 
of all compounds did not meet the criteria for further testing against the five-dose NCI60 cell 
line panel.  
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 Chapter 1: General introduction  
 Medicinal plants as a source of drugs 
Plants have been used as a source of medicine from early times.1  The first records of herbal 
medicine come from Mesopotamia in 2600 BC. Details of approximately a thousand plant 
derived substances were written on clay tablets in cuneiform, for example, use of oils of 
Cedrus species, Commiphora species and Glycyrrhiza glabra.1,2  These plants are still being 
used as traditional medicines for treating and preventing diseases such as colds, coughs and 
inflammation.1,2  In 1500 BC, Egyptian plant medicine use was recorded in the Ebers 
Papyrus.2  More than seven hundred drugs including the formulae to prepare them in forms 
such as pills, infusions and ointment were described.2  Most of these drugs were derived from 
plants with some minerals included.2  The Chinese pharmaceutical record was documented in 
about 1100 BC in the Wu Shi Er Bing Fang which described more than fifty prescriptions, 
followed by other documents such as the Tang Herbal with more than 8000 drugs.2   Due to 
the development of organic chemistry and pharmacological testing, the use of medicinal 
plants has progressed from the use of crude extracts such as teas, powders and tinctures to the 
isolation of active compounds.  The first reports of the isolation of pharmacologically active 
compounds was in the early nineteenth century when alkaloids such as morphine [Figure 
1.1], which is used as a painkiller, was isolated from the opium poppy, and quinine [Figure 
1.1], which was used for the treatment of malaria, was isolated from Cinchona bark.3  Their 
discoveries led to an increase in the attention towards plants as a source of new drugs.3  This 
was followed by the first semi-synthetic drug from a natural product, asprin, by Bayer in 
1899, from acetylation of salicylic acid [Figure 1.1].2   
Although, combinatorial chemistry, molecular modelling and other drug synthetic techniques 
have recently been developed, natural products still play a vital role in drug discoveries,4,5  
Natural products cannot be only as a new drugs themself, but also as leads or starting points 
for new synthetic drugs, as they have different structures that can be difficult to produce 
synthetically.5  For example, they have multiple chiral centres, complex ring systems, a 
number of heteroatoms and a higher frequency of oxygen atoms.5  It had been recorded that 
between 1981 and 2002, natural product or natural product-derived compounds were the 
source of about 48% of new chemical entities (NCEs).  In 1996, six out of the top twenty 
2 
 
drugs were natural products and half of these were derived from natural product research, 
which shows that natural products are a crucial source of new drugs and important in future 
drug development.3  Between 2000-2005 23 new drugs from natural products sources were 
marketed, and 84 of 150 prescription drugs were natural products or derivative drugs in the 
United States.1  Some examples of medicinal plant-derived drugs that have been introduced 
in the last decade to the market are Tiotropium bromide (trade name Spiriva®, 2004) [Figure 
1.1], which is used for treatment of chronic obstructive pulmonary disease (COPA).1,4  
Tiotropium is derived from atropine that comes from Atropa belladonna L. (Solanaceae).1,4  
Apomorphine hydrochloride (trade name Apokyn®, 2004) [Figure 1.1], is used to treat 
Parkinson’s disease and is a derivative of morphine isolated from the poppy Papaver 
somniferum L (Papaveraceae).1,4  Nitisinone (trade name Orfadin®, 2002) [Figure 1.1], is 
used to treat hereditary tyrosinaemia type 1 (HT-1) and is a derivative of leptospermone from 
the bottlebrush Callistemon citrinus Stapf. (Myrtaceae).1,4  Galanthamine (trade name 
Reminyl®, 2001) [Figure 1.1], is used to treat Alzheimer’s disease and is isolated from 
Galanthus woronowii Losinsk. (Amaryllidaceae).1,4  More compounds that have been isolated 
from plants and are used are shown in Table 1.1.2,6 
 
Figure 1.1: Structures of plant compounds used as drugs1,4 
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Table 1.1: Plant derived compounds that have been used as source of drugs2,6 
Cocaine Topical anaesthetic Codeine Anti-cough Pilocarpine Antiglaucoma 
Erythroxylum coca Papaver somniferum Pilocarpus jaborandi 
 
 
 
Atropine Spasmolytic Artemisinin Antimalarial Berberine Anti-leishmanial 
Hyoscyamus niger Artemesia annua Berberis species 
 
  
Plumbagin Antifungal, amoebiasis Allicin Antifungal Forskolin Hypotensive, cardiotonic 
Plumbago indica Allium sativum Coleus forskohlii 
 
 
 
Homoharringtonine Anticancer Ephedrine Antiasthma Pristimerin Antimalarial 
Cephalotaxus Ephedra sinaica Celastrus paniculata 
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Rescinnamine   Tranquilizer Sophoradin Antiulcer 
Rauvolfia serpentina  Sophora subprostrata 
 
 
Vinblastine Anticancer Camptothecine Anticancer 
Catharanthus roseus Camptotheca acuminata 
 
 
Taxol Breast and ovarian anticancer Quassin Antiamoebic agent 
Taxus baccata Ailanthus landulosa 
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In the last 40 years, the popularity of using herbs and traditional medicine has increased in 
both industrialized and developing countries.7  In 1985, the World Health Organization 
estimated that over 75% of the world population relied on plants for health care.8  A survey in 
2007, reported that complementary and alternative medicine (CAM) were used by 
approximately 11% of children and 40% of adults.7  Another study in 2012 showed that CAM 
was used more by people with a higher education level.7  This reliance on traditional 
medicine could be due to the resistance of many pathogens to synthetic drugs, the side effects 
of numerous types of treatments, and shortages or costs of other drugs.6 
 
  The Process of drug discovery 
The process of drug discovery from plants is long and requires the collaboration of different 
disciplines such as, botanists, pharmacologists, chemists and toxicologists.  The process 
begins with plant collection and identification.  The collection of plant material can be 
random or from ethnomedicinal and chemotaxonomic information.  This is followed by 
preparation of appropriate extracts and biological screening, purification and identification of 
compounds product by different chromatographic methods.  Pure compounds are subjected to 
further bioassay screening [Figure 1.2]. 
 
 
 
 
 
 
 
 
Figure 1.2: Procedure of the Process of plant discovery  
 
 
Extraction 
Structural elucidation 
Medicinal 
plant 
Extract Pure 
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Structure modification 
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 Objective of the study 
The objectives of this study were: 
 To determine the chemical constituents of Croton dichogamus Pax 
[Euphorbiaceae family] 
 To determine the chemical constituents of three Crinum species: Crinum 
species 1 6538, Crinum hardyi Lehmiller and Crinum species 2 6529 
[Amaryllidaceae family] and compare them to these of Crinum firmifolium 
Var. hygrophilum H. Perr 
 To compare the chemical constituents Toona sinensis [Meliaceae family] 
grown in the UK and in Asia. 
 To determine the biological activities of most compound isolated by 
submitting to the National Cancer Institute (NCI), and to test some of the 
compounds isolated for cytotoxicity against Caco-2 cancer cell lines. 
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 Chapter Two: The phytochemistry of Croton dichogamus Pax 
[Euphorbiaceae family] 
 Introduction to the Euphorbiaceae family 
The Euphorbiaceae family is one of the largest and most complex Dicot families.9,10  The 
Euphorbiaceae family displays a wide range of growth forms from trees and shrubs to herbs, 
and it is widely distributed in the tropics with high occurrence in Africa including 
Madagascar.9,10  Between 1975 and 1994 more than 300 genera of Euphorbiaceae were 
classified into two groups depending on the number of ovules present, and five subfamilies: 
the first group contains the Acalyphoideae, the Crotonoideae and the Euphorbioideae that are 
uniovulate, and the second group contains the Phyllanthoideae and the Oldfieldioideae that 
are biovulate.9,11  Later on the Angiosperm Phylogeny Group (APG ІІ, 2003) found that there 
was no molecular evidence to keep the Euphorbiaceae as one family, and they divided it into 
three families: the Euphorbiaceae that includes the uniovulate subfamilies, and the 
Phyllanthaceae and Picrodendraceae that include the biovulate subfamilies, the 
Phyllanthoideae and Oldfieldioideae respectively.12  However, in 2005, Wurdack et al. 
proposed two new subfamilies in the Euphorbiaceae, the Cheilosoideae and Peroideae 
according to molecular data obtained from investigations of the plastid regions of DNA.13   
 
 Introduction to the Croton genus 
 The Croton genus 
Croton belongs to the Crotonoideae subfamily, which is categorized by having crotonoid 
pollen with lactiferous taxa.13,14  The Crotonoideae subfamily has been divided into four 
clades: Adenoclineae, Articulated Crotonoideae, Gelonieae and Inaperturate Crotonoideae,13 
12 tribes and 73 genera.15  The Croton genus is placed into the Crotoneae tribe of the 
Inaperturate Crotonoideae clade,13 and it is one of the largest genera of the Euphorbiaceae 
family with more than 800 species occurring in the tropics and subtropics, the majority in 
America.15,16  The main morphological characteristics of the Croton genus, which differ from 
other genera, are that the petals and pistillate flowers can either be reduced or absent, the 
filament in the staminate flowers are inflexed in the bud and the terminal flowers in the 
thyrses are usually pistillate, while distal flowers in cymules are staminate.15,16 
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 Ethnobotany and biological screening of the Croton genus 
Various types of Croton plant parts and fractions have been used in folk medicine.17  In the 
1600s, the wide use by Mexican  tribes of Croton’s sap known as dragon’s blood which is a red 
resin produced by scratching the stem or bark of plants, was reported for the first time.18  
Dragon’s blood has been found from different sources such as Venezuelan dragon’s blood from 
Croton gossypifolium Vahl and Mexican dragon’s blood from Croton lechleri Müll. Arg. and it 
also can be produced from other plants like Zanzibar dragon’s blood from Dracaena cinnabari 
Balf. f.and West Indian dragon’s blood from Pterocarpus draco L..19  The Croton’s sap has been 
used as a household remedy to cure many diseases such as diarrhoea, stomach ulcers, pain and 
swelling of insect bites and herpes infection.18,20  Several species of Croton are used in South 
America, Asia and Africa in traditional medicine.  Pharmacological and clinical studies of 
plant extracts and compounds isolated from some of these species have been undertaken.  
Examples of the ethno-medicinal applications and biological activities of different Croton 
species are given in Table 2.1.  
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Table 2.1: Selected examples of ethno-medicinal applications of Croton species in 
different areas and their pharmacological effects. 
Plant name Plant part Region Traditional uses Compounds Bioassay Activities 
C. arboreous Millsp Aerial parts  Mexico Supplementary anti-
inflammatory agent 
to treat respiratory 
diseases.21 
Sesquiterpenes Anti-inflammatory.21 
C. crassifolius Geisel Roots China Stomach ache, 
snake bites, 
sternalgia, 
pharyngitis, joint 
pain, jaundice and 
rheumatoid 
arthritis.22 
Sesquiterpenes Anti-angiogenic.22 
C. kongensis Gapnep Not stated Thailand Dysmenorrhea Diterpenes Antimycobacterial 
and antimalarial and 
cytotoxic toward 
Vero, KB and BC 
cell lines.23  
Croton lechleri Muell.-
Arg 
Red sap South America Treat wounds.17,24 Alkaloids Enhancer of wound 
healing.25,26 
C. malambo Karst Bark  Venezuela and 
Colombia 
Gastric ulcers 
diabetes, 
rheumatism, 
diarrhoeas and 
analgesic agent.27 
Aqueous 
extract 
Anti-inflammatory 
and 
antinociceptive.27 
C. membranaceus 
Müll.Arg 
Roots Nigeria Improves digestion 
and tonic.28 
Diterpenes Antibacterial.29 
C. tonkinensis Gagnep Leaves Vietnam Dyspepsia, 
abscesses, 
abdominal pain, 
impetigo, and 
gastric 
and duodenal 
ulcers.30 
Diterpenes Inhibit LPS-Induced 
NF-KB activation.30 
C. zambesicus Müll. 
Arg. 
Roots West Africa Aperient.31 Diterpenes Cytotoxic against 
human cervix 
carcinoma cells.32 
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 Chemical constituents of the Croton genus  
Phytochemical studies of the Croton genus have revealed various classes of compounds.  The 
predominant class of compounds in the Croton genus is terpenoids, and mainly diterpenoids, 
which includes acyclic or cyclic diterpenoids, such as clerodane, halimane, kaurane, 
secokaurane and labdane classes.17  Alkaloids and phenolic compounds have also been 
reported from the different Croton species.  Examples of compounds isolated from each class 
from the Croton genus are given in Table 2.2-Table 2.7 below with some of their recorded 
activities. 
Table 2.2: Examples of triterpenids compounds isolated from the Croton genus and 
their biological activities. 
Source and compounds isolated Activity 
C. cascarilloides33 and C. cajucara.34 
  
Acetyl aleuritolic acid (3β-O-acetyl-D-friedoolean-14-en-28-oic-acid). 
Showed cytotoxicity 
activity against human 
cancer central  nervous 
system (U251, Glia) cell 
line, with IC50 8.4 μM.35 
C. macrostachys.36 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lupeol: R= H 
Betulin: R= OH 
Betulin showed antibacterial 
and antifungal activity 36 
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Table 2.3: Examples of acyclic diterpenoids isolated from the Croton genus and some of 
their biological activities.  
C. kerrii A.37 
 
(E,E,Z)-11-Hydroxymethyl-3, 7, 15-trimethyl-2, 6 10, 14-hexadecatetraen-1-ol   
 
C. salutarys Casar.38  
 
(10E)-3, 12- Dihydroxy-3, 7, 11, 15-tetramethyl-1, 10, 14-hexadecatrien-5, 13-dione 
Author did not determine configuration at other chiral centres. 
 
C. sublyratus Kurz,39 renamed as C. stellatopilosus.40 
 
(E,Z,E)-7-Hydroxymethyl-3, 11, 15-trimethy-2, 6, 10, 14-hexadecatetraen-1-ol (plaunotol) 
Treatment of peptic ulcer.39,41 
C. zambesicus Muell. Arg.42 
 
(E)-3,7R,11R,15-Tetramethylhexadec-2-en-1-ol (trans-phytol) 
 
 
 
 
12 
 
Table 2.4: Examples of cyclic diterpenoids isolated from the Croton genus and some of 
their biological activities. 
Name of class Source and compounds isolated 
Labdane C. oblongifolius Roxb.43  
 
C1: 2α-acetoxy-3β-hydroxy-labda-8(17),12(E), 14-triene 
C2: 3β-acetoxy-2α-hydroxy-labda-8(17),12(E), 14-triene 
C3: 2α,3β-dihydroxy-labda-8(17),12(E),14-triene  
C4: 2α,3β-diacetoxy labda-8(17),12(E),14-triene. 
C3 showed moderate cytotoxicity against non-specific human cell lines.43 
        R1 R2     
C1   Ac H          
C2   H Ac 
C3   H H 
C4   Ac Ac 
 
C. stipuliformis.44 
 C1                C2 
C1: ent-12,15-dioxo-8,13-labdadien-3α-ol  
C2: ent-12,15-epoxy-3,4-seco-4,8,12,14-labdatetraen-3-oic acid 
Halimane C. crassifolius 45 
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Name of class Source and compounds isolated 
Crassifoliusin A                                                       Chettaphanin I         
Clerodane 
 
C. cajucara.34 
                                       
Trans-dehydrocrotonin                                                     Trans-crotonin      
Showed high activity against promastigotes and axenic amastigotes of Leishmania 
amazonenesis.34 
C. yanhuii.46 
                                              
Crotonpene A                                                                    Crotonpene B 
Increase Nerve growth factor (NGF)-mediated neurite outgrow from PC12.46 
Abietane  C. caudatus Geisel var. tomentosus Hook.47  
                            
  Crotontomentosin A                                                       Crotontomentosin B     
14 
 
Name of class Source and compounds isolated 
                             
 Crotontomentosin C                                                         Crotontomentosin D        
Showed moderate to weak activity against Hela, Hep G2 and MDA-MB-321 cancer cell lines.47 
Isopimarane C. zambesicus Muell. Arg.42 
 
Isopimara-7,15-dien-3β-ol 
Showed weak cytotoxicity against Hela, human cervix, carcinoma and HL-60, human 
promyelocytic leukemia cell lines.42 
Casbane C. nepetaefolius stalks.48 
 
(E, E, E)-1β,4β-Dihydroxy-2,6,12-trien-5-one-casbane 
Showed control on the biofilm formation of the some types of bacteria and Candida species.48 
15 
 
Name of class Source and compounds isolated 
Crotofolane  C. argyrophyllus.49 
  
 
C1: 5β,6β : 13,16-diepoxycrotofola-4(9),10(18),13,15-tetraen-1-one 
C2: 5β,6β : 13,16-diepoxy-2-epicrotofola-4(9),10(18),13,15-tetraen-1-one 
C3: 5β,6β : 13,16-diepoxy-16-hydroxycrotofola-4(9),10(18),13,15-tetraen-1-one 
C4: 5β,6β : 13,16-diepoxy-16-hydroxy-2-epicrotofola-4(9),10(18),13,15-tetraen-1-one 
 
 R1 R2 R3 
C1: Me H H 
C2: H Me H 
C3: Me H OH 
C4: H M OH 
C. cascarilloides Rauschel.50 
  
Crotocascarin B    
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Table 2.5: Examples of sesquiterpenes isolated from the Croton genus and some of their 
biological activities 
Source and compounds isolated 
C. caudatus Geisel var. tomentosus Hook.47 
 
5-Epi-eudesm-4(15)-ene-1β,6β-diol     
C. crassifolius Geisel.22 
                                     
Cyperenoic acid                   (4S,7R,8R,10S)-8-Hydroxy-α-guaiene              (+)-Guaia-l(10),ll-dien-9-one 
Anti-angiogenic activity 
C. muscicarpa Müll.51 
                    
6α-Methoxycyperene                                  Ent-Spathulenol 
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Table 2.6: Examples of flavonoids isolated from the Croton genus 
Source and compounds isolated 
C. muscicarpa Müll.51 
 
 
 R1 R2 R3 R4 R5 R6    
C1 CH3 H CH3 H CH3 O CH3 
C2 CH3 H CH3 H CH3 H 
C3  H H CH3 H CH3 OH 
C4  CH3 H CH3 H H O CH3 
C5 H H H H H H 
C6 CH3 O CH3 CH3 OH CH3 H 
C7 CH3 O CH3 CH3 H CH3 H 
C8 CH3 OCH3 CH3 O CH3 CH3 H 
C1: retusin   C2: 3,7,4'-trimethyl ether kaempferol  C3: 4',7-dimethyl ether quercetin   C4: 3,3',7-trimethyl ether   
quercetin   C5: kaemferol   C6: casticin   C7: 4'-methyl ether penduletin   C8: artemetin 
C. lechleri L.52 
 
 
 
Procyanidin β-l  
 R1 R2 
Catechin β-OH H 
Gallocatechin β-OH OH 
Epicatechin α-OH H 
Epigallocatechin  
 
 
 
α-OH 
 
 
OH 
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Table 2.7: Examples of alkaloids isolated from the Croton genus and some of their 
biological activities 
Source and compounds isolated 
C. echinocarpus Bill.53 
 Showed anti-HIV activity.53 
 
 R1 R2 R3 
Corydine CH3 OCH3 H 
Norisoboldine H H OH 
C. hemiargyreus.54 
 
Hemiargyrine  
C. pullei var. glabrior Lanj.55 
 
  R      
Julocrotine CH3CHCH2CH3 
Crotonimide A CH2CH3 
Crotonimide B 
 
 
 
 
CH3CHCH3 
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 The biosynthesis of terpenoids 
The terpenoids are a large family of natural products derived from C5 isoprene units joined in 
a head-to-tail fashion [Figure 2.1].56  Chemical modification of the carbon skeleton produces 
hemiterpenes (C5), monoterpenes (C10), sesquiterpenes (C15), diterpenes (C20), 
sesterterpenes (C25), triterpenes (C30) and tetraterpenes (C40) [Figure 2.2].56  In addition, 
many natural products contain terpenoid elements in their molecules in combination with 
products of the acetate and shikimate pathways, for example, in the cannabinoids.56  The 
head-to-tail fashion is not the only way for terpenoid linkage, cyclisation may occur via a tail-
to-tail linkage such as in squalene where two C-15 units are linked tail to tail [Figure 2.1].56 
 
Figure 2.1: Structures of terpenes showe isoprene units56 
The isoprene unit, the building block of terpenoids, is formed from dimethylallyl diphosphate 
(DMAPP) and isopentenyl diphosphate (IPP).56  The biochemical isoprene units may be 
derived by two pathways, the mevalonate pathway (MVA) and the deoxyxylulose phosohate 
(DXP) (mevalonate-independent pathway), which is probably more used in nature than the 
mevalonate pathway.56  The process starts from combination of IPP and DMAPP via the 
enzyme prenyl tranferase to yield geranyl diphosphate (GPP) the precursor from which 
various terpenes are derived [Scheme 2.1].56   
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 Figure 2.2: Type of terpenes.56 
 
 
Scheme 2.1: Biosynthetic of geranyl diphosphate (GPP)56 
2.2.4.1 Biosynthesis of sesquiterpenes 
A combination between a C5 IPP unit and GPP yields farnesyl diphosohate (FPP) from 
which sesquiterpenes are derived.56  The position of the double bond nearest the phosphate 
can give the E configuration like in FPP, or the Z configuration such as in nerolidyl PP 
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[Scheme 2.2].56  The different configurations of precursor give different possibilities of 
folding the carbon chain.  Scheme 2.3 shows some common sesquiterpene structures.56     
 
 
Scheme 2.2: Biosynthetic of different cofigurations of farnesyl diphosphate (FPP).56 
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Scheme 2.3: Biosynthetic of a selection of sesequiterpenoids.56,57 
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2.2.4.2 Biosynthesis of diterpenes 
The precursor of diterpenes is geranylgeranyl diphosphate (GGPP).  GGPP is formed by 
adding an IPP unit to FPP [Scheme 2.4].56  Loss of the pyrophosphate group leads to 
carbocation formation, which is followed by cyclisation and Wagner-Meerwein 
rearrangements to form the cyclic diterpenoids.56 
As clerodane, halimane and crotofolane diterpenoids have been isolated in this study, their 
mechanism of formation is discussed.   
 
 
Scheme 2.4: Biosynthetic of geranylgeranyl diphosphate (GPP)56 
The biosynthesis of crotofolene starts with the loss of the diphosphate from GGPP to form a 
carbocation and then generate a cembrene dierpenoid.56  A 2,15-cyclization of cembrene 
produces the casbene diterpentoid skeleton, followed by 6,10-cyclization to from lathyrene 
that undergoes 5,13 cyclization to yielded jatropholene.58 56  The opening of the C-14/C-15 
cyclopropane ring of jatropholene produces crotofolene, while the cleavage of the C-1/C-15 
bond leads to isocrotofolene [Scheme 2.5].58 
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Scheme 2.5: Possible biosynthetic pathway for crotofolene.56,58 
The labdanes are an important cyclic diterpenoid class from which other classes can derive.  
The formation of labdane starts, like many other diterpenes, by protonation of GGPP.  The 
protonation of the C-14 double bond generates a carbocation and starts the cyclization 
sequence.  The cyclization process is terminated by the loss of a proton from a C-19 methyl 
to from a double bond and give the trans-decalin intermediate.  This intermediate product 
undergoes folding to form two bicyclic enantiomers (+)-copalyl PP (labdadienyl PP) and   
(-)-copalyl PP, which are the major intermediates that lead to the formation of various cyclic 
diterpenes [Scheme 2.6].56  Reduction and further enzyme modifications of (+)-copalyl PP 
and (-)-copalyl PP give the labdane and ent-labdane series respectively.59  The two 
enantiomers differ in the configuration at the C-5, C-9 and C-10 chiral centres.  The two 
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clerodane diterpene enantiomers and their cis- and trans-isomers are generated from two 
methyl migrations. [Scheme 2.6].59-62 
Halimane diterpenes also are derived from labdane by a 1,2-hydride shift from C-9 to C-8 
followed by a 1,2-methyl shift from C-10 to C-9 to produce a C-10 carbocation and 1,2 
hydride shift from C-5 to C-10 gives a C-5 carbocation, which is followed by a methyl shifts 
[Scheme 2.6].61,62   
2.2.4.3 The biosynthesis of triterpenoids 
A combination of two molecules of farnesyl PP (FPP) that are linked tail to tail, gives  the 
hydrocarbon squalene from which triterpenoids are derived.  O2 and NADPH cofactors are 
required for cyclization of squalene via squalene-2,3-oxide.  Folding of squalene oxide on 
the enzyme surface produced a series of cyclization, followed by a sequence of Wagner-
Meerwein migrations of methyls and hydrides.  Depending on the stereochemistry of this 
cation (squalene oxide), different transient cations will be produced, for example protosteryl 
cation and the dammarenyl cation.  These cations undergo a sequence of Wagner-Meerwein 
1,2-shifts, and loss of protons to form different triterpenoid structures like cycloartenol, 
euphol and β-amyrin.56 
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Scheme 2.6: Biosynthetic pathway of clerodane and halimane diterpenes.59-62 
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Scheme 2.7: Biosynthetic pathway of Triterpenoids56 
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 The chemistry of Croton dichogamus Pax 
 C. dichogamus Pax  
Croton dichogamus is a tree with a pyramidal crown or shrub, the leaves are usually 
glabrous, membranous, covered with silvery scales and the upper surface is yellowish-
brown.63  The flowers are monoecious, the flower stamens have six sepals and twenty 
stamens; the flower pistils have five sepals, petals are absent, segments are glabrous and 
linear, styles are bipartite and the ovary is covered with round membranous scales [Picture 
2.1].63  The plant has been recorded to occur in Ethiopia, Kenya, Madagascar, Mozambique 
Tanzania and Somalia.64,65 
  
Picture 2.1: Tree and leaves of C. dichogamus.66  
 Ethnobotany and biological screening of C. dichogamus Pax species 
C. dichogamus has been used as a dietary additive to milk or meat soup by the Maasai and 
Batemi of Kenya and Tanzania respectively.  This species is known as “Mhand” in Tanzania, 
and it has been used there to cure respiratory disease, by inhalation of smoke of the plant 
leaves.67  Moreover, this plant has been used to treat chest complaints, malaria and stomach 
upset in Samburu (Kenya), where it is commonly known as “l-akirding’ai”,68 while in another 
part of Kenya, the Loitoktok district, it is known as “Oloibor benek”, and it is used to treat 
arthritis and gonorrhea.69  
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However, pharmacological studies have shown that the crude extracts of the rootbark, 
stembark and leaves of C. dichogamus do not show significant antifungal, antibacterial and 
nematicidal activities.70  The essential oil of the species did not shown insecticidal activity 
against Anopheles gambiae.71  
 Chemical constituents of the C. dichogamus Pax species 
C. dichogamus has been reported to have 6.8 and 5.1 mg/g dry weight of total phenolic and 
tannin content respectively.72  However, the chemical constituents of C. dichogamus have not 
been examined since Jogia et al. (1989), who identified two new crotofolane diterpenoids: 
crotoxide A and crotoxide B [Figure 2.3] from the leaves of the species collected in Kenya.73  
 
 
Crotoxide A 
 
Crotoxide B 
Figure 2.3: Compounds isolated previously from the leaves of C. dichogamus 
 Results and discussion  
Four known sesquiterpenoids, 4-patchoulene (CD.1), patchoulen-3-one (CD.2), cadin-
1(6),2,4,7,9-penta-ene (CD.3) and 1(6),7,9-cadinatriene-4α,5β-diol (CD.4) with one new 
enantiomer 1,3,5-cadinatriene-7R,10S-diol (CD.5), four known ent-clerodane diterpenoids, 
15,16-epoxy-13(16),14-ent-clerodadien-3-on (CD.6), 15,16-epoxy-4(18),13(16),14-ent-
clerodatrien-3-ol (CD.7), 15,16-epoxy-3-keto-3(16),14-ent-clerodadien-17,12S-olide (CD.8) 
and 15,16-epoxy-3,4-dihydroxy-3(16),14-ent-clerodadien-17,12S-olide (CD.9), two new 
halimane diterpenoids, 15,16-epoxy-5,13(16),14-ent-halimatriene-3-ol (CD.10) and 15,16-
epoxy-3-hydroxy-5(10),13(16),14-ent-halimatriene-17, 12S-olide (CD.11), one known 
crotofolane diterpenoid crotohaumanoxide (CD.12), two new crotofolane diterpenoids, 
crotodichogamoin A (CD.13) and crotodichogamoin B (CD.14) and one known triterpenoid, 
acetyl aleuritolic acid (CD.15), were isolated from the roots extract of C. dichogamus 
[Figure 2.4].  The following section will describe the structural elucidation of these 
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compounds.
 
Figure 2.4: Compounds isolated from the roots extract of C. dichogamus 
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 Structure elucidation of Compound CD.1: 4-patchoulene (cyperene)    
(Appendices 1-11) 
 
Figure 2.5: Structure of compound CD.1: 4-patchoulene (cyperene) 
Compound CD.1 was isolated as a white oil from the dichloromethane extract of the roots of 
C. dichogamus.  This compound was found to be the known 4-patchoulene, previously 
isolated from Cyperus rotundus L (Cyperaceae),74 and a constituent of the essential oils of 
African Croton zambesicus,75 and many South American Croton species.76 
 
The GC-MS for compound CD.1 showed a molecular ion peak at at m/z 204.3 which 
indicated a molecular formula of C15H24 for the compound.  A double bond equivalence of 
four was calculated.  The FTIR spectrum showed the presence of absorption bands at 2923 
and 2853 cm-1 that were attributed to C-H aliphatic stretches, 1459 and 1379 cm-1 for 
methylene and methyl C-H bending respectively.77 
 
The 13C NMR and DEPT spectra showed fifteen carbon resonances including two methine, 
five methylene, four methyl group and four quaternary carbon resonances at δC 127.9 and δC 
142.4 for a double bond, δC 65.8 for spirocyclic carbon and δC 41.6 [Figure 2.5 and Table 
2.8]. A double bond accounted for one of the four units of double bond equivalence 
suggesting that this compound was a tricyclic sesquiterpenoid.   
 
The use of 2D-NMR spectra to solve the structure of this compound was not straight forward 
therefore the CSEARCH/NMR PREDICT–SERVER was employed to propose the structure 
of CD.1.  The server is a 13C NMR spectral similarity search tool, which is based on over 
seventy-four million predicted 13C NMR spectra for PUBCHEM-structures.   
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The CSEARCH/NMR PREDICT–SERVER proposed that the 13C NMR spectroscopic data 
for compound CD.1 were similar with those of the known 4-patchoulene.78  A comparison of 
the reported 13C NMR data and those of CD.1 is shown in Table 2.8. 
 
The spirocyclic carbon resonance at c 65.8 was assigned as C-1 as it showed correlations 
with three methyl groups proton resonances at δH 0.76 (3H-12), δH 0.94 (3H-13) and δH 0.80 
(3H-14, J = 6.2 Hz), one methine proton resonance at δH 1.94 (H-10), the 2H-2 (δH 1.62, 
1.39) resonances, and one of the H-9 resonances at δH 1.41 (H-9β) and 2H-3 at δH 2.18, in the 
HMBC spectrum.  The two fully substituted olefinic carbon resonances δC 127.9 (C-4) and δC 
142.4 (C-5) were assigned due to their correlations in the HMBC spectrum with the 2H-2 (δH 
1.62, 1.39) resonances, one of the H-3 (δH 2.18) and 2H-6 (δH 2.18) resonances, H-7 (δH 1.85) 
resonance, and the 3H-15 (δH 1.62) resonance.  The doublet methyl group proton resonances 
at δH 0.80 (3H-14) showed correlations in the HMBC spectrum with carbon resonances at δC 
35.5 (C-10), δC 28.5 (C-9) and δC 65.8 (C-1).  The two singlet methyl group proton 
resonances at δH 0.94 (3H-13) and δH 0.76 (3H-12) displayed correlations in the HMBC 
spectrum with each other’s carbon resonances, with two fully substituted carbon resonances 
at δC 41.6 (C-11), δC 65.8 (C-1) and methine group carbon resonances at δC 48.9 (C-7).  The 
third singlet methyl group proton resonances at δH 1.62 (3H-15) was assigned as C-15 due to 
its correlations with two fully substituted olefinic carbon resonances δC 127.9 (C-4) and δC 
142.4 (C-5), and with the methylene carbon resonance at δC 42.5 (C-3), in the HMBC 
spectrum. 
 
The COSY spectrum showed coupling between  The 3H-14 (δH 0.80) resonance and the H-10 
(δH 1.94) resonance.  The H-10 (δH 1.94) resonance showed coupling with the 2H-9 (δH 1.08, 
1.41) resonances, which showed further coupling with the 2H-8 (δH 1.85, 1.27) resonances.  
The H-7 (δH 1.85) resonance showed coupling in the COSY spectrum with proton resonances 
at δH 1.27 (H-8β) and δH 2.18 (H-6α).  The 2H-2 (δH 1.39 and 1.62) proton resonances were 
seen to be coupled with 2H-3 (δH 2.62 and 2.18) resonances, in the COSY spectrum.   
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The NOESY spectrum, run in acetonitrile, was used to confirm the relative configuration of 
CD.1.  The H-10 (δH 1.94, hept, J=6.2) resonance showed correlation in the NOESY 
spectrum with the 3H-12 (δH 0.76) and one of the H-9 resonances at δH 1.41, which showed a 
further correlation with one of the H-8 resonances at δH 1.27 resonance.  All these protons 
(H-10, H-9β and H-8β) were assigned as β.  The H-7 resonances (δH 1.85) showed 
correlations with the 3H-14 (δH 0.80) and one of the H-2 (δH 1.62) resonances, 2H-6 (δH 2.18) 
and 2H-9 (δH 1.08) in the NOESY spectrum.  All these protons (3H-14, H-7, H-2α, H-6α, H-
9α) were assigned as α. 
NMR analysis of compound CD.1 after storing the sample in the fridge for about two months 
showed that the compound had been converted to compound CD.2.  Thus, an optical rotation 
could not be measured.  
 
Table 2.8: NMR data for compound CD.1: 4-patchoulene (cyperene) against literature 
reference values 
No. 
13C NMR (125 
MHz) CDCl3 
13C NMR(25.2 
MHz) CDCl378 
1H NMR (500 
MHz) 
CDCl3 
HMBC (H→C) COSY NOESY** 
1 65.8 C 
 
65.6 - - - - 
2α 26.5 CH2 26.3 1.62* m 1, 3, 4, 5, 10, 11 2α, 3α, 3β 2β, 3α, 3β, 
6α, 7 
2β 1.39 m 1, 3, 4, 5, 10 2α, 3α 2α, 3α 
3α 42.5 CH2 
 
42.3 2.62 m  2α, 2β, 3β 2α, 3β 
3β 2.18* m Hz 1, 2, 4, 5 2α, 3α 2α, 3α 
4 127.9 C 127.5 - - - - 
5 142.4 C 142.0 - - - - 
6α 27.7 CH2 27.5 2.18* m  4, 5, 7, 8 6β, 7 2α, 3α, 6β 
6β 1.77 m - 6α 6α, 3α 
7 48.9 CH 48.5 1.85* m 5, 6, 8, 9, 11 8β, 6α 2α, 6α, 9α, 
14 
8α 28.0 CH2 27.8 1.85* m 6, 7, 9, 10, 11 8β, 9α,9β 2α, 8β, 9α 
8β 1.27 m 6, 7, 9, 10, 11 7, 8α, 9α 8α, 9α, 9β 
9α 28.5 CH2 
 
28.3 1.08 m 8, 10, 14 8α, 8β, 9β, 10 7, 8α, 9β 
9β 1.41 m 1, 7, 8, 10 8α, 9α, 10 8β, 9α, 10 
10 35.5 CH 35.3 1.94 hept J=6.2 Hz 1, 8, 9, 11, 14 9α, 9β, 14 9β, 12 
11 41.6 C 41.3 - - - - 
12 26.3 CH3 26.1 0.76 s 1, 7, 11, 13  10, 15 
13 19.6 CH3 18.3 0.94 s 1, 7, 11, 12  14, 15 
14 18.2 CH3 18.0 0.80 d J=6.2 Hz 1, 9, 10  7, 13 
15 14.4 CH3 14.1 1.62* s 3, 4, 5  12, 13 
* Refer to overlapped proton resonances  
** In acetonitrile solvent 
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 Structure elucidation of Compound CD.2: 4-patchoulen-3-one (cyperotundone) 
(Appendices 12-18) 
.  
Figure 2.6: Structure of compound CD.2: 4-patchoulen-3-one (cyperotundone) 
Compound CD.2 was determined to be an air oxidation product of CD.1.  CD.2 had also 
been isolated as a white oily material from the methanol extract of the roots of C. dichogamus 
by a visiting Kenyan PhD student, Beth E. Ndunda.  This compound was found to be the 
known 4-patchoulen-3-one, previously isolated from Cyperus rotundus L (Cyperaceae)79 and 
not from any Croton species. 
GC-MS analysis showed that the compound had decomposed and no M+ could be found.  The 
FTIR spectrum showed the presence of absorption bands at 2925 and 2861 cm-1 that were 
attributed to C-H aliphatic stretches, 1710 cm-1 for carbonyl group stretches and 1461 and 
1379 cm-1 for methyl and methylene C-H bending respectively. 
 
The 13C NMR and DEPT spectra showed fifteen carbon resonances including two methine, 
four methylene and four methyl group carbon resonances and five quaternary carbon 
resonances at δC 133.6 and 181.9 for double bond carbon resonances, δC 211.0 for a carbonyl 
carbon resonance and at δC 58.9 characteristic of a spirocyclic carbon [Table 2.9 and Figure 
2.6].   
 
The NMR spectra indicated that CD.2 was a similar compound to CD.1, except for the 
absence of the one methylene carbon resonance and present one ketone group resonance at δC 
211.0 in the CD.2.  Since this ketone group resonance displayed correlations in the HMBC 
spectrum, with the 2H-2 (δH 2.15 and 2.01) and 3H-15 (δH 1.70) proton resonances, it was 
placed at C-3.  This was confirmed using the CSEARCH/NMR PREDICT–SERVER.  The 
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compound was identified as 4-patchoulen-3-one.79  A comparison of the reported 13C NMR 
data and those of CD.2 is shown in Table 2.9. 
 
The relative configuration of compound CD.2 was the same as for Compound CD.1.  In the 
NOESY spectrum, the 3H-14 (δH 0.61) proton resonance showed correlations with the both 
H-7 (δH 1.95) and 2H-2 (δH 2.15 and 2.01) resonances, they were assigned as α.  The H-10 
(δH 2.31) resonances showed correlations with the 3H-12 (δH 1.10) resonances, and were 
assigned as β.   
Table 2.9: NMR data for compound CD2: 4-Patchoulen-3-one (cyperotundone) in 
CDCl3 compared against literature reference values 
No. 
13C 
NMR(125 
MHz) 
CDCl3 
13C NMR(125 
MHz) CDCl379 
1H NMR (500 
MHz) 
CDCl3 
HMBC (H→C) COSY NOESY** 
1 58.9 C  58.7 - - - - 
2α 41.4 CH2 41.1 2.15 d J = 17.4 
Hz 
1, 3, 4, 5, 10, 11 2β, 14 7, 9α, 14 
2β 2.01 d J = 17.4 
Hz 
1, 3, 5, 10, 11 2α 14 
3α 211.0 C 210.9 - - - - 
4 133.6 C 133.4 - - - - 
5 181.9 C 181.6 - - - - 
6α 30.7 CH2 30.5 2.59 dd J = 6.0, 
18.6 Hz 
4, 5, 8 6β, 7 6β, 7 
6β 2.30 m 4, 5, 7, 8, 11 6α 6α, 9β 
7 45.6 CH 48.4* 1.95 m 5, 6, 8, 9, 11 6α, 8β 2α, 6α, 9α, 
14 
8α 27.2 CH2 27.0 1.95 m 6, 7, 9, 11 8β. 9α, 9β 9α, 14 
8β 1.41 m 6, 7, 9, 10, 11 8α, 9α - 
9α 28.6 CH2 28.4 1.03 m 8, 10, 14 8α, 9α, 9β 2α, 7, 8α 
9β 1.59 m 1, 7, 8, 10 8α, 9α, 10 6β, 10 
10 34.0 CH 33.7 2.31 m 2, 8, 9, 11 9β 9β, 12 
11 41.8 C 41.7 - - - - 
12 19.8 CH3 19.6 1.10 s 1, 7, 11, 13 - 10 
13 25.1 CH3 24.8 0.74 s 1, 7, 11, 12  - 
14 17.1 CH3 16.8 0.61 d J = 6.5 Hz 1, 9, 10 2α 2α, 2β, 7, 
8α 
15 8.6 CH3 8.3 1.70 s 3, 4, 5 - - 
*This appears to be an error 
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 Structural elucidation of compound CD.3: cadin-1(6),2,4,7,9-penta-ene (cadalene) 
(Appendices 19-27)  
 
Figure 2.7: Structure of compound CD.3: cadin-1(6),2,4,7,9-penta-ene (cadalene) 
 
Compound CD.3 was isolated as a white oily compound from the dichloromethane extract of 
the roots of C. dichogamus and was found to be the known sesquiterpenoid called cadin-
1(6),2,4,7,9-penta-ene, which was the first aromatic cadinane to be identified.80  Compound 
CD.3 has been isolated previously from many sources such as Boenninghausenia albiflora 
Reichb (Rutaceae),81 Siparuna macrotepala Led (Monimiaceae),82 and in the identified 
volatile constituents of the leaves of Croton sellowii Baill and stem bark of Croton 
stipuliformis by GC/MS.83,84 
 
The GC-MS for compound CD.3 showed a molecular ion peak at m/z 198.2 which indicated 
a molecular formula of C15H18.  The GC-MS spectrum showed fragment ions at m/z 183.1, 
168.1 and 153.1 [M-15, M-30 and M-45] + for the loss of one, two and three CH3 fragments 
respectively.  A double bond equivalence of seven was calculated.  The FTIR spectrum 
showed the presence of absorption bands at 2925 and 2854 cm-1 attributed to C-H aliphatic 
stretches, 1601 cm-1 for C=C stretching in an aromatic ring and 1455 cm-1 for methyl 
bending.77 
 
The 13C NMR spectrum displayed fourteen carbon resonances, including four methyl, six 
methine, and five fully substituted carbon resonances.  1H NMR spectrum revealed two 
singlet proton resonances at δH 2.56 (3H-15) and 2.64 (3H-14) for methyl groups, and 
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resonances at δH 1.38 (6H, d, J= 6.9 Hz, 3H-12 and 3H-13) and δH 3.72 (H, hept, J= 6.9 Hz) 
due to protons of an isopropyl group [Figure 2.7 and Table 2.10]. 
The 1H and 13C NMR spectra also displayed sets of aromatic proton resonances at δH 7.92 (d, 
J= 8.5 Hz, H-2), δH 7.90 (H-5), δH 7.35 (H, d, J= 8.5 Hz, H-3), and δH 7.28 (H, d, J= 7.2 Hz, 
H-8) and δH 7.22 (H, d, J= 7.2 Hz, H-9), which corresponded in the HSQCDEPT spectrum to 
five aromatic carbon resonances at δC 125.0, 123.1, 127.4, 121.6 and 125.8 respectively. 
 
The H-5 (δH 7.90) resonance showed correlations, in the HMBC spectrum, with the aromatic 
carbon resonances at δC 131.3 (C-1), δC 127.4 (C-3), δC 134.9 (C-4), δC 131.7 (C-6), δC 142.3 
(C-7) and one methyl group at δC 22.3 (C-15).  The HMBC spectrum showed correlations 
between the 3H-14 resonance at δH 2.64 and the carbon resonances at δC 131.3 (C-1), δC 
125.8 (C-9) and δC 132.1 (C-10).  The other singlet methyl group proton resonance at δH 2.56 
(3H-15) was assigned as C-15 due to its correlations with the carbon resonances at δC 127.4 
(C-3), δC 134.9 (C-4) and δC 123.1 (C-5) in the HMBC spectrum.  The isopropyl group was 
placed at C-7 based on HMBC correlations between the doublet methyl group proton 
resonance δH 1.38 (3H-12+3H-13) and the aromatic carbon resonance at 142.3 (C-7) and the 
carbon resonances at δC 28.4 (C-11) [Figure 2.8]. The NMR data were in agreement with the 
literature values.82 
 
 
Figure 2.8: The HMBC correlations seen in compound CD.3: cadalene 
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Table 2.10: NMR data for compound CD.3: cadalene in CDCl3 compared against 
literature reference values 
 
 
 
13C NMR(125 
MHz) CDCl3 
13C 
NMR(50 
MHz) 
CDCl3 82 
1H NMR (500 
MHz) 
CDCl3 
HMBC (H→C) COSY 
NOESY 
1 131.3 C 129.2 - - - - 
2 125.0 CH 125.3 7.92 
d J=8.5 Hz 
1, 3, 4, 6, 10 3 3, 14 
3 127.4 CH 127.7 7.35 d J=8.5 Hz 1, 5, 15 2 2, 15 
4 134.9 C 135.2 - - - - 
5 123.1 CH 123.4 7.90 s 1, 3, 4, 6, 7, 15 - 11, 15 
6 131.7 C 131.6 - - - - 
7 142.3 C 142.6 - - - - 
8 121.6 CH 121.9 7.28 d J=7.2 Hz 6, 10, 11 9 12, 13 
9 125.8 CH 126.1 7.22 d J=7.2 Hz 1, 7, 8 8 14 
10 132.1 C 132.3 - - - - 
11 28.4 CH 28.7 3.72 hept J=6.9 
Hz 
6, 7, 8, 12, 13 12, 13 5, 12, 13 
12 23.9 CH3 24.1 1.38 d J=6.9 Hz 7, 11, 13 11 8, 11 
13 23.9CH3 24.1 1.38 d J=6.9 Hz 7, 11, 12 11 8, 11 
14 19.7 CH3 44.3* 2.64 s 1, 9, 10 - 2, 9 
15 22.3 CH3 22.6 2.56 s 3, 4, 5 - 3, 5 
*Value showed by author must be an error as methyl groups do not occur so far downfield 
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 Structural elucidation of compound CD.4: 1(6),7,9-cadinatriene-4α,5β-diol (trans-
4,5-dihydroxycorocalane; 4α,5β-corocalanediol) (Appendices 28-36)  
 
Figure 2.9: Structure of compound CD.4: 1(6),7,9-cadinatriene-4α,5β-diol 
Compound CD.4 was isolated as a white oily compound from the dichloromethane extract of 
the roots of C. dichogamus and was found to be the known sesquiterpenoid 1(6),7,9-
cadinatriene-4α,5β-diol.  It has been isolated previously from Juniperus formosana var. 
concolor Hay (Cupressaceae).85   
 
The GC-MS for compound CD.4 showed a molecular ion peak at m/z 234.2 which indicated 
a molecular formula of C15H22O2 for the compound.  Peaks were seen at m/z 216.2 and m/z 
198.2 resulting from loss of one and two units of water respectively.  A double bond 
equivalence of five was calculated for this compound.  The FTIR spectrum showed 
absorptions bands at 3414 cm-1 for an OH stretch, 2920 and 2857 cm-1 for C-H aliphatic 
stretches, 1631 cm-1 for C=C stretching and 1460 and 1379 cm-1 for methyl and methylene 
bending respectively.77  
 
The 1H NMR spectrum displayed a pair of non-first order, ortho-coupled proton resonances 
at δH 7.15 (d, J = 8.0 Hz, H-8) and δH 7.14 (d, J = 8.0 Hz, H-9), one isopropyl group shown 
by resonances at δH 1.23 (d, J= 6.9 Hz, 3H-12), δH 1.30 (d, J= 6.9 Hz, 3H-13) and δH 3.45(H, 
sep, J= 6.9 Hz, H-11), a singlet oxymethine group proton resonance at δH 4.55 (H-5) and two 
singlet methyl group proton resonances at δH 2.22 (3H-14) and 1.49 (3H-15) [Figure 2.9 and 
Table 2.11]. 
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The two doublet methyl group proton resonances of an isopropyl group were assigned as 3H-
12 and 3H-13 due to the correlations seen in the HMBC spectrum with carbon resonances at 
δC 147.0 and 27.9 that were attributable to C-7 and C-11 respectively.  The HMBC spectrum 
showed also correlations between the 2H-3 (δH 1.84 and δH 2.09) and the oxygenated fully 
substituted carbon resonance C-4 (δC 71.3), the C-5 (δC 71.2) oxygenated methine carbon 
resonance and a singlet methyl group carbon resonance, C-15 (δC 27.7). 
 
The COSY spectrum confirmed the assignment of 2H-2, 2H-3 and the isopropyl group (H-11, 
3H-12 and 3H-13) as it showed coupling between the 2H-2 (δH 2.75) resonance and the 2H-3 
(δH 1.84 and 2.09) resonances, and between H-11(δH 3.45) and 3H-12 (δH 1.23) and 3H-13 
(δH 1.30) resonances.  The NOESY spectrum showed correlations between the H-5 (δH 4.55) 
resonance and H-11 (δH 3.45) and 3H-15 (δH 1.49) resonances and between the 2H-2 (2.75) 
resonance and 3H-14 (2.22) resonance.   
 
A search in the Dictionary of Natural Products (DNP) for this compound indicated two 
compounds cis-4,5-dihydroxycorocalane (CD.4A) and trans-4,5-dihydroxycorocalane 
(CD.4B) have been reported [Figure 2.10].85  Kuo and Yu used selective NOESY 
experiments to assign the relative configuration of CD.4A and CD.4B, as they observed a 
correlation between 3H-15 and H-2α in compound CD.4A, but this correlation was not seen 
for CD.4B.85  In addition, they proposed that 1H/13C NMR chemical shifts for 3H-15/C-15 
can be used to distinguish the configuration at C-4.  When 3H-15 is in an axial position, its 
chemical shift is δH 1.14 and when is it in an equatorial position, its chemical shift is δH 1.47.  
Furthermore, the 13C NMR chemical shift of the axially configured C-15 is δC 22.4 and when 
it is equatorially configured, the C-15 resonance is further downfield at δC 27.7. 
 
The NMR data for compoundCD.4 matched the trans-4,5-dihydroxycorocalane compound 
(CD.4B).  The specific rotation for the known compound CD.4B was +1.5 and for isolated 
CD.4 was -10.0.  However, no conclusion can be draw from there different specific rotation.  
The structure of CD.4 was determined to be trans-4,5-dihydroxycorocalane (1(6),7,9-
cadinatriene-4α,5β-diol). 
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Trans-4,5-dihydroxycorocalane (CD.4B) has been reported to show inhibitory effects against 
e HIV-1 replication with an IC50 value of 91.2 µM when tested using a green fluorescent 
protein (GFP) based reporter cell line (HOG.R5).86 
 
  
CD.4A: cis-4,5-dihydroxycorocalane [α]20 D -3.7 CD.4B: trans-4,5-dihydroxycorocalane [α]20 D +1.5 
Figure 2.10: The reported isomeres CD.4A and CD.4B 
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Table 2.11: NMR data for compound CD.4: 1(6),7,9-cadinatriene-4α,5β-diol in CDCl3 compared against literature reference values for cis-4,5-
dihydroxycorocalane (CD.4A) and trans-4,5-dihydroxycorocalane (CD.4B) 
No. 13C NMR(125 
MHz) CDCl3 
13C NMR(75 MHz) 
CDCl3 85 for CD.4B 
13C NMR(75 MHz) 
CDCl3 85 for CD.4A 
1H NMR (500 MHz) 
CDCl3 
1H NMR (500 MHz) 
CDCl3 85 for CD.4B 
1H NMR (500 MHz) 
CDCl3 85 for CD.4A 
HMBC (H→C) COSY NOESY 
1 134.1 C 134.0 133.9 - - - - - - 
2 23.7 CH2 23.5 26.2 2.75 dd J=4.2, 9.5 Hz 2.72 dd J=4.3, 9.3 Hz 2.56 ddd J=6.8, 12.4. 18.0 Hz / 2.82 dd 
J=6.8, 18.0 Hz 
1, 3, 4, 6, 10 3, 3 3α, 3β, 14 
3 28.8 CH2 28.5 30.0 1.84 m 1.82 dt J=4.3, 13.6 Hz 1.76 dd J=6.8, 12.4Hz 1, 2, 4, 5, 15 2, 3 2, 3β 
3 2.09 dt J=9.5, 13.6 Hz 2.05 dt J=9.6, 13.6 Hz 2.07 td J=6.8, 12.4Hz 2, 4, 5 2, 3 2, 3α 
4 71.3 C 71.1 17.1 - - - - - - 
5 71.2 CH 71.0 17.1 4.55 s 4.53 s 4.55 s 1, 3, 4, 6, 7, 15 3 11, 15 
6 132.9 C* 147.4 147.3 - - - - - - 
7 147.6 C* 133.8 133.4 - - - - - - 
8 123.9 CH 123.7 123.5 7.15 d J=8.0 Hz 7.10 d J=8.1 Hz 7.10 d J=8.0 Hz 6, 7, 10, 11 9 13 
9 130.3 CH 130.0 130.1 7.14 d J=8.0 Hz 7.14 d J=8.1 Hz 7.13 d J=8.0 Hz 1, 7, 10,  14, 8 14 
10 134.3 C 132.6 133.1 - - - - - - 
11 27.9 CH 26.5 27.8 3.45 sep J=6.9 Hz 3.42 sep J=6.9 Hz 3.43 sep J=6.8 Hz 6, 7, 8, 12, 13 12, 13 5, 12, 13 
12 25.5 CH3 25.3 23.7 1.23 d J=6.9 Hz 1.21 d J=6.9 Hz 1.19 d J=6.8 Hz 7, 11, 13 11 11 
13 24.2 CH3 24.0 25.4 1.30 d J=6.9 Hz 1.28 d J=6.9 Hz 1.28 d J=6.8 Hz 7, 11, 12, 11 8, 11 
14 19.8 CH3 19.6 19.6 2.22 s 2.20 s 2.17 s 1, 9,  10 - 2, 9 
15 26.7 CH3 27.7 22.4 1.49 s 1.47 s 1.14 s 3, 4, 5 - 5 
*The 13C NMR chemical shifts have been corrected from the literature values by using HMBC and COSY correlation 
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 Structural elucidation of compound CD.5: 1,3,5-cadinatriene-7R,10S-diol             
(10-epi maninsigin D). (Appendices 37-46) .  
 
Figure 2.11: Structure of compound CD.5: 1,3,5-cadinatriene-7R,10S-diol                     
(10-epi maninsigin D) 
Compound CD.5 was isolated as a yellow oily compound from the dichloromethane extract 
of the roots of C. dichogamus and was found to be a new C-10 epimer of maninsigin D.     
Maninsigin D was isolated previously from Manglietia insignis Rehd (Magnoliaceae).87  
 
The HRMS showed a molecular ion peak at m/z 233.1550 for [M-H]+ which indicated a 
molecular formula C15H22O2 for the compound.  A double bond equivalence of five was 
calculated for this compound.  The FTIR spectrum showed absorptions bands at 3485 cm-1 for 
an OH stretch, 2926 and 2857 cm-1 for C-H stretches, 1601 cm-1 for aromatic C=C stretching 
and 1460 and 1375 cm-1 for methyl and methylene bending respectively.77 
  
The 13C NMR spectrum showed six aromatic carbon resonances at δC 120.9 (C-2), δC 122.5 
(C-5), δC 128.2 (C-3), δC 137.5 (C-4), δC 137.6 (C-1) and δC 138.9 (C-6) which indicated the 
presence of one benzene ring.  This accounted for four double bond equivelances.  The 13C 
NMR spectrum also showed two oxygenated quaternary carbon resonances at δC 75.9 (C-10) 
and δC 80.2 (C-7), two aliphatic methylene group carbon resonances at δC 24.4 (C-8) and δC 
30.5 (C-9), four methyl group carbon resonances and one methine group carbon resonance 
[Table 2.12 and Figure 2.11]. 
 
The 1H NMR and the HMBC spectra showed the presence of an isopropyl group as in 
compounds CD.3 and CD.4 due to the presence of two doublet methyl group proton 
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resonances at δH 1.15 (d, J= 6.9 Hz, 3H-12) and δH 1.21 (d, J = 6.9 Hz, 3H-13) and one 
methine proton resonance at δH 2.60 (hept, J = 6.9 Hz, H-11).  The methine proton resonance 
at δH 2.60 (H-11) showed correlations in the HMBC spectrum with the oxygenated 
quaternary carbon resonance at δC 80.2 (C-7), one aromatic carbon resonance at δC 138.9 (C-
6) and one methylene carbon resonance at δC 24.4 (C-8).  The singlet methyl group proton 
resonance at δH 1.64 (3H-14) displayed correlations with an oxygenated quaternary carbon 
resonance at δC 75.9 (C-10), one aromatic carbon resonance at δC 137.6 (C-1) and a 
methylene carbon resonance at δC 30.5 (C-9).  Therefore, the methyl group was placed at C-
14.   
 
The COSY spectrum confirmed the assignment of the ortho-coupled proton resonances at δH 
7.21 (H, d, J= 8.0 Hz) and δH 7.18 (H, d, J= 8.0 Hz) as H-2 and H-3 respectively.  Further 
coupling between the two proton resonances at δH 2.36 and δH 1.49 for 2H-8 and the 
methylene proton resonances at δH 1.59 and δH 2.26 for 2H-9 was also observed in the COSY 
spectrum. 
 
Based on the above 1D and 2D NMR spectroscopic data the structure of this compound was 
proposed to be 1,3,5-cadinatriene-7,10-diol.  Due to the presence of two chiral centres at C-7 
and C-10, there are four possible absolute stereostructures [Figure 2.12].  A search in 
Dictionary of Natural Products (DNP) for this compound indicated that 1,3,5-cadinatriene-
7β,10β-diol (CD.5D, maninsigin D), has been previously reported by Shang et al.87  In order 
to confirm the structure of CD.5, a 13C NMR spectrum was run in CD3OD to compare with 
the literature data of CD.5D (maninsigin D).87  Comparison of 13C NMR chemical shifts of 
the reported compound CD.5D and the isolated one (CD.5) showed differences especially at 
resonances δC 81.6 (C-7), δC 77.3 (C-10) and δC 19.5 (C-14) for CD.5, and δC 73.5, δC 70.1 
and δC 28.8 respectively for CD.5D [Table 2.12].  Shang et al. used ROESY experiments to 
assign the relative configuration of CD.5D, and they found that the 3H-14 and the isopropyl 
groups were cis to each other.  Correlations between the H-11 and 3H-14 resonances of 
compound CD.5D in the ROESY experiment as reported by Shang et al. are given in Figure 
2.13.   
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The relative configuration of the compound CD.5 was assigned using the NOESY 
experiment.  The 3H-14 resonance did not show correlations with the 2H-8 and isopropyl 
group proton resonances (H-11, 3H-12 and 3H-13).  Based on the correlations observed in the 
NOESY spectrum and by use of a model, and the NMR data comparison, the 3H-14 and the 
isopropyl group were trans to each other, whereas Shang et al reported them as cis 
configured.  From Figure 2.12 the absolute stero studies for isolated compound from this 
study would be either CD.5A or CD.5B. 
 
The absolute configuration of compound CD.5 was determined using electronic circular 
dichroism (ECD) studies.  The experimental ECD curve showed negative Cotton effects at 
201 nm (–18.68) and 307 nm (- 4.12) for compound CD.5.  This experimental ECD data was 
compared with the calculated ECD curves for 3,5-cadinatriene-7R,10S-diol (CD.5A) and 
1,3,5-cadinatriene-7S,10R-diol (CD.5B).  Initially, a conformational search was done using 
Spartan14.  A conformer distribution study at ground state with the molecular mechanics 
force fields (MMFF) was undertaken.  MMFF analysis of 3,5-cadinatriene-7R,10S-diol 
(CD.5A) gave 25 conformers, 21 of which were under 3 kcal/mol.  The M0001 (-4.01 
kcal/mol) conformer, which was consistent with NOESY NMR experimental data and had 
Boltzmann distribution of 0.775, was subjected to TDDFT calculations using a B3LYP 
method at 6-311G level built into Gaussian09 software.  MMFF analysis of the 1,3,5-
cadinatriene-7S,10R-diol (CD.5B) gave 24 conformers, 21 of which were under 3 kcal/mol.  
The M0001 (-4.01 kcal/mol) conformer, which had Boltzmann distributions of 0.777, was 
subjected to TDDFT calculations using a B3LYP method at 6-311G level built into 
Gaussian09 software. The calculates ECD curves from both isomers were compared to the 
experimental ECD curve for compound CD.5 [Figure 2.14].  The theoretical ECD curve of 
compound CD.5 was opposite and equal in intensity to that of compound CD.5B and similar 
to the experimental ECD curve for compound CD.5A.  The compound CD.5 was confirmed 
to be 1,3,5-cadinatriene-7R,10S-diol.  The specific rotation for compound CD.5 was 
determined to be -96.0 which differed to that of the reported CD.5D at -9.4.   
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CDA.5: 3,5-cadinatriene-7R,10S-diol, [α]23 D -96.0 
 
  CD.5B: 1,3,5-cadinatriene-7S,10R-diol  
  
CD.5C: 1,3,5-cadinatriene-7R,10R-diol    CD.5D: 1,3,5-cadinatriene-7S,10S-diol, [α]25 D-9.4 
 
Figure 2.12: The four possible absolute stereostructures of compound 1,3,5-
cadinatriene-7,10-diol (CD.5A-CD.5D) 
 
Figure 2.13: ROESY experiment of compound CD.5D reported by Shang et al. (2013) 
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Figure 2.14: The ECD spectrum for calculated compound CD.5A and CD.5B overlaid 
with the CD.5 experimental 
Table 2.12: NMR data for compound CD.5: 10-epi maninsigin D in CDCl3 and CD3OD 
compared against maninsigin D literature reference values 
 
 
 
13C 
NMR(125 
MHz) 
CDCl3 
13C 
NMR(12
5MHz) 
CD3OD 
13C 
NMR(125
MHz) 
CD3OD 87 
1H NMR (500 
MHz) 
CDCl3 
HMBC 
(H→C) 
COSY NOESY 
1 137.6 C 138.9 141.4 - - - - 
2 120.9 CH 121.9 125.1 7.21 d J=8.0 Hz 1, 3, 4, 6, 10 3, - 
3 128.2 CH 129.2 127.7 7.18 d J=8.0 Hz 1, 4, 5, 15 2 - 
4 137.5 C 138.7 136.2 - - - - 
5 122.5 CH 123.4 125.9 7.20 s 1, 3, 4, 6, 7, 
15 
- 11, 12, 
13 
6 138.9 C 140.2 139.5 - - - - 
7 80.2 C 81.6 73.5 - - - - 
8α 24.4 CH2 25.5 26.9 2.36 
ddd J=3.5,9.6 , 
13.0 Hz 
6, 7, 9, 11 8β, 9α, 9β 8β, 11, 
12, 13 
8β 1.49 dt J=3.9, 
12.4 Hz 
7, 9, 10 11 8α, 9α, 9β 8α, 9β 
9α 30.5 CH2 31.6 34.2 1.59 dt J=3.9, 
12.4 Hz 
1, 7, 8 8α, 8β, 9β 9β, 14 
9β 2.26 ddd 
J=3.5,9.6 , 13.0 
Hz 
1, 7, 8, 10, 14 8α, 8β, 9α 9α, 14, 
8β 
10 75.9 C 77.3 70.1 - - - - 
11 30.6 CH 31.7 36.9 2.60 hep J=6.9 
Hz 
6, 7, 8, 12, 13 12, 13 5, 8α, 12 
12 17.1 CH3 17.4 15.0 1.15 d J=6.9 Hz 7, 11, 13 11, 5, 8α, 11 
13 18.7 CH3 19.0 17.5 1.21 d J=6.9 Hz 7, 11, 12 11 5, 8α, 8β 
14 19.3 CH3 19.5 28.8 1.64 s 1, 9, 10 - 9α, 9β 
15 21.9 CH3 21.8 19.9 2.41 s 3, 4, 5 -  
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 Structural elucidation of compound CD.6: 15,16-epoxy-13(16),14-ent-clerodadien-
3-one (trans-cascarillone) (Appendices 47-54) 
 
Figure 2.15: Structure of compound CD.6: 15, 16-epoxy-13(16),14-ent-clerodadien-3-one 
(trans-cascarillone) 
 
Compound CD.6 was isolated as a yellow oily compound from the dichloromethane extract 
of the roots of C. dichogamus and was found to be the known clerodane-type diterpenoid, 
trans-cascarillone.  This compound has been isolated previously from many sources such as 
Croton sonderianus, 88 Croton argyrophylloides (Euphorbiaceae),89 and Stachys rosea 
(Lamiaceae).90 
 
The GC-MS for compound CD.6 showed a molecular ion peak at m/z 302.3 which indicated 
a molecular formula of C20H30O2.  A double bond equivalence of six was calculated for this 
compound.  The FTIR spectrum showed the presence of absorption bands at 2926 cm-1 for C-
H aliphatic stretches, 1740 cm-1 for C=O stretching and 1462 and 1384 cm-1 for methyl and 
methylene bending.77 
 
The 1H NMR spectrum showed that a β-substituted furan ring was present in compound CD.6 
due to proton resonances δH 6.27 (H-14), δH 7.23 (H-16) and δH 7.36 (H-15), which were seen 
to be coupled in the COSY spectrum.  Two singlet proton resonances seen in the 1H NMR 
spectrum at δH 0.75 (3H-19) and 0.77 (3H-20) and two doublet proton resonances at δH 0.86 
(d, J= 6.8 Hz, 3H-17) and 0.90 (d, J= 6.1 Hz, 3H-18) demonstrated the presence of four 
methyl groups [Figure 2.15 and Table 2.13].  
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The 13C NMR spectrum showed twenty carbon resonances, including four carbon resonances 
at δC 111.2 (C-14), δC 125.6 (C-13), δC 138.7 (C-16) and δC 143.1 (C-15) for furan ring 
carbons and one ketone group carbon resonance at δC 213.2 (C-3), which supported a 
clerodane diterpenoid structure.  The carbonyl group and furan ring accounted for four out of 
six units of unsaturation, the remaining two units indicated two more rings.   
 
The ketone group was placed at the C-3 position as it showed correlations with the H-1β (H 
1.97), H-2 (H 2.29), H-2 (H 2.40), H-4 (δH 2.26) and 3H-18 (H 0.90, d, J= 6.1) proton 
resonances in the HMBC spectrum.  The two singlet methyl group proton resonances at δH 
0.75 and δH 0.77 were assigned to 3H-19 and 3H-20 respectively due to their HMBC 
correlations.  The 3H-19 proton resonance showed correlations with the C-4 (C 58.2), C-5 
(C 42.1), C-6 (C 39.5) and C-10 (C 49.1) carbon resonances, in the HMBC spectrum.  In 
addition, the 3H-20 proton resonance showed HMBC correlations with the C-8 (δC 36.8), C-9 
(δC 39.5), C-10 (C 49.1) and C-11 (δC 38.7) carbon resonances. 
 
The COSY spectrum displayed coupling between the doublet methyl group proton resonance 
at δH 0.86 (d, J= 6.8, 3H-17) and the methine proton resonance at δH 1.63 (H-8).  This 
methine proton resonance showed a correlation in the HMBC spectrum with the C-9 (δC 39.5) 
resonance.  Moreover, the other doublet methyl group proton resonances at δH 0.90 (3H-18, d 
J= 6.1) was seen to be coupled with the methine proton resonance at δH 2.26 for H-4, in the 
COSY spectrum.  The HMBC and COSY spectra confirmed the assignment of two methylene 
group carbon resonances at δC 38.7 (C-11) and 18.5 (C-12). 
 
The above NMR spectroscopic data suggested that compound CD.6 was a furanoclerodane 
possessing a keto group at the C-3 position, two methyl groups attached to the C-5 and C-9 
positions and two secondary methyl groups attached to the C-4 and C-8 positions.  This 
information was consistent with the structure of the known cascarillone, previously reported 
from Croton sonderianus.88 and Croton eluteria.  A comparison of the spectroscopic data for 
compound CD.6 with that found in the literature for trans-cascarillone88 showed a difference 
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at the C-3 carbon position which resonated further up field (C 216.6) for the reported trans-
cascarillone, compared to C 213.2 for compound CD.6 [Table 2.13].   
 
In the ROESY spectrum, the H-4 (H 2.26) resonance showed correlations with one H-2 (H 
2.40), the 3H-18 (H 0.90) resonances and a proton resonance at H 1.75 for either, or both, of 
the superimposed H-1 and H-10 resonances.  H-4 did not show a correlation with the 3H-19 
resonance (H 0.75).  The 3H-17 resonances showed correlations with 3H-19 (H 0.75) and 
3H-20 (H 0.77) resonances in the ROESY spectrum.  From the absence of a correlation in the 
ROESY spectrum between the H-4 resonance and 3H-19 resonances in one direction, and 
presence of a correlation between the H-4 and superimposed resonance (H-1 and H-10) and 
H-2β resonances, in conjunction with model, it could be concluded that H-4 was β [Figure 
2.16].  
 
Figure 2.16: ROESY correlations of compound CD.6 
 
To investigate whether electronic circular dichroism (ECD) spectroscopy is useful in 
determined the configuration at C-4 (as there is confusion in the literature) a CD study of the 
different C-4 enantiomers in both the normal and ent series was undertaken [Figure 2.17]. 
The experimental ECD curve of CD.6 showed positive Cotton effects at 294 nm (+ 3.03) and 
190 nm (+ 3.81) and a negative Cotton effect at 209 nm (- 4.96) for compound CD.6. This 
experimental ECD data was compared with the calculated ECD curves for the normal and ent 
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enantiomers of the two possible arrangement at C-4 [CD.6A, CD.6B, CD.6C and CD.6D].  
Conformational searches on each of the four structures were done using Spartan14.  A 
conformer distribution study at ground state with the molecular mechanics force fields 
(MMFF) was undertaken.   
 
MMFF analysis of structure CD.6A (ent enantiomer)- [4R, 5R, 8R, 9S, 10R]- 15, 16-epoxy-
13(16), 14-ent-clerodadien-3-one [Figure 2.17] gave 33 conformers, 11 of which were under 
3 kcal/mol.  The two conformers M0001 (-1.95 kcal/mol) and M0002 (-1.93 kcal/mol), which 
were consistent with ROESY and NOESY NMR experimental data and had Boltzmann 
distributions of 0.412 and 0.403 respectively, were subjected to TDDFT calculations using a 
B3LYP method at 6-311G level built into Gaussian09 software.  On the other hand, MMFF 
analysis of structure CD.6B (normal enantiomer), [4S, 5S, 8S, 9R, 10S]- 15, 16-epoxy-13(16), 
14-ent-clerodadien-3-one [Figure 2.17] gave 37 conformers, 11 of which were under 3 
kcal/mol.  The two conformers M0001 (-1.91 kcal/mol) and M0002 (-1.89 kcal/mol), which 
had Boltzmann distributions of 0.412 and 0.403, were subjected to TDDFT calculations using 
a B3LYP method at 6-311G level built into Gaussian09 software. The resulting ECD curves 
were Boltzmann weighted and compared to the experimental ECD curve for compound CD.6 
[Figure 2.18]. 
 
MMFF analysis of structure CD.6C (ent enantiomer)- [4S, 5R, 8R, 9S, 10R]- 15, 16-epoxy-
13(16), 14-ent-clerodadien-3-one [Figure 2.17] gave 27 conformers, 6 of which were under 3 
kcal/mol.  The two conformers M0001 (0.00 kcal/mol) and M0002 ( 0.01 kcal/mol), which 
were consistent with ROESY NMR experimental data and had Boltzmann distributions of 
0.426 and 0.415 respectively, were subjected to TDDFT calculations using a B3LYP method 
at 6-311G level built into Gaussian09 software.  On the other hand, MMFF analysis of 
structure CD.6D (normal enantiomer), [4R, 5S, 8S, 9R, 10S]- 15, 16-epoxy-13(16), 14-ent-
clerodadien-3-one [Figure 2.17], gave 29 conformers, 6 of which were under 3 kcal/mol.  
The two conformers M0001 (1.11 kcal/mol) and M0002 (1.12 kcal/mol), which had 
Boltzmann distributions of 0.426 and 0.415, were subjected to TDDFT calculations using a 
B3LYP method at 6-311G level built into Gaussian09 software. The resulting ECD curves 
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from both possible C-4 configuration were Boltzmann weighted and compared to the 
experimental ECD curve for compound CD.6 [Figure 2.19]. 
 
The experimental ECD curve for compound CD.6 was only similar in certain regions to that 
calculated for CD.6A, the structure shown to be correct using the NOESY experiment.  The 
region at 290 nm was comparable in the experimental and calculated spectra.  The calculated 
spectra of CD.6B, CD.6C and CD.6D did not match the experimental spectrum [Figure 2.18 
and Figure 2.19].  The specific rotation for compound CD.6 was determined to be +66.1 the 
reported trans-cascarillone is +35.7.88 
 
Previous research showed that normal enantiomers of compound CD.6 had wide cytotoxicity 
against the five human cancer cell lines, BT-474, KATO-3, CHAGO, SW-620 and HEP-G2 
in tissue culture with LC50 values of  3.26, 6.78, 6.67, 4.44 and 6.37 µg/mL/cell line.
91 
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CD.6A (ent enantiomer) 
 [4S, 5R, 8R, 9S, 10R]- 15, 
16-epoxy-13(16),14-ent-
clerodadien-3-one 
 
 
CD.6B (normal enantiomer) 
[4R, 5S, 8S, 9R, 10S]- 15, 16-
epoxy-13(16),14-clerodadien-
3-one 
  
CD.6C (ent enantiomer)  
[4R, 5R, 8R, 9S, 10R]- 15, 16-
epoxy-13(16),14-ent-
clerodadien-3-one 
  
CD.6D (normal enantiomer) 
[4S, 5S, 8S, 9R, 10S]- 15, 16-
epoxy-13(16),14-clerodadien-
3-one 
Figure 2.17: The structure of compounds CD.6A, CD.6B, CD.6C and CD.6D 
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Figure 2.18: The ECD spectrum for calculated structure CD.6A and CD.6B overlaid 
with the CD.6 experimental curve.  
 
Figure 2.19: The ECD spectrum for calculated structres CD.6C and CD.6D overlaid 
with the experimental CD.6 curve 
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Table 2.13: NMR data for compound CD.6: trans-cascarillone in CDCl3 compared 
against literature reference values 
No. 13C NMR(125 
MHz) CDCl3 
13C 
NMR(1
5 MHz) 
CDCl388 
1H NMR  (500 
MHz) CDCl3 
HMBC (H→C) COSY ROESY 
 
1α 23.4 CH2 23.2 1.75 m* 1, 9, 10 1β, 2α, 2β, 10 1β, 2α, 19 
1β 1.97 m 1, 3, 10 1α, 2α, 10 1α, 2β, 10 
2α 41.8 CH2** 39.4 2.29 m 2, 3, 5, 10 1α 1β, 2β 1α, 2β, 6α 
2β 2.40 m* 2, 3, 10 1α,  2α 1α, 2α, 4 
3 213.2 C 216.6- - - - - 
4 58.4 CH 58.2 2.26 2, 3,  5, 6, 10, 18, 19 18 2β, 10, 18 
5 42.1 C 41.8 - -  - 
6α 39.5 CH2** 41.5 1.68 m 4, 7, 8, 10, 19, 6β, 7 2α, 6β, 7, 17, 
19, 
6β 1.23 m 4, 7, 8, 19 6α, 7 6α, 8 
7 27.5 CH2 27.4 1.43 m 5, 6, 8, 9, 17 6, 8 6α, 8 
8 36.8 CH 36.6 1.63 m 6, 7, 11, 17, 20 17, 7 6β, 7 
9 39.5 C 39.4 - - - - 
10 49.1 CH 49.0 1.75 m* 1, 2, 6, 9,11, 19, 20 1α, 1β 1β, 4 
11 38.7 CH2 38.6 1.59 m 8, 9, 10, 12, 20 12a, 12b - 
12a 18.5 CH2 18.1 2.40 m* 10, 11, 14, 13, 16 11, 12b - 
12b 2.32 m 9, 11, 13, 14, 16 11, 12a - 
13 125.6 C 125.4 - - - - 
14 111.2 CH 110.9 6.27 brs W1/2=3.7 
Hz 
12, 13, 15, 16 15 - 
15 143.1 CH 138.5 7.36 btr W1/2=3.9 
Hz 
13, 14, 16 14, 16 - 
16 138.7 CH** 142.8 7.23 brs W1/2=3.6 
Hz 
13, 14, 15 12, 15 - 
17 16.0 CH3** 14.4 0.86 d J=6.8 Hz 7, 8,  9 8 4, 6α, 19, 20 
18 7.1 CH3 6.8 0.90 d J=6.1 Hz 3, 4, 5 4 4 
19 14.6 CH3** 18.3 0.75 s 4, 5, 6, 10 - 1α, 6α, 17 
20 18.3 CH3 - 0.77 s 8, 9, 10, 11 -  17 
* Refer to overlapped proton resonances  
**The 13C NMR chemical shifts have been corrected from the literature values by using HMBC and COSY 
correlations 
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 Structural elucidation of compound CD.7: 15,16-epoxy-4(18),13(16),14-ent-
clerodatrien-3-ol (agbaninol) (Appendices 55-63) 
 
Figure 2.20: Structure of compound CD.7: agbaninol 
Compound CD.7 was obtained from the dichloromethane extract of the roots of C. 
dichogamus and was isolated as a white oil and found to be the known clerodane-type 
diterpenoid, agbaninol.  It has been isolated previously from Gossweilerodendron 
balsamiferum Harms (Caesalpiniaceae).92 
 
The GC-MS for compound CD.7 showed a molecular ion peak at m/z 302.1 which indicated 
a molecular formula of C20H30O2.  The GC-MS spectrum showed fragment ions at m/z 287.1, 
[M-15] for the loss of a CH3 fragment.  A double bond equivalence of six was calculated for 
this compound.  The FTIR spectrum showed the presence of absorption bands at 3419 cm-1 
for OH stretching, 2916 cm-1 for C-H aliphatic stretches and 1435 cm-1 for methyl bending.77 
 
The 1H NMR spectrum showed that a β-substituted furan ring was present in compound CD.7 
with proton resonances at δH 6.24 (H-14), δH 7.19 (H-16) and δH 7.34 (H-15), which were 
seen to be coupled in the COSY spectrum.  Two singlet proton resonances at δH 0.79 (3H-20) 
and 1.26 (3H-19) and one doublet proton resonance at δH 0.83 (d, J= 6.0 Hz, 3H-17) seen in 
the 1H NMR spectrum demonstrated the presence of three methyl groups in compound CD.7.  
Two coupled broad singlets at δH 4.87 and δH 4.81 were assigned to the non-equivalent 
protons of a terminal methylene group.[Figure 2.20 and Table 2.14].  
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The 13C NMR spectrum showed twenty carbon resonances, including one oxygenated 
methine carbon resonance at δC 74.9 (C-3), two olefinic carbon resonances one methylene 
carbon resonance at δC 109.7 (C-18) and one quaternary carbon resonance at δC 161.0 (C-4), 
and four carbon resonances at δC 111.2 (C-14), 125.9 (C-13), 138.6 (C-16) and 142.9 (C-15) 
for the furan ring.  A double bond and a furan ring accounted for four out of six units of 
unsaturation, the remaining two units indicated two further rings.   
 
The NMR data for CD.7 showed many similarities to the NMR data of CD.6 except for the 
absence of a ketone group at C-3 and a methyl group at C-4 and the presence of a hydroxyl 
group and an extra two olefinic carbon resonances.  The additional olefinic methylene carbon 
resonance at c 109.7, which corresponded to the proton resonances at δH 4.87 and 4.81 in the 
HSQC spectrum, showed correlations in the HMBC spectrum with carbon resonances at C 
74.9 (C-3), C 161.0 (C-4) and C 40.1 (C-5).  Therefore, the olefinic methylene carbon was 
assigned as C-18 and a hydroxy group was placed at C-3.  Coupling was seen in the COSY 
spectrum between the H-3 (δH 4.34) and the 2H-2 (δH 2.03 and δH 1.57) proton resonances.  
 
The configuration of the hydroxy group at C-3 was assigned based on the observation of a 
broad singlet pattern for H-3 with the 13C NMR shift at c 74.9 , which indicated a β-
equatorial orientation for H-3.93  The literature reports a doublet of doublet pattern J1,2= 11.6 
and 5.7 Hz for α-axial orientation for H-3 with the 13C NMR shift of c 69.7 for compound 
3β,12(S)-dihydroxycleroda-4(18),13-dien-15,16-olide (compound 1) [Figure 2.21 and Table 
2.14].94  The ROESY spectrum displayed correlations between the proton resonance of the 
3H-20 group (δH 0.79) and the proton resonances of 3H-17 (δH 0.83, d, J = 6.0 Hz) and 3H-19 
(δH 1.26).  Moreover, the 3H-19 and 3H-20 proton resonances showed correlations in the 
ROESY spectrum with one of the H-1 (δH 1.83) and one of the H-2 (δH 2.03) proton 
resonances respectively.  However, the 3H-19 and 3H-20 proton resonances did not show 
correlation with the H-3 resonance.  This indicated that the 3H-17, 3H-19, 3H-20, H-1α and 
H-2α were on the α face of the molecule, and opposite to H-3 and confirmed that CD.7 
belonged to the ent-clerodane series. 
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There are no reports on the NMR data of compound CD.7 in the literature.  Therefore, the 13C 
NMR literature values of 3β, 12(S)-dihydroxycleroda-4(18),13-dien-15,16-olide           
(Compound 1) and crotonolide F (Compound 2) [Figure 2.21], which have similar rings A 
and B to CD.7, were used to compare NMR data values and were found to be 
comparable.93,94  
 
 
Compound 1 
 
Compound 2 
Figure 2.21: Structure of compound 3β,12(S)-dihydroxycleroda-4(18),13-dien-15,16-
olide (compound 1) and crotonolide F(compound 2) which were used to compare with 
NMR data of CD.7.93,94 
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Table 2.14: NMR data for compound CD.7: agbaninol in CDCl3 compared against 
literature reference values of compound 3β,12(S)-dihydroxycleroda-4(18),13-dien-15,16-
olide (compound 1) and crotonolide F(compound 2) 
No. 13C 
NMR(125 
MHz) 
CDCl3 
13C NMR(125 
MHz) CDCl3 
compound 194 
13C NMR(75 
MHz) CDCl3 
compound 293 
1H NMR (500 
MHz) CDCl3 
HMBC 
(H→C) 
COSY ROESY 
1α 16.9 CH2 21.16 16.9 1.83 dd J=3.2, 12.8 
Hz 
2, 3, 5, 9,10 1β,  2α, 10 1β, 19, 2α 
1β 1.47 m* 9, 10 1α, 2α, 2β 1α, 2β 
2α 34.9 CH2 37.31 34.6 2.03 m 10 1α, 1β, 2β, 3 1α, 2β, 20 
2β 1.57 m - 1β, 2α, 3 1β, 2α, 3 
3 74.9 CH 69.7 74.4 4.34 br s W1/2=7.8 
Hz 
- 2α, 2 2β, 18a, 
4 161.0 C 162.0 159.6 - - - - 
5 40.1 C 40.2 39.3 - - - - 
6α 38.1 CH2 37.3 37.1 1.72 m 8 6β, 7 6β, 19 
6β 1.47 m* 5, 10 6α, 7 6α, 
7 27.3 CH2 27.2 18.3 1.46 m
* 5, 9 6α, 6β, 7, 8 - 
8 36.8 CH 37.4 51.6 1.52 m 9, 20 17, 7 - 
9 39.5 C 40.4 37.4 - - - - 
10 48.9 CH 49.2 55.0 1.17 dd J=1.9, 12.1 
Hz 
1, 5, 6, 9, 19, 
20 
1α - 
11a 38.8 CH2 44.1 44.4 1.63 m 8, 9, 20 11b, 12a, 12b - 
11b 1.51 m 9, 10, 20 11a, 12a, 12b - 
12a 18.5 CH2 65.2 72.1 2.29 td J=4.5, 13.5 
Hz 
11 13, 14, 16, 11a, 11b, 12b - 
12b 2.13 td J=4.5, 13.5 
Hz 
11, 13 11a, 11b, 12a - 
13 125.9 C 174.3 126.0 - - - - 
14 111.2 CH 114.2 108.6 6.24 brs W1/2=3.9 Hz 13, 15, 16 15 - 
15 142.9 CH 173.6 143.9 7.34 btr W1/2=4.0 Hz  13, 16 14, 16 - 
16 138.6 CH 70.9 139.5 7.19s W1/2=3.8 Hz 14, 15 15 - 
17 16.3 CH3 16.0 172.6 0.83 d J=6.0 Hz 7, 8, 9 8 20 
18a 109.7 CH2 99.6 110.0 4.87 brs J=3.0 Hz 3, 4, 5 - 3 
18b 4.81 brs J=3.2 Hz 3, 4, 5 - 1α, 6α, 6β, 7 
19 23.2 CH3 21.24 23.1 1.26 s 4, 5, 6, 10 - 6α,  20 
20 18.4 CH3 17.6 14.9 0.79 s 8, 9, 10, 11 - 2α, 17, 19 
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 Structural elucidation of compound CD.8: 15,16-epoxy-3-keto-3(16),14-ent-
clerodadien-17, 12S-olide (crotonolide E.) (Appendices 64-72) 
 
 
 
 
 
 
 
Figure 2.22: Structure of compound CD.8: crotonolide E 
 
Compound CD.8 was isolated as a yellow oil from the dichloromethane extract of the roots of 
C. dichogamus and was found to be the known clerodane-type diterpenoid called crotonolide 
E.  It has been isolated previously from Croton laui (Euphorbiaceae).93 
 
The LCMS spectrum of compound CD.8 gave a [M + H]+ ion at m/z 331.1 which indicated a 
molecular formula of C20H26O4 for the compound. A double bond equivalence of eight was 
calculated for this compound.  The FTIR spectrum showed the presence of absorption bands 
at 2925 and 2852 cm-1 for C-H aliphatic stretches, 1739 and 1710 cm-1 for C=O stretching of 
the lactone and ketone group respectively, 1452 and 1381 cm-1 for methyl and methylene 
bending and 1221 cm-1 for the epoxide C-O stretch.77 
 
The 1H NMR spectrum showed the presence of a β-substituted furan ring in compound CD.8 
due to the proton resonance at δH 6.44 (H-14), δH 7.43 (H-15) and δH 7.46 (H-16), which 
were seen to be coupled in the COSY spectrum.  The presence of two singlet proton 
resonances at δH 0.82 (3H-19) and δH 1.11 (3H-20) and one doublet proton resonance at δH 
0.93 (d, J= 6.6 Hz, 3H-18) in the 1H NMR spectrum demonstrated the presence of three 
methyl groups in compound CD.8 [Figure 2.22 and Table 2.15]. 
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The 13C NMR spectrum displayed twenty carbon resonances, including four carbon 
resonances at δC 108.7 (C-14), C 126.0 (C-13), C 139.6 (C-16) and C 144.1 (C-15) for the 
furan ring, one ketone group carbon resonance at δC 211.4 and a lactone group carbon 
resonance at δC 172.2 (C-17).  The carbonyl groups and furan ring accounted for five out of 
eight units of double bond equivalence, and the remaining three indicated the presence of 
three additional rings.  
 
The NMR data of CD.8 showed many similarities to the NMR data of CD.6.  The 13C NMR 
data of compound CD.8 showed the presence of one additional carbonyl group carbon 
resonance at C 172.2 (C-17) and one oxygenated methine carbon resonances at C 72.0     
(C-12).  The oxymethine proton resonance at δH 5.50 (dd, J=5.5, 11.2), which corresponded 
to the carbon resonance at δC 72.0 in the HSQC spectrum, was assigned as H-12 due to its 
correlation with three furan ring carbon resonances at δC 126.0 (C-13), C 108.7 (C-14) and C 
139.6 (C-16), one lactone carbon resonance at δC 172.2 (C-17) and one methylene carbon 
resonance at δC 44.7 (C-11).   
 
In the COSY spectrum, an AMX system with coupling between H-12 (δH 5.50, dd, J=5.5, 
11.2 Hz) and the two H-11(δH 2.39 and 1.78) proton resonances confirmed the assignment of 
H-12.  
 
The NOESY experiment was used to determine the relative configuration for compound 
CD.8.  The proton resonances at H 2.25 for H-4 and H 2.22 for H-8 showed correlations in 
the NOESY spectrum with the H-10 (H 1.65) resonance, indicating that they were on the 
same face of the molecule.  The NOESY spectrum also showed a correlation between the  
3H-18 (H 0.93) methyl group proton resonance and the 3H-19 (H 0.82) methyl group proton 
resonance, which, in turn, showed a correlation with the 3H-20 (H 1.11) methyl group proton 
resonance.  All these groups (3H-18, 3H-19 and H-20) were placed on the same face of the 
molecule.  The NOESY spectrum showed a correlation between the H-12 (H 5.50) and     
3H-20 (H 1.11) resonances, confirming they are on the same side.  The NMR data of 
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compound CD.8 was compared with the literature data and found to be the known 
crotonolide E [Table 2.15].93  
 
The absolute configuration of compound CD.8 was determined using electronic circular 
dichroism (ECD) studies.  The experimental ECD curve showed positive Cotton effects at 
292 nm (+ 2.56) and 191 nm (+ 14.82) and a negative Cotton effect at 221 nm (- 11.59).  The 
trend of the curve was similar to the reported crotonolide E95 indicating that compound CD.8 
belonged to the ent-clerodane series.  The specific optical rotation for compound CD.8 was 
found to be + 84.5, similar to the reported specific optical rotation value of + 95.93  
 
Previous research showed that CD.8 did not show cytotoxic nor antibacterial activity against 
the human premyelocytic leukemia HL-60 and murine leukemia P-388 cell lines with IC50 ≥ 
10µM, and against four Gram-positive bacteria Staphylococcus epidermidis ATCC 12228, 
Staphylococcus aureus ATCC 25923, Bacillus subtilis CMCC 63501 and Micrococcus luteus 
ATCC 9341 with MIC > 150 µM.93 
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Table 2.15: NMR data for compound CD.8: crotonolide E in CDCl3 compared against 
literature reference values. 
No. 13C 
NMR(125 
MHz) 
CDCl3 
13C 
NMR(125 
MHz) 
CDCl393 
1H NMR (500 
MHz) CDCl3 
HMBC (H→C) COSY NOESY 
1α 22.8 CH2 
 
22.7 1.79  m* 2, 3, 5, 9, 10 1β, 2, 10 1β, 2α, 2β, 19, 20 
1β 2.01 m 2, 3,  5, 10 1α,  2, 10 1α, 10, 11α, 11β 
2α 41.2 CH2 41.1 2.32 m 1, 3, 10 1α, 1β, 2β 1α, 2β 
2β 2.49 m 1, 3,  4, 10 1β 1α, 2α 
3 211.4 C 211.4 - - - - 
4 58.1 CH 58.0 2.25 m 2, 3, 5, 6, 10, 11, 18, 19 18 6β, 10, 18 
5 41.0 C 40.9 - - - - 
6α 38.1 CH2 38.0 1.86 dt J=3.0, 
13.5 Hz 
5, 7, 8, 10, 19 6β, 7α, 7β 7β, 18, 19 
6β 1.28 m 4, 5, 7, 8, 19 6α, 7α, 7β 4, 6α 
7α 18.7 CH2 18.6 2.15 m 5, 6, 8,  9, 17 6α, 6β, 7β 6, 7β 
7β 1.61 m 6, 8 6α, 6β, 7α 7α, 8, 19 
8 51.7 CH 51.6 2.22 m 6, 7, 10, 11, 17, 20 7α, 7β 7β, 10, 11β 
9 37.4 C 37.3 - - - - 
10 55.2 CH 55.1 1.65 m 1, 2, 5, 8, 9, 11, 19, 20 1α, 1β 1β, 4, 8 
11α 44.7 CH2 44.6 2.39 m 8, 9, 10, 13, 20 11β, 12 1β, 11β, 12 
11β 1.78 m* 8, 9, 10, 12, 13, 20 11α, 12 1β, 11α 
12 72.0 CH 71.9 5.50 dd J=5.5, 
11.2 Hz 
11, 13, 14, 16, 17 11a, 11b 11α, 20 
13 126.0 C 125.9 - - - - 
14 108.7 CH 108.6 6.44 W1/2=3.9 
Hz 
13, 15, 16 15 - 
15 144.1 CH 144.0 7.43 btr 
W1/2=3.9 Hz 
13, 14, 16 14, 16 - 
16 139.6 CH 139.5 7.46 brs 
W1/2=3.6 Hz 
13, 14, 15 15 - 
17 172.2 C 172.1 - - - - 
18 7.0 CH3 6.9 0.93 d J=6.6 Hz 3, 4, 5 4 4, 6α, 19 
19 14.6 CH3 14.5 0.82 s 5,  6, 10 - 1α, 6α, 7β, 18, 20 
20 15.2 CH3 15.1 1.11 s 8, 9, 10, 11 - 1α, 12, 19 
* Refer to overlapped proton resonances 
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 Structural elucidation of compound CD.9: 15,16-epoxy-3,4-dihydroxy-3(16),14-ent-
clerodadien-17,12S-olide (furocrotinsulolide A) (Appendices 73-81) 
 
 
Figure 2.23: Structure of compound CD.9: furocrotinsulolide A 
Compound CD.9 was isolated as a yellow oil from the dichloromethane extract of the roots of 
C. dichogamus and was found to be the known clerodane-type diterpenoid, furocrotinsulolide 
A, a 3α,4β-dihydroxy derivative of compound CD.8.  It has been isolated previously from 
Croton insularis (Euphorbiaceae).96 
 
The HRMS spectrum of compound CD.9 gave a [M + Na]+ ion at m/z 371.1831 which 
indicated a molecular formula of C20H28O5 for the compound.  A double bond equivalence of 
seven was calculated for this compound.  The FTIR spectrum showed absorption bands at 
3448 cm-1 for an OH stretch, 2932 and 2870 cm-1 for C-H aliphatic stretches, 1718 cm-1 for a 
carbonyl stretch, 1456 and 1375 cm-1 for methyl and methylene bending and 1230 cm-1 for an 
epoxide C-O stretch.77 
 
The 1H NMR spectrum showed three broad singlet proton resonances at δH 6.41 (H-14), δH 
7.43 (H-16) and 7.40 (H-15), which were seen to be coupled in the COSY spectrum and are 
characteristic of a β-substituted furan ring in compound CD.9.  Three singlet proton 
resonances at δH 1.07 (3H-20), δH 1.18 (3H-19) and δH 1.27 (3H-18) in the 1H NMR spectrum 
demonstrated the presence of three methyl groups in compound CD.9 [Figure 2.23 and 
Table 2.16]. 
65 
 
The 13C NMR spectrum displayed twenty carbon resonances, including four carbon 
resonances at δC 108.8 (C-14), C 126.1 (C-13), C 139.6 (C-16) and C 143.9 (C-15) for the 
furan ring, lactone group carbon resonance at δC 173.1 (C-17) and three oxygenated carbon 
resonances at δC C 72.3 (C-12), C 76.5 (C-3) and C 76.4 (C-4).  A carbonyl group and a 
furan ring accounted for four out of seven units of double bond equivalence, and the 
remaining three indicated the presence of three rings. 
 
An oxymethine proton resonance at δH 3.58 (H-3) showed correlations in the HMBC 
spectrum with the methyl carbon resonance at C 21.8 (C-18), the fully substituted carbon 
resonance at C 41.0 (C-5), the quaternary oxygenated carbon resonance at C 76.4 (C-4) and 
the methylene carbon resonance at c 16.7 (C-1).  The chemical shift of the C-4 (C 76.4) 
resonance indicated the precence of a hydroxy group at C-4.  In addition, the HMBC 
spectrum showed correlations between C-4 (C 76.4) resonance and H-3 (δH 3.58 ), 3H-18 (δH 
1.27) and 3H-19 (δH 1.18) resonances.  The H-3 (δH 3.58) resonance showed coupling in the 
COSY spectrum with the 2H-2 proton resonances at δH 1.71 and δH 2.03.  The other 
oxymethine proton resonance at δH 5.48 (dd, J=5.7, 11.5), which corresponded to the carbon 
resonance at δC 72.3 in the HSQC spectrum, was assigned as C-12 due to its correlation with 
three furan ring carbon resonances at δC 126.1 (C-13), C 108.8 (C-14) and C 139.6 (C-16), 
one lactone carbon resonance at δC 173.1 (C-17) and one methylene carbon resonance at δC 
44.6 (C-11) in the HMBC spectrum.   
 
The relative configuration at C-3 was assigned based on the observation of a broad singlet 
pattern for H-3 (δH 3.58, brs, W1/2=7.8 Hz), which indicated a β-equatorial orientation for H-
3,93,96 whereas the literature reported a doublet of doublet pattern for α-axial orientation for 
H-3.94  In addition, the presence of a correlation seen in the NOESY spectrum between H-3 
and both the H-2 (δH 1.71 and 2.03) resonances confirmed the relative configuration of OH-
3.96.  The NOESY spectrum displayed correlations between the H-8 proton resonance at δH 
2.13 and the H-10 proton resonance at δH 1.75 and the absence of any NOESY correlation 
with H-20 (δH 1.07) or H-19 (δH 1.18) proton resonances.  Moreover, the 3H-20 proton 
resonance showed correlations in the NOESY spectrum with the methyl group proton 
resonance at δH 1.18 (3H-19), which showed a further correlation with the methyl group 
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proton resonance at δH 1.28 (3H-18).  This confirmed that these three methyl groups were in 
an α-orientation and on the opposite side to 3-H , H-8 and H-10, and hence the hydroxyl 
group at C-4 was assigned as β.  In order to confirm this assignment, a 13C NMR spectrum 
was performed in CD3OD for comparison with the literature data, and they were found to be 
comparable.96  The literature data reported the same relative stereochemistry of compound 
CD.9 by using NMR NOESY spectroscopy.96  The specific optical rotation for compound 
CD.9 was found to be + 6.0, similar to the reported specific optical rotation value of + 6.8.96 
 
Table 2.16: NMR data for compound CD.9: furocrotinsulolide A in CDCl3 and CD3OD 
compared against literature reference values 
No. 13C 
NMR(125 
MHz) 
CDCl3 
13C 
NMR(125 
MHz) 
CD3OD 
13C 
NMR(50 
MHz) 
CD3OD96 
1H NMR (500 
MHz)CDCl3 
HMBC 
(H→C) 
COSY NOESY 
1 16.7 CH2 17.9 18.3 1.39 m 2, 10 2, 2 2, 18 
2 30.6 CH2 31.3 31.5 1.71 m 1, 3, 4, 10 1, 2, 3 2β, 3, 18 
2 2.03 m* 1, 10 1, 2, 3 2, 3 
3 76.5 CH 77.0 77.2 3.58 br s. W1/2=7.8 1, 4, 5, 18 2, 2 2, 2β, 18 
4 76.4 C 77.3 77.5 - - - - 
5 41.0 C 42.0 42.4 - - - - 
6 31.7 CH2 32.8 33.1 1.59 m 5, 6, 7, 8, 10 7, 7 7β,18 
7 17.8 CH2 19.0 19.3 1.64 m 5, 8, 9 6, 7, 8 7β, 19, 20 
7 2.04 m* 5, 6, 8, 9, 17 6, 7 6, 7α 
8 51.2 CH 52.2 52.4 2.13 m 6, 7, 9, 11, 
17, 20 
7 10 
9 37.0 C 38.0 38.3 - - - - 
10 47.4 C 48.4 49.0 1.75 m 1, 2, 5, 11, 20 1 8 
11 44.6 CH2 45.6 45.8 1.66 m 8, 9, 10, 12, 
13, 20 
11, 12 11β, 12, 20 
11 2.33 dd J=5.7, 13.2 
Hz 
8, 9, 10, 20 11, 12 11α, 12 
12 72.3 CH 74.1 74.3 5.48 dd J=5.7, 11.5 
Hz 
11, 13, 14, 
16, 17 
11, 11 11α, 11β, 20 
13 126.1 C 127.7 127.9 - - - - 
14 108.8 CH 109.9 110.2 6.41 brs W1/2=4.0 Hz 12, 13, 15, 16 15 - 
15 143.9 CH 145.2 145.5 7.40 btr W1/2=4.3 Hz 13, 14, 16 14, 16 - 
16 139.6 CH 141.3 141.6 7.43 brs W1/2=3.6 Hz 13, 14, 15 12, 15 - 
17 173.1 C 175.9 176.2 - - - - 
18 21.8 CH3 21.3 21.5 1.27 s 3, 4, 5 - 1, 2α, 3β, 6, 
19 
19 17.5 CH3 18.0 18.1 1.18 s 4, 5, 6, 10 - 7 α, 18, 20 
20 14.9 CH3 15.1 15.4 1.07 s 8, 9, 10, 11 - 7 α, 12, 11α, 
19 
* Refer to overlapped proton resonances. 
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 Structural elucidation of compound CD.10: 15,16-epoxy-5,13(16),14-ent-
halimatriene-3-ol. (Appendices 82-90) 
 
Figure 2.24: Structure of compound CD.10: 15,16-epoxy-5, 13(16), 14-ent-halimatriene-
3-ol 
Compound CD.10 was isolated as a yellow oil from the dichloromethane extract of the roots 
of C. dichogamus and was found to be a new halimane-type diterpenoid.  
 
The HRMS spectrum of compound CD.10 gave a [M + Na]+ ion at m/z 325.2138 which 
indicated a molecular formula of C20H30O2 for the compound.  A double bond equivalence of 
six was calculated for this compound.  The FTIR spectrum showed absorption bands at 3424 
cm-1 for an OH stretch, 2922 and 2852 cm-1 for C-H aliphatic stretches, 1456 and 1384 cm-1 
for methyl and methylene bending respectively and 1239 cm-1 for an epoxide C-O stretch.77 
 
The 1H NMR spectrum showed that a β–substituted furan ring was present in compound 
CD.10.  Three coupled proton resonances at δH 6.28 (H-14), δH 7.35 (H-15) and at δH 7.22 
(H-16), were seen in the COSY spectrum.  Three singlet proton resonances at δH 1.07 (3H-
18), δH 1.15 (3H-19) and δH 0.71 (3H-20) and one doublet proton resonance at δH 0.88 (d, 
J=6.7, 3H-17) in the 1H NMR spectrum demonstrated the presence of four methyl groups.  In 
addition, one olefinic methine proton resonance at δH 5.56 (H-6) and one oxymethine proton 
resonance at δH 3.49 (H-3) were seen in the 1H NMR spectrum [Figure 2.24 and Table 2.17]. 
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The 13C NMR spectrum, displayed twenty carbon resonances, including four carbon 
resonances at δC 111.2 (C-14), C 125.9 (C-13), C 138.6 (C-16) and C143.0 (C-15) for a 
furan ring, a secondary alcohol carbon resonance at δC 76.6 (C-3) and double bond carbon 
resonances at δC 142.5 (C-5) and C 121.0 (C-6).  The double bond and the furan ring 
accounted for four out of six units of double bond equivalence, and the remaining two 
indicated the presence of two additional rings  
 
The secondary oxymethine resonance at δC 76.6 was assigned as C-3 due to its correlations in 
the HMBC spectrum with the two singlet methyl group proton resonances at δH 1.07 (H-18) 
and δH 1.15 (H-19), methylene proton resonances at δH 1.68 and δH 1.55 (2H-1) and one 
proton of the methylene proton resonances at δH 1.72 (H-2).  The coupling in the COSY 
spectrum between δH 3.49 (H-3) and the H-2 (δH 1.72) proton resonances confirmed the 
placement of the hydroxyl group at C-3.  The placement of a double bond between C-5 (δC 
142.5) and C-6 (δC 121.0) was due to the correlations in the HMBC spectrum and coupling in 
the COSY spectrum.  The two methylene proton resonances at 2H-1 (δH 1.55 and 1.69) and 
2H-7 (δH 1.85 and 1.90) showed correlations in the HMBC spectrum with the C-5 (δC 142.5 ) 
carbon resonances.  Moreover, the correlations in the HMBC spectrum between the H-6 (δH 
5.56) proton resonances and the C-4 (δC 41.5), C-7 (δC 32.0), C-8 (δC 33.7) and C-10 (δC 39.0) 
carbon resonances, and coupling seen in the COSY spectrum between the H-6 and 2H-7 
resonances confirmed the position of the double bond.  The two methylene proton resonances 
at δH 1.56 (H-11) and 2.36 (H-12) showed correlations in the HMBC spectrum with the furan 
ring carbon resonances, C-13 (δC 125.9), C-14 (δC 111.3) and C-16 (δC 138.6). 
 
The relative configuration at C-3 was assigned based on the observation of a broad singlet 
pattern for H-3 (δH 3.49, brs W1/2=8.6 ), which indicated a β-equatorial orientation for H-
3.93,96  In addition, the presence of a correlation in the NOESY spectrum between H-3 and 
2H-2 (δH 1.72 and 1.89) confirmed the relative configuration of H-3.96  The H-3 proton 
resonance also showed correlations in the NOESY spectrum with the two methyl group 
proton resonances 3H-18 and 3H-19.  The correlations displayed in the NOESY spectrum, 
between the H-8 proton resonance (δH 1.62) and the H-10 proton resonance (δH 2.31) which 
showed a further correlation with the 3H-18 proton resonance at δH 1.07 confirmed that all 
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these protons (H-8, H-10 and H-18) were on the same face of the molecule, in the β-
orientation.   
Table 2.17: NMR data for compound CD.10: 15, 16-epoxy-5, 13(16), 14-ent-
halimatriene-3-ol in CDCl3. 
No. 13C NMR(125 
MHz) CDCl3 
1H NMR (500 
MHz)CDCl3 
HMBC (H→C) COSY NOESY 
1α 37.1 CH2 1.55 m* 1, 2, 3, 5, 10 1β, 2α, 2β 1β, 2α,2β, 10, 20 
1 β 1.68 m 3, 5, 9,10 1α, 2, 2, 10 1α, 2β,  3, 10 
2α 28.5 CH2 1.72 m 1, 3, 4, 10 1α, 1β, 2β, 3 1α, 3 
2β 1.89 m 1, 10 1α, 1β,2α 1α, 1β, 2α, 3, 18 
3 76.6 CH 3.49 brs W1/2=8.6 Hz - 2α 2α, 2β, 18, 19 
4 41.5 C - - - - 
5 142.5 C - - - - 
6 121.0 CH 5.56 brd W1/2=10.8 Hz 7, 8, 4, 10 7, 7 19, 7α, 7β 
7α 32.0 CH2 1.85 m 5, 6, 8, 9, 17 6, 7β, 8 17, 20 
7β 1.90 m 5, 6, 8, 9, 6, 7α, 8 8, 18 
8 33.7 CH 1.62 m 7, 9, 17, 20 7, 7 7β, 10, 12, 17 
9 37.4 C - - - - 
10 39.0 CH 2.31 m 1, 9 1α, 1β 1α, 1β , 8, 18 
11 20.3 CH2 1.56 m* 8, 9, 10, 12, 13, 20 12 12, 17,  20 
12 18.5 CH2 2.36 m 9, 13, 14, 16, 11 11, 14 
13 125.9 C - - - - 
14 111.2 CH 6.28 brs W1/2=3.9 Hz 13, 15, 16 15 12, 15 
15 143.0 CH 7.35 brt W1/2=4.0 Hz 13, 14, 16 14, 16 14 
16 138.6 CH 7.22 brs W1/2=3.8 Hz 13, 14, 15 12, 15 17 
17 15.3 CH3 0.88 d J=6.7 Hz 7, 8, 9 - 7α, 8, 11 
18 28.6 CH3 1.07 s 3, 4, 5, 19 - 3, 6, 7α, 10 
19 25.7 CH3 1.15 s 3, 4, 5, 18 - 3 
20 16.4 CH3 0.71 s 8, 9, 10, 11 - 1α, 7α, 11 
*Refer to overlapped proton resonances.  
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 Structural elucidation of compound CD.11: 15,16-epoxy-3-hydroxy-5(10), 13(16), 
14-ent-halimatriene-17, 12S-olide  (Appendices 91-99) 
 
Figure 2.25: Structure of compound CD.11: 15, 16-epoxy-3-hydroxy-5(10), 13(16), 14-
ent-halimatriene-17, 12S-olide 
 
Compound CD.11 was isolated as a white solid compound from the dichloromethane extract 
of the roots of C. dichogamus and was found to be a new halimane -type diterpenoid 
 
The HRMS spectrum of compound CD.11 gave a [M ]+ ion at m/z 330.1830 which indicated 
a molecular formula of C20H26O4 for the compound.  A double bond equivalence of eight was 
calculated for this compound.  The FTIR spectrum showed absorption bands at 3436 cm-1 for 
an OH stretch, 2936 and 2876 cm-1 for C-H aliphatic stretches, 1731cm-1 for carbonyl stretch, 
1458 and 1381 cm-1 for methyl and methylene bending respectively and 1246 cm-1 for 
epoxide C-O stretch.77 
 
The 1H NMR spectrum displayed three broad singlet proton resonances at δH 6.42 (H-14), δH 
7.45 (H-16) and δH 7.41 (H-15), which were seen to be coupled in the COSY spectrum and 
indicated the presence of a β-substituted furan ring in compound CD.11.  Three singlet proton 
resonances at δH 0.98 (3H-18), δH 1.07 (3H-19) and δH 1.19 (3H-20) demonstrated the 
presence of three methyl groups, The 1H NMR spectrum also displayed two oxygenated 
methine proton resonances at δH 3.46 (H-3) and δH 5.47 (H-12) [Figure 2.25 and Table 2.18]. 
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The 13C NMR spectrum, displayed twenty carbon resonances, including two oxygenated 
carbon resonances at δC 75.9 (C-3) and C 72.4 (C-12), a lactone group carbon resonance at 
δC 172.8 (C-17) and six olefinic carbon resonances which were classified by HSQCDEPT 
and DEPT spectra as three quaternary carbon resonances at δC 135.1 (C-5), C 132.1 (C-10) 
and C 125.9 (C-13), and three methine carbon resonances at δC 108.8 (C-14), C 139.7 (C-16) 
and C 143.9 (C-15) for the furan ring.  A double bond, a carbonyl group and a furan ring 
accounted for five out of eight units of double bond equivalence, and the remaining three 
indicated the presence of three rings. 
 
In the HMBC spectrum, an oxymethine proton resonance at δH 3.46 (H-3) showed 
correlations with the two methyl carbon resonances at C 20.4 (C-18) and 24.5 (C-19), two 
methylene carbon resonances at C 24.3 (C-1) and 27.3 (C-2) and two quaternary carbon 
resonances at C 39.8 (C-4) and C 135.1 (C-5).  The coupling in the COSY spectrum between 
the H-3 (δH 3.46) and 2H-2 (δH 1.66, δH 1.81) proton resonances confirmed the placement of 
the hydroxyl group at C-3.  The other oxymethine proton resonance at δH 5.47 (dd, J=5.0, 
12.0), which corresponded to the carbon resonance at δC 72.4 in the HSQC spectrum, was 
assigned to C-12 due to its correlation with three aromatic carbon resonances at δC 125.9 (C-
13), C 108.8 (C-14) and C 139.7 (C-16), one lactone carbon resonance at δC 172.8 (C-17) 
and one methylene carbon resonance at δC 41.1 (C-11) in the HMBC spectrum.  The coupling 
between the H-12 (δH 5.47) and 2H-11 (δH 1.82 and 2.32) proton resonances seen in the 
COSY spectrum confirmed this assignment.  The placement of the double bond between C-5 
(δC 135.1) and C-10 (δC 132.1) was due to the correlations in the HMBC spectrum.  The 2H-1 
(δH 2.08), one of the H-2 proton (δH 1.81), 2H-6 (δH 2.11 and 2.22) and 2H-11 (δH 1.82 and 
2.32) resonances showed correlation in the HMBC spectrum with the C-10 carbon resonance.  
Furthermore, The 2H-1, H-3, and one of the H-6 and H-7 proton resonances showed 
correlations in the HMBC spectrum with the C-5 carbon resonance. 
 
The relative configuration of compound CD.11 was assigned based on the NOESY 
experiments.  The H-3 resonance showed correlations with the 3H-19 resonance.  In addition, 
the coupling constants of the H-3 resonance which occurred as a doublet of doublets (H 4.46, 
dd, J=3.3, 11.7 Hz) indicated the -orientation of H-3 and therefore, 3H-19.93,94,96,97  The 
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difference in shape between the H-3β resonance in compound CD.10 and H-3α resonance of 
compound CD.11 can be seen on pages 84 and 93 in the Appendix.  The 3H-19 (δH 1.07) 
proton resonance showed correlations in the NOESY spectrum with the methyl group proton 
resonance at δH 1.19 (3H-20), which showed further correlation with methine proton 
resonance at δH 5.47 (3H-12).  This confirmed that these protons (3H-19, 3H-20 and H-12) 
were in an α-orientation and furan ring was in a β position.  This also indicated that 
compound CD.11 belonged to the ent-clerodane series as with all the compounds isolated 
from this extract.  The specific optical rotation for compound CD.11 was found to be +56.4. 
Table 2.18: NMR data for compound CD.11: 15, 16-epoxy-3-hydroxy-5(10), 13(16), 14-
ent-halimatriene-17, 12S-olide in CDCl3.  
No. 13C NMR(125 
MHz) CDCl3 
1H NMR (500 
MHz) CDCl3 
HMBC (H→C) COSY NOESY 
1 24.3 CH2 2.08 m 2, 3, 5, 10 2, 2 19, 2α, 2β, 11, 
11b 
2α 27.3 CH2 1.66 m 1, 3, 4 1, 2, 3 2β, 19 
2β 1.81 m 1, 3, 4, 10 1, 2, 3 2α 
3 75.9 CH 3.46 dd J=3.3, 11.7 
Hz 
1, 2, 4, 5, 18, 19 2, 2 19 
4 39.8 C - - - - 
5 135.1 C - - - - 
6 25.0 CH2 2.11 m* 4, 5, 10 6, 7, 7 6β , 19, , 20 
6 2.22 m 5, 8, 10 6, 7 6α, 18 
7α 18.6 CH2 1.60 m 6, 9, 6, 6, 7, 8 6α, 7β 
7β 2.30 m* 5, 6, 8, 9, 17 7, 8 7α, 
8 48.3 CH 2.31 m* 6, 7, 9, 11, 17, 20 7, 7 - 
9 37.0 C - - - - 
10 132.1 C - - - - 
11α 41.1 CH2 2.32 m 8, 9, 10, 20 11, 12 1, 11β, 12 
11β 1.82 m 8, 9, 10, 12, 13, 20 11, 12 1, 11α 
12 72.4 CH 5.47 dd J=5.0, 12.0 
Hz 
11, 13, 14, 16, 17 11, 11 20, 11α 
13 125.9 C - - - - 
14 108.8 CH 6.42 brs W1/2=4.0 
Hz 
12, 13, 15, 16 15 - 
15 143.9 CH 7.41 brt W1/2=4.1 Hz 13, 14, 16 14, 16 - 
16 139.7 CH 7.45 brs W1/2=3.7 
Hz 
13, 14, 15 12, 15 - 
17 172.8 C - - - - 
18 20.4 CH3 0.98 s 3, 4, 5, 19 - 6β 
19 24.5 CH3 1.07 s 3, 4, 5, 18 - 1, 2α,  3, 6α, 20 
20 20.3 CH3 1.19 s 9, 8, 10, 11 - 6α, 12, 19 
*Refer to overlapped proton resonances 
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 Structural elucidation of compound CD.12: crotohaumanoxide            
(Appendices 100-106) 
 
 
Figure 2.26: Structure of compound CD.12: crotohaumanoxide 
Compound CD.12 was isolated as a yellow oil from the methanol extract of the roots of C. 
dichogamus by cooperative work with PhD student visitor from Kenya, B. E. Ndunada who 
worked on some fractions of the extract during her visit to the University of Surrey.  It has 
been isolated previously from Croton haumanianus J,98 and was found to be the known 
crotofolane-type diterpenoid, crotohaumanoxide. 
 
Unfortunately, compound CD.12 decomposed before the MS and IR analysis.  However, the 
NMR spectrum showed clear correlations and comparable values with the literature.98 
The 13C NMR and DEPT spectra, displayed twenty-two carbon resonances, including one 
carbonyl carbon resonance at δC 169.7 for the carbon of an acetyl group, five oxygenated 
carbon resonance at δC 57.4 (C-6), C 57.8 (C-5), C 60.7 (C-4), C 69.0 (C-9) and C 75.3 (C-
3), four methyl group carbon resonances at δC 8.8 (C-17), C 12.8 (H-19), C 20.2 (C-20) and 
C 20.8 for methoxy group carbon and six olefinic carbon resonances, which were classified 
as one fully substituted and one methylene carbon resonances at δC 145.3 (C-10) and C 114.1 
(C-18) respectively and four carbon resonances at δC 117.5 (C-15), C 122.3 (C-14), 137.0 
(H-16) and 150.4 (C-13) for the furan ring [Figure 2.26 and Table 2.19]. 
 
The HMBC and COSY spectra suggested the presence of a cyclopentane ring in compound 
CD.12.  The oxygenated methine proton resonance at δH 5.50 (d, J=5.6 Hz), which 
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corresponded to a resonance at δC 75.3 in the HSQCDEPT spectrum, was assigned as C-1 of 
the cyclopentane ring due to its correlations in the HMBC spectrum with two fully substituted 
oxygenated carbon resonances at δC 60.7 (C-4) and 69.0 (C-9), one acetate carbonyl 
resonance at c 169.7, two methine carbon resonances at δC 33.8 (C-2) and 37.1 (C-8) and one 
methylene carbon resonances at δC 37.2 (C-3).  The doublet methyl proton resonance at δH 
0.91 (3H-19, d, J=7.1 Hz) was seen to be coupled in the COSY spectrum with the methine 
proton resonance at δH 2.21 (H-2), and showed correlations with C-1 (δC 75.3) and C-3 (δC 
37.2) resonances in the HMBC spectrum.   
 
The carbon resonances at δC 57.4, 57.8, 60.7 and 69.0 were assigned to the epoxide carbons.  
The two fully substituted oxygenated carbon resonances at δC 60.7 and 69.0 were identified as 
C-4 and C-9 as they displayed correlations with proton resonances at δH 5.50 (H-1), 2.47 and 
1.64 (2H-3), 2.80 (H-7), 3.06 (H-8) and the oxygenated methine proton resonance at δH 3.14 
(H-5) in the HMBC spectrum.  The second epoxide group in the compound was placed at C-
5/C-6.  This placement was due to the correlations between the trisubstituted and fully 
substituted oxygenated carbon resonances at δC 57.8 (C-5) and 57.4 (C-6) respectively with 
proton resonances at δH 1.64 (H-3), δH 2.80 (H-7), δH 3.06 (H-8) and δH 1.09 (3H-20) in the 
HMBC spectrum.   
 
The NMR data identified a seven-membered carbocyclic ring C fused to the furan ring.  The 
H-7 (δH 2.80), H-11 (δH 2.47) and H-12 (δH 2.98 and δH 2.77) proton resonances showed 
correlations with the furan ring carbon resonances at δC 150.4 (C-13), δC 122.3 (C-14) and δC 
117.5 (C-15) in the HMBC spectrum.  The broad singlet methyl group proton resonance at δH 
1.96 was attached to the furan ring at position C-15 due to correlations seen in the HMBC 
spectrum with the C-14, C-15 and C-16 carbon resonances.  The double bond carbon 
resonances at δC 145.3 (C) and 114.1 (CH2) were placed in the cycloheptane ring at position 
C-10 as they showed correlations with the H-7 (δH 2.80), H-8 (δH 3.06), 2H-11 (δH 2.58 and 
2.47) and 2H-12 (δH 2.98 and δH 2.77) proton resonances in the HMBC spectrum. 
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The correlations in the NOESY spectrum were not clear enough to determine the relative 
configuration of compound CD.12.  Tchissambou et al. carried out the assignment of 
crotohaumanoxide by using 13C NMR, 1H NMR and X-ray analysis to determine the relative 
configuration.98  They reported that the two epoxide group, H-1 and H-7 were on the same 
face of the molecule (α-orientation) which was in the opposite direction to the methyl groups 
3H-19 and 3H-20 and two methine proton H-5 and H-8 (β-orientation).  Kawakami et al. 
assigned the absolute configuration of a crotofolane diterpenoid called crotocascarin A 
[Figure 2.27], which differs from compound CD.12 in having a C-16 oxygenated furan ring, 
a hydroxy group at C-13,and different C-1 ester, using X-ray analysis and circular dichroism 
studies.99  They confirmed the relative stereochemistry of compound crotohaumanoxide 
which was reported by Tchissambou et al.98  The NMR data of compound CD.12 were the 
same with literature values for crotohaumanoxide and crotocascarin A.98,99 
 
 
Figure 2.27: Structure of compound crotocascarin A.99 
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 Table 2.19: NMR data for compound CD.12: crotohaumanoxide in CDCl3 compared 
against literature reference values for crotohaumanoxide and crotocascarin A 
n 
 
13C 
NMR(125 
MHz) 
CDCl3 
13C NMR(100MHz) 
CDCl3 
crotohaumanoxide98 
13C NMR(100 
MHz) CDCl3 
crotocascarin A99 
1H NMR (500 
MHz) 
CDCl3 
1H NMR 
(400 MHz) 
CDCl398 
HMBC 
(H→C) 
COSY 
1 75.3 CH 75.02 74.6 5.50 d J=5.6 Hz 5.53 d J=5 
Hz  
2, 3, 4, 8, 
9 
- 
2 33.8 CH 33.57 33.3 2.21 m                                                                    2.23 m 3, 19 3α, 3β, 
19 
3a 37.2 CH2 36.93 36.9 1.64 dd J=7.3, 
13.7 Hz 
1.65 dd 
J=10, 14 Hz 
1, 2, 4, 5, 
19 
2, 3 
3b 2.47 dd* J=7.3, 
13.7 Hz 
2.13 dd J=7, 
14 Hz 
1, 2, 4, 9 2, 3 
4 60.7 C 60.45 60.4 - - - - 
5 57.8 CH 57.48 57.9 3.14 s 3.16 s 3, 4, 6, 9, 
20 
- 
6 57.4 C 57.0 56.5 - - - - 
7 41.8 CH** 36.93 44.3 2.80 d **J=12.5 
Hz 
3.06 d J=12 
Hz 
5, 6, 8, 9, 
10, 13, 14, 
15, 20 
- 
8 37.1 CH**  41.64 39.5 3.06 d **J=12.5 
Hz 
2.81 dd J=1, 
12 Hz 
6, 7, 9, 10, 
11, 18 
- 
9 69.0 C 68.63 68.9 - - - - 
10 145.3 C 145.3 146.8 - - - - 
11 36.5 CH2 36.29 34.8 2.47 m* 2.13 m 8, 10, 12, 
13, 18 
11, 12α 
11 2.58 m 2.60 m 8, 10, 12, 
18 
11, 12α, 
12β 
12 22.9 CH2 22.59 41.9 2.77 m 2.76 m 10, 11, 13 11α, 12 
12 2.98 m 2.89 m 11, 13, 14 11α, 
11β, 12 
13 150.4 C 150.1 107.5 - - - - 
14 122.3 C 121.89 159.0 - - -  
15 117.5 C 117.2 130.4 - - - - 
16 137.0 CH 136.69 170.8 7.0 brs 
W1/2=3.49 Hz 
7.03 t J=1 
Hz 
13, 14, 15 - 
17 8.8 CH3** 19.83 9.6 1.96 brs 
W1/2=2.53 Hz 
1.96 d J=1 
Hz 
14, 15, 16 - 
18 114.1 CH2 113.6 115.1 4.91 brs 
W1/2=4.93 Hz  
4.91 m 8, 10, 11 - 
18 5.01 brs W1/2= 
4.85 Hz 
5.03 d J=2 
Hz 
8, 10, 11 - 
19 12.8 CH3** 8.43 12.7 0.91 d J=7.1 Hz 0.91 d J=7 
Hx 
1, 2, 3 2 
20 20.2 CH3** 12.46 20.2 1.08 s  1.10 s 5, 6, 7 - 
COO 169.7 C 169.2 175.4 - - - - 
COCH3 20.8 20.46 - 2.11 s 2.11 s 1, COO - 
*Refer to overlapped proton resonances, **The 13C NMR chemical shifts have been corrected by using HMBC and COSY 
correlations 
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 Structural elucidation of compound CD.13: crotodichogamoin A         
(Appendices 107-115) 
 
Figure 2.28: Structure of compound CD.13: crotodichogamoin A 
Compound CD.13 was isolated as a yellow gum from the dichloromethane extract of the 
roots of C. dichogamus and was found to be a new crotofolane-type diterpenoid.  This 
compound differed from CD.12 as the acetate group at C-1 was replaced with a ketone group 
in CD.13. 
 
The HRMS spectrum of compound CD.13 gave a [M+H ]+ ion at m/z 327.1590 which 
indicated a molecular formula of C20H22O4.  A double bond equivalence of ten was calculated 
for this compound.  The FTIR spectrum showed absorption bands at 2917 and 2848 cm-1 for 
C-H aliphatic stretches, 1747 cm-1 for a carbonyl stretch, 1649 cm-1 for a double bond stretch, 
1451 and 1384 cm-1 for methyl and methylene bending and 1269 cm-1 for an epoxide C-O 
stretch.77 
 
The 13C NMR and DEPT spectra displayed twenty carbon resonances, including one ketone 
group resonance at δC 206.1, four oxygenated carbon resonances at δC 56.2 (C-5), δC 61.5 (C-
6), δC 65.8 (C-4) and δC 66.1 (C-9), three methyl group carbon resonances at δC 8.9 (C-17), δC 
16.0 (C-19) and δC 20.3 (C-20) and six aromatic/olefinic carbon resonances, four of them for 
the furan ring at δC 117.0 (C-15), δC 121.8 (C-14), δC 137.0 (C-16) and δC 150.4 (C-13), one 
fully substituted and a methylene olefinic carbon resonances at δC 141.9 (C-10) and δC 116.9 
(C-18) respectively [Figure 2.28 and Table 2.20].  
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The NMR data indicated that CD.13 was a similar compound to CD.12, except for the 
absence of the acetyl group resonance, instead of which, one ketone group carbon resonance 
at δC 206.1 was observed.  Since this ketone group resonance displayed correlations in the 
HMBC spectrum with the H-2 (δH 2.49) and 2H-3 (δH 2.66 and 1.84) proton resonances, it 
was placed at C-1.  The assignment of the relative configuration of compound CD.13 was 
based on the NOESY spectrum and in comparison with the previous compound.  The H-5 (δH 
3.29) resonance showed a correlation with the 3H-20 (δH 1.09) resonance, which, in turn, 
showed further correlations with the H-8 (δH 2.49) and 3H-17 (δH 1.96) resonances.  
Therefore, the H-5, H-8, 3H-20 were assigned the β-orientation.  The specific optical rotation 
for compound CD.13 was found to be + 11.3.  
Table 2.20: NMR data for compound CD.13: crotodichogamoin A in CDCl3 
N 13C NMR(125 
MHz) CDCl3 
1H NMR (500 MHz) 
CDCl3 
HMBC (H→C) COSY NOESY 
1 206.1 C - - - - 
2 38.7 CH 2.49 m* 1, 3, 4, 9, 19 3α, 3β, 19 3α, 3β, 19 
3α 31.2 CH2 2.66 dd J=8.3, 14.0 Hz 1, 2, 4, 9, 19 2, 3 2, 3β 
3β 1.84 dd J=6.8, 14.0 Hz 1, 2, 4, 9, 19 2, 3 2, 3α,19 
4 65.8 C - - - - 
5 56.2 CH 3.29 s 4, 6, 9, 20 - 20 
6 61.5 C - - - - 
7 49.0 CH 2.49 d* J=13.0 Hz 6, 8, 9, 10, 13, 14, 15, 20 8 12α 
8 39.9 CH 2.78 d* J=13.0 Hz 4, 6, 7, 9, 10, 14, 18 7 20, 12a 
9 66.1 C - - - - 
10 141.9 C - - - - 
11α 37.8 CH2 2.53 m 8, 10, 12, 13, 18 11, 12α 11β, 12α, 18a 
11β 2.78 m* 10, 12, 13, 18 11, 12α, 12β 11α, 12β 
12α 23.1 CH2 2.81 m 10, 11, 14 11α,  12 7, 11α, 12β 
12β 2.95 m 10, 11, 13, 14 11α, 11β, 12 8, 11β 
13 150.4 C - - - - 
14 121.8 C - - - - 
15 117.0 C - - - - 
16 137.0 CH 7.03 s 13, 14, 15, 17 -  
17 8.9 CH3 1.96 s 14, 15, 16 - 20 
18a 116.9 CH2 5.06 s 8, 10, 11 - 11α, 18b 
18b 4.67 brs 8, 10, 11  11a 
19 16.0 CH3 1.11 d J=7.5 1, 2, 3 2 2, 3β 
20 20.3 CH3 1.09 s 5, 6, 7  5, 8, 17 
*Refer to overlapped proton resonances 
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 Structural elucidation of compound CD.14: crotodichogamoin B         
(Appendices 116-124) 
 
Figure 2.29: Structure of compound CD.14: crotodichogamoin B 
Compound CD.14 was isolated as a yellow oil from the dichloromethane extract of the roots 
of C. dichogamus and was found to be a new crotofolane-type diterpenoid. 
 
The HRMS spectrum of compound CD.14 gave a [M+H]+ ion at m/z 295.1694 which 
indicated a molecular formula of C20H22O2 for the compound.  A double bond equivalence of 
ten was calculated for this compound.  The FTIR spectrum showed absorption bands at 2928 
and 2856 cm-1 for C-H aliphatic stretches, 1730 cm-1 for a carbonyl stretch, 1594 cm-1 for a 
double bond stretch, and 1449 and 1377 cm-1 for methyl and methylene bending 
respectively.77 
 
The 13C NMR and DEPT spectra, displayed twenty carbon resonances, including two ketone 
group resonances at δC 208.1 (C-1) and δC 202.5 (C-13), four methyl group carbon 
resonances at δC 16.1 (C-19), δC 20.6 (C-20), δC 22.1 (C-17) and δC 23.5 (C-16) and ten 
double bond or aromatic carbon resonances.  Six of them at δC 126.9 (C-5), δC 131.0 (C-4), δC 
137.9 (C-6), δC 139.2 (C-8), δC 143.4 (C-7) and δC 153.3 (C-9) were assigned to benzene ring 
carbons, three fully substituted resonances at δC 134.3 (C-14), δC 142.0 (C-10), δC 147.5 (C-
15) and one methylene olefinic carbon resonances occurred at δC 114.8 (C-18) [Figure 2.29 
and Table 2.21].  
 
The NMR data of CD.14 showed some similarity with that of CD.13 but with the absence of 
the two epoxide groups and furan ring and the presence of a benzene ring and second ketone 
80 
 
group.  The singlet proton resonance at δH 7.22, which corresponded to the carbon resonance 
at δC 126.9 in the HSQCDEPT spectrum, displayed correlations in the HMBC spectrum with 
four olefinic carbon resonances at δC 131.0 (C-4), δC 137.9 (C-6), δC 143.4 (C-7) and δC 153.3 
(C-9), one methylene carbon resonances at δC 34.4 (C-3) in the cyclopentenone ring and one 
methyl group carbon resonance at δC 20.6 (C-20).  This resonance was assigned as H-5 and 
confirmed the presence of the benzene ring.  The ketone group carbon resonances at δC 202.5 
was assigned to C-13 due to its correlations with methylene proton resonances at δH 2.82 and 
δH 2.72 (2H-11) and δH 2.27 and δH 2.43 (2H-12) in the HMBC spectrum.  Moreover, the 
NMR spectrum revealed one isopropenyl group with two fully substituted olefinic carbon 
resonances at δC 134.3 (C-14) and δC 147.5 (C-15) and two methyl group carbon resonances 
at δC 23.5 (C-16) and δC 22.1 (C-17). 
 
This molecule is the likely precursor of CD.12 and CD.13.  Oxidation of the Δ5 and 4,9-
double bonds to epoxides, reduction of the Δ7 double bond, and formation of the furan ring 
from the oxygen C-13 and C-16 would occur. 
 
The relative configuration of the H-2/3H-19 in compound CD.14 was assumed to be the same 
as in the previous compounds CD.12 and CD.13.  The specific optical rotation for compound 
CD.14 was found to be +111.1. 
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Table 2.21: NMR data for compound CD.14: crotodichogamoin B in CDCl3 
No. 
 
13C NMR(125 
MHz) CDCl3 
1H NMR (500 MHz) 
CDCl3 
HMBC (H→C) COSY NOESY 
1 208.0 C - - - - 
2 42.9 CH 2.72 m* 1, 3, 9, 19 3α, 3β, 19 3α 
3α 34.4 CH2 3.34 dd J= 8.0, 16.8 1, 2, 4, 5, 9, 19 2, 3 2, 3, 5 
3β 2.66 m 2, 4, 5, 9,19 2, 3 5, 19 
4 131.0 C - - - - 
5 126.9 CH 7.22 s 3, 4, 6, 7, 9, 20 - 3α, 3β, 20 
6 137.9 C - - - - 
7 143.4 C - - - - 
8 139.2 C - - - - 
9 153.3 C - - - - 
10 142.0 C - - - - 
11α 31.7 CH2 2.82 m 8, 10, 12, 13, 18 11, 12α, 
12β 
12α, 18a 
11β 2.72 m* 8, 10, 12, 13, 18 11, 12α, 
12β 
12β, 18a 
12α 40.9 CH2 2.27 m 10, 11, 13, 14 11α, 11β, 
12 
11α, 12β 
12β 2.43 m 10, 11, 13 11α, 11β, 
12 
11β, 12α 
13 202.5 C - - - - 
14 134.3 C - - - - 
15 147.5 C - - - - 
16 23.5  CH3 1.49 s 14, 15, 17 - 17 
17 22.1 CH3 2.13 s 14, 15, 16 - 16 
18a 114.8 CH2 5.26 s 8, 10, 11 - 11α, 11β, 
18b 
18b 4.93 brs 8, 10, 11  18a 
19 16.1 CH3 1.28 d J=7.1 1, 2, 3 2 3β 
20 20.6 CH3 2.21 s 5, 6, 7 - 5, 17 
*Refer to overlapped proton resonances 
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 Structural elucidation of compound CD.15: acetyl aleuritolic acid          
(Appendices 125-131) 
 
 
 
 
 
 
Figure 2.30: Structure of compound CD.15: acetyl aleuritolic acid 
Compound CD.15 was isolated as a white crystalline compound from the dichloromethane 
extract of the roots of C. dichogamus and was found to be the common triterpenoid, acetyl 
aleuritolic acid.  It has been isolated previously from Croton cajucara,100 Croton 
cascarilloides33 and Spirostachys africana (Euphorbiaceae).101 
 
The LREIMS spectrum for compound CD.15 gave a molecular ion peak at m/z 497.3829 
which indicated a molecular formula of C32H50O4.  A double bond equivalence of eight was 
calculated for this compound.  The FTIR spectrum showed the presence of absorption bands 
at 2934 and 2861 cm-1 for C-H aliphatic stretches, 1732 and 1686 cm-1 for acetate carbonyl 
and free carboxylic acid carbonyl group stretches respectively, 1453 cm-1 for methyl bending 
and 1246 cm-1 for C-O stretch.77 
 
The 13C NMR spectrum, displayed thirty-two carbon resonances, including nine fully 
substituted carbons, five methine, ten methylene and eight methyl group carbon resonances.  
The HSQCDEPT and 13C NMR spectra also showed two carbonyl carbon resonances at δC 
171.2 and 181.8, two olefinic carbon resonances at δC 116.8 (C-15) and δC 160.9 (C-14).  The 
1H NMR spectrum showed seven singlet methyl group proton resonances at δH 0.85 (3H-23), 
δH 0.88 (3H-24), δH  0.92 (3H-30), δH 0.93 (3H-27), δH 0.94 (3H-29), δH 0.95 (3H-25), δH 
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0.96 (3H-26) and one acetyl methyl group proton resonances at δH 2.05. These data supported 
a triterpenoid structure [Figure 2.30 and Table 2.22].  
 
The oxygenated carbon resonance at δC 81.1 was assigned as C-3 due to its correlations with 
two methyl singlet proton resonances at δH 0.85 (3H-23) and δH 0.88 (3H-24) in the HMBC 
spectrum and coupling with the 2H-2 (δH 1.62) resonance in the COSY spectrum.  The fully 
substituted carbon resonance δC 160.9 was assigned to C-14 due to the correlations with the 
two methyl singlet proton resonances at δH 0.96 (3H-26) and 0.93 (3H-27) in the HMBC 
spectrum.  Compound CD.15 showed the same 13C NMR chemical shifts to those of the 
known acetyl aleuritolic acid which has been reported previously.33  
 
Compound CD.15 has been reported to have antibacterial activity against Escherichia coli, 
Salmonella typhi, Shigella dysentery, Staphylococcus aureus and Vibrio cholera with MIC 
values of 50 µg/ml.101  Moreover, it showed cytotoxic activity against human cancer central 
nervous system (U251, Glia) cell line, with IC50 8.4 μM.35 However, it did not show cytotoxic 
activity against Vero cell lines (African green monkey) in vitro with IC50 > 400 µg/ml)  and 
against cultured human lung cancer cell line (A459) with ED50 >20.
33 
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Table 2.22: NMR data for compound CD.15: acetyl aleuritolic acid in CDCl3 compared 
against literature reference values 
No. 13C MR(125 
MHz) CDCl3 
13C MR(125 
MHz) CDCl333 
1H NMR (500 
MHz) CDCl3 
HMBC (H→C) COSY NOESY 
1α 37.6 CH2 
 
37.4 1.61  m - 1, 2 3 
1β 1.03 m - 1, 2 2 
2 23.7 CH2 23.5 1.62 m - 1α, 1β, 3 1β 
3 81.1 CH 80.9 4.46 dd J=5.7, 11 
Hz 
- 2 1α, 2, 24 
4 37.9 C 37.7 - - - - 
5 55.8 CH 55.6 0.86 J=13.0 Hz - 6B 11α 
6α 18.9 CH2 18.7 1.64 m - 6 - 
6β 1.48 m - 5, 6 25 
7α 41.1 CH2 40.7 1.96 m - 7 27 
7β 1.29 m - 7 - 
8 39.3 C 39.0 - - - - 
9 49.3 CH 49.1 1.42 m - 11α, 11β - 
10 38.1 C 37.9 - - - - 
11α 17.5 CH2 17.3 1.59 m - 9, 11, 12α, 12β 5, 12α 
11β 1.47 m - 9, 11, m12α, 
12β 
25 
12α 33.6 CH2 33.3 1.77 - 11α, 11β, 12 11α 
12β 1.62 - 11α, 11β, 12 25 
13 37.6 C 37.3 - - - - 
14 160.9 C 160.5 - - - - 
15 116.8 CH 116.9 5.54 dd J=3.2, 7.9 
Hz 
- 16, 16 - 
16α 31.7 CH2 31.3 1.96 md - 15, 16 27 
16β 2.39 brdd J=7.9, 
14.2 Hz 
- 15, 16 16 
17 51.4 C 51.5 - - - - 
18 41.8 CH 41.4 2.28 J=3.8, 13.5 Hz - 19α, 19β - 
19 35.6 CH2 35.3 1.26 m 18, 20, 29 18, 19- - 
19 1.10 m - 18, 19 - 
20 29.5 C 29.3 - - -- - 
21α 33.9 CH2 33.7 1.18 - 21 - 
21β 1.08 - 21, 22α, 22β 18, 22β 
22α 31.0 CH2 30.7 1.43 m - 21B, 22 30 
22β 1.70 m - 21B, 22 21β 
23 28.2 CH3 27.9 0.85 s 3, 4, 5, 24 - - 
24 16.8 CH3 16.6 0.88 s 3, 4, 5, 23 - - 
25 15.8 CH3 15.6 0.95 s* 5, 9 - 6β, 11β, 12β 
26 26.3 CH3 26.2 0.96 s 7, 8,  9, 14 -  
27 22.6 CH3 22.5 0.93 s 12,  13, 14, 18 - 7α, 16α 
28 181.8 C 184.5 - - - - 
29 32.2 CH3 31.8 0.94 s* 20, 30 - 18 
30 28.9 CH3 28.6 0.92 s 22, 29 - 22α 
Ac-M 21.5 CH3 21.3 2.05 s Ac -  
Ac 171.2 C 171.0 - - -- - 
*Refer to overlapped proton resonances 
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 Conclusion  
This chapter described the phytochemistry of the Kenya Croton species, C. dichogamus Pax 
[Euphorbiaceae family].  Previous studies in 1989 showed that two new crotofolane 
diterpenoids: crotoxide A and crotoxide B were isolated from the leaves of this species  
collected in Kenya.73  In this study, fifteen compounds were isolated from the the roots 
extract of C. dichogamus.  They include four known sesquiterpenoid (CD.1-CD.4), one new 
enantiomer of a known sesquiterpenoid (CD.5), four known ent-clerodane diterpenoids 
(CD.6-CD.9), two new halimane diterpenoids (CD.10-CD.11), one known crotofolane 
(CD.12) two new crotofolane diterpenoids (CD.13-CD.14) and one known triterpenoid 
(CD.15) [Figure 2.30]. 
 
The CSEARCH/NMR PREDICT–SERVER was employed to propose the structure of CD.1 
and CD.2.  CD.1 and CD.3 have been isolated previously from a constituent of the essential 
oils of different Croton species.75,76,83,84  CD.2, CD.4 and CD.5 have not been previously 
isolated from Croton species.  Even the known enantiomers of sesquiterpenoid CD.5 have 
not been isolated previously from Croton species.   
 
The known clerodane-type diterpenoid CD.6, CD.8 and CD.9, and know triterpenoid CD.15 
have been isolated from Croton species,88,89  while CD.7 has not been isolated before from 
Croton species and this study is the first report for its NMR data.  In addition, two new 
halimane diterpenoids (CD.10-CD.11) and two new crotofolane diterpenoids (CD.13-CD.14) 
have been isolated in this study. 
 
The absolute configuration of compound CD.5 and CD.8 were determined using electronic 
circular dichroism (ECD).  The experimental ECD was compared with the calculated ECD 
curves for the normal and ent enantiomers compounds of the possibilities stereochemistry.  A 
conformational search on each compound was done using Spartan14.  The NOESY and 
ROESY correlations, 1H and 13C resonance values, and specific optical rotation were used to 
determine the relative configuration of the rest of the compounds and by comparing against 
reported literature values.   
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Figure 2.31: Compounds isolated from the roots extract of C. dichogamus 
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 Chapter 3. The phytochemistry of three Crinum species: Crinum species 
6538, Crinum hardyi Lehmiller and Crinum species 6529 
[Amaryllidaceae family] 
 Introduction to the Amaryllidacea family 
The Amaryllidaceae family are bulbous plants, mostly geophytic, terrestrial and perennial.  
Leaves are persistent or annual, linear, sessile, and usually glabrous.  Inflorescences are 
scapose and pseudoumbellate.  Flowers are perfect, mostly showy and large, sessile or 
pedicellate, actinomorphic or zygomorphic, consisting of 3+3 segments and inner segment 
usually shorter than the outer.  Stamens are 3+3 and varying in length, ovaries are 
tricarpellate and inferior.  Mature fruits are a loculicidal capsule, seeds are globose or 
subglobose, hard or flesh and winged.102,103  The Amaryllidaceae family is composed of 59 
genera and 850 species that are classified into three subfamilies, the Agapanthoideae, 
Allioideae and Amaryllidoideae.102,104  This family are widely distributed in the tropical and 
subtropical regions with more diversity in South America and South Africa, also many genera 
of this family such as Crinum have been cultivated for ornamental because of their beautiful 
flowers.102,103 
 
The Amaryllidaceae family is included in the top 20 of the most widely used plants in 
ethnobotany.105,106  Since 1877, when the first alkaloid, lycorine, was isolated from 
Amaryllidaceae lycoris, more than 500 different alkaloids, known as the Amaryllidaceae 
alkaloids, have been isolated from this family and have been shown to exhibit various 
pharmacological activities, such as antibacterial, antifungal, antimalarial, antitumor and 
acetylcholinesterase inhibitory activity.105,106  One of the most important and largest genera of 
the Amaryllidaceae family is Crinum [Picture 3.1].105,107 
 
 Introduction to the Crinum genus  
 The Crinum genus and ethnopharmacology  
Crinum belongs to the Amaryllidoideae subfamily, Amaryllideae tribe and Crininae 
subtribe.102  According to Kubitzki (1998) the Crininae subtribe is composed of four genera, 
Ammocharis, Boophone, Crinum and Cybistetes.102  The Crinum genus consists of 
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herbaceous plants with large tunicated bulbs, perennial, linear or lorate leaves, and free 
stamens.102,108  Flowers are zygomorphic to actinomorphic, fruits are usually beaked and 
succulent.  Seeds are large, pale to dark and subglobose.102  This genus comprises more than 
150 species distributed in the tropics of Africa, Madagascar, America and Asia and in the 
warm temperate regions of South Africa, Australia, Japan and southern regions of the 
U.S.A.108,109  Due to the broad geographical distribution of the genus in the regions where the 
plants are widely used in herbal medicine, there are many reports of their use in the treatment 
of diseases and, in some cases, the same species is used for the same purpose in several 
countries.110  Therefore, Crinum has attracted the attention of many researchers during the 
last decades to find potential pharmaceutical uses.107  Pharmacological studies of Crinum 
species have indicated various biological activities.  Fennell and Van Staden, and Tram et al. 
reviewed the medicinal uses of Crinum species in different countries.110,111  Table 3.1 shows 
some examples of the traditional uses and results of bioactivity screening of Crinum 
species.110,111   
   
Crinum sp. Narcissus sp. 
 
 
Zephyranthes sp. Hippeastrum sp. 
Picture 3.1: Flowers of the Amaryllidaceae genus112 
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Table 3.1: Selected examples of ethno-medicinal applications of Crinum species in 
different areas and their pharmacological effects 
Plant name  Plant 
part 
Region Traditional uses Plant part/ 
Compound  
Bioassay activity 
C. asiaticum L Seeds India  Tonics, purgatives and 
diuretics111  
Ethanol leaf 
extract 
Antioxidant,113  
Not 
stated 
Malaysia Rheumatism114 Methanol leaf 
extract 
Anti-
inflammatory114 
C. amabile Donn Not 
stated  
Vietnams 
Emetic, earache and 
rheumatism110,111 
Augustine, and 
crinamine  
Cytotoxic and 
antimalarial115 
C. bulbispermum 
(Burm.) Milne-
Redhead and 
Schweickerdt 
Leaves / 
bulbs  
Sotho, 
Tswana and 
Zulu 
Aching joint, cold, 
rheumatism and kidney 
and bladder 
infections110,111 
Aqueous leaf 
extract 
Antinociceptive 116 
Leaves  Sri Lankan Earache116 
C. giganteum Andr Not 
stated 
Congo Leprosy110 Aqueous bulbs 
extract 
Sedative117 
Mexico Ceremonies and 
festival110 
C. jagus Bulbs  Nigeria Anticonvulsant110, 
memory loss118 
Hamayne and 
lycorine  
Acetylcholinesterase 
inhibitory 118 
Crinum macowanii 
Bak 
Bulbs Zimbabwe Backache and increase 
lactation and blood 
supply110 
Methanolic bulb 
extract 
In vitro antiviral 
RNA activity119 
Sotho, Xhosa 
and Zulu  
Urinary tract problems 
and swellings110 
C. modestum Baker Not 
stated 
Madagascar Otitis, anthrax and 
abscesses111 
Not stated Not stated 
C. pupurascens 
Herb 
Not 
stated 
Cameroon Sleeping troubles and 
sexual asthenia111 
Not stated Not stated 
 
 Chemical constituents of the Crinum genus 
Phytochemical analyses of Crinum species have shown that this genus produces a wide 
variety of compounds.  Non-alkaloid compounds such as flavonoids, chromones, terpenoids, 
sterols and fatty acids have been isolated but have received less attention than the alkaloid 
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constituents.111  Approximately 180 alkaloids have been isolated from the Crinum genus, and 
they are known as Amaryllidaceae alkaloids.107 
Amaryllidaceae alkaloids are a large group of isoquinoline alkaloids-over 300 alkaloids-
found only in the Amaryllidaceae family.120  However, Amaryllidaceae alkaloids have been 
reported three times from species belong to other families.  Miyakado et al. reported the 
isolation of lycorine  and acetylcaranine from Urginea altissima Bak (Hyacinthaceae).121  
Later Mulholland et al. isolated crinamine from the Dioscorea dregeana (Dioscoreaceae).122  
Recently Wang et al. reported lycorine, haemanthamine, haemanthidine and other 
Amaryllidaceae alkaloids from Hosta plantaginea (Liliaceae) [Figure 3.1].123  However, 
misidentification or contamination of plant materials could have been the reason for these 
rare discoveries. 
 
The Amaryllidaceae alkaloids can be classified into nine groups [Figure 3.2], lycorine, 
homolycorine, crinine, haemanthamine, narciclasine, tazettine, galanthamine, montanine and 
miscellaneous classes according to the position of rings C and D and the heteroatom present 
in ring B.  The characteristics of montanine, and miscellaneous types somewhat differ from 
the rest of the alkaloid types.  Montanine alkaloids have a seven membered B ring and a six 
membered C ring, while the miscellaneous group do not show similarity with any of other 
classes and are therefore grouped in one different class.  
  
 R1 R2  R1 R2 R3 
C1: Lycorine H OH C3: Crinamine α Me β OH H 
C2: Acetylcaranine Ac H C4: Haemanthamine β Me αOH H 
 C5: Haemanthidine β Me α OH α/β OH 
Figure 3.1: Amaryllidaceae alkaloids reported in another families 
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Figure 3.2: Types of Amaryllidaceae alkaloids 
 
 The biological activities of Amaryllidaceae alkaloids 
The most important Amaryllidaceae alkaloid is galanthamine which has been commercially 
approved in the USA and several countries in Europe for the treatment of mild-to-moderate 
Alzheimer’s disease.124  Galanthamine [Figure 3.3] is competitively and reversibly a 
cholinesterase inhibitor, and it is use leads to better functioning. and cognitive and behaviour 
effects than a placebo to treat patients.125   
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Lycorine [Figure 3.1] has shown analgesic and antinociceptive activity126 and antioxidant 
activity against CCl4 induced oxidative stress in Swiss albino mice liver cells.
127  In addition, 
lycorine inhibits the Mcl-1 protein in human leukaemia cells which induces apoptosis in a 
cultured cell line and patient samples.128  Lycorine hydrochloride [Figure 3.3] was a 
candidate for ovarian cancer therapy as it showed selectively inhibition against ovarian 
cancer cell proliferation.129  Moreover, some lycorine derivative showed anti-parasitic 
activity against Trypanosoma brucei brucei, and Plasmodium falciparum.130  (+)-8-
Hydroxyhomolycorine-α-N-oxide [Figure 3.3] showed significant cytotoxicity against head 
and neck squamous cell carcinoma, CAL-27, Hep-2, SCL-1, UMSCC-1, Detroit-562, SCC-
PKU, and TCA-83 cell lines with IC50 values of 12.3, 11.6, 13.2, 12.3, 12.9, 13.2 and 16.7 
µM respectively.131  Lycorenine [Figure 3.3] exhibited cytotoxic activity against HepG2 
hepatoma.110  (+)-Hippeastrine [Figure 3.3] showed antifungal activity against Candida 
albicans with a MIC value 125 µg/ml.132  Crinamine and haemanthamine [Figure 3.1] 
induced apoptosis at 25µM after 48h in rat liver hepatoma 5123tc cells.133  Doskocil et al. 
reported strong cytotoxicity for haemanthamine and haemanthidine against p53-mutated 
Caco-2 and HT-29 colorectal adenocarcinoma cells.134  Crinine and 6-hydroxycrinamine 
[Figure 3.3] showed acetylcholinesterase inhibitory activity.135  Haemanthidine [Figure 3.1] 
has been reported for its promising cytotoxicity against different cancer cell lines such as, 
LNCaP (prostate) and HT (sarcoma) cell lines.136,137  In addition, it showed an ability to 
decrease cell viability and mitochondrial membrane potential which leads to an increase in 
apoptosis and caspase activity in p53-negative human leukemic Jurkat cells within 24h of 
treatment.137    
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Galanthamine  Lycorine hydrochloride 
 
 
(+)-9-Hydroxyhomolycorine-α-N-oxide 
Lycorenine 
 
 
(+)-Hippeastrine Crinine 
 
 
6-Hydroxycrinamine  
Figure 3.3: Some Amaryllidaceae alkaloids 
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 Amaryllidaceae alkaloid types in the Crinum genus  
Ghosal et al. reported the occurrence of 12 types of alkaloids in the Crinum genus.138  In 
2012, Refaat et al. reported that crinine, lycorine, and tazettine alkaloids were the most 
commonly isolated alkaloids from the Crinum genus, while montanine had not been isolated 
yet.107  Since only alkaloids of the lycorine, homolycorine, crinine and haemanthamine type 
have been isolated in this work, these types will be discussed in detail. 
 
3.2.4.1 Lycorine type alkaloids 
Lycorine itself is the most common of the isoquinoline alkaloids.120  It consists of four rings: 
A, B, C and an additional five membered heterocyclic D ring.  The A and B rings form the 
isoquinoline skeleton.  The C and / or D rings in many cases display some degree of 
unsaturation and oxygenation.111  Lycorine alkaloids show a trans B/C ring junction except 
kirkine which has a cis B/C ring junction.120  
 
Many lycorine type alkaloids have been isolated from the Crinum genus, usually from bulbs 
and fruits, and quaternary lycorine salts have been isolated as well from this genus.111  Some 
examples of lycorine type alkaloids isolated from Crinum species are given in Figure 3.4 
compounds 1-6. 
 
3.2.4.2 Homlycorine type alkaloids 
The main characteristic of the homolycorine or lycorenine type of alkaloids is having the B 
ring with a hemiacetal, lactone or cyclic ether group.120  Usually the nitrogen in this type of 
alkaloid is methylated.  Most of these compounds contain a cis B/C ring junction, and are 
substituted at position H-5α as in compounds 7-10 in Figure 3.4.120 
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C. americanum139 C. asiaticum140 R C. asiaticum140  R 
1: Ungeremine 2: 1,2-0-β-D-
Diglucosidelycorine  
β-D-glc 3: Lycorine N-oxide O- 
 
     
 
  
 
 
C. latifolium141 C. latifolium141 C. latifolium141 
4: Pancrassidine 5: Dehydroanhydrolycorine 6: Hippadine 
 
  
C. defixum 142 C. latifolium 142 
 R R1 R2 R3  
7: 5α-Hydroxyhomolycorine Me Me H OH 10: Hippeastrine 
8: Homolycorine Me Me H H  
9: 9-O-Demethylhomolycorine H Me H H  
Figure 3.4: Lycorine and Homolycorine type alkaloids isolated from Crinum species142 
 
3.2.4.3 Crinine and haemanthamine type alkaloids 
Crinine and haemanthamine types of alkaloids are also known as 5,10b-ethanophenathridine 
type alkaloids.  This type of alkaloid is the most common alkaloid in the Amaryllidaceae 
family and Crinum genus with variation in substituents, double bonds and oxygenation in 
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ring C.111  The distinction between crinine and haemanthamine alkaloids lies in the 
orientation of the 5,10b-ethano bridge.  In the crinine class the bridge is in the β-position, 
while in the haemanthamine alkaloids is in the α-orientation [Figure 3.5 and Figure 3.6].  
The absolute configuration of 5,10b-ethano bridge may be determined by circular dichroism 
spectroscopy.120 
 
 
C. erubescens143 
Crinamine 
 
 
 
C. delagoense144 
Delagoensine R1+R2= OCH2O     
Delagoenine R1= R2= OMe    
 
 
 
C. amabile145 
Vittatine 
 
Figure 3.5: Haemanthamine type alkaloids isolated from Crinum species 
 
 
 
 
 
 
 
 
 
 
97 
 
 
 
 
 
C. erubescens143 R1 R2 R3 C. amabile145 R 
1-Epidemethylbowdensine H OAc OH Crinamabine OH 
1-Epidemethoxybowdensine H OAc H 4a-Dehydroxycrinamabine |H 
Bowdensine OAc H OMe  
 
 
C. latifolium146 C. amabile145 R 
6-Hydroxycrinamidine  Flexinine  H 
 Augustine  Me 
 
 
 
C. augustum147 C. americanum139 
 R1 R2 R3  R1 R2 
6α- Hydroxybuphanisine Me OH H O-Acetylcrinine H OAc 
6β- Hydroxybuphanisine Me H OH  
6α-Hydroxycrinine H OH H  
6β-Hydroxycrinine H H OH  
Figure 3.6: Crinine type alkaloids isolated from Crinum species 
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  The biosynthesis of Amaryllidaceae alkaloids  
Amaryllidaceae alkaloids are biosynthetically derived from the amino acids L-phenylalanine 
and L-tyrosine via norbelladine.  Phenylalanine is a primary precursor of the C6-C1 unit from 
which the aromatic A ring and benzylic carbon are derived, while tyrosine is the precursor of 
the nitrogen atom and C6-C2 unit from which the aliphatic C ring and two carbon side chain 
are derived.148   
 
The biosynthesis of Amaryllidaceae alkaloids begins with the decarboxylation of tyrosine to 
tyramine via a decarboxylase enzyme [Scheme 3.1].  Meanwhile, the phenylalanine ammonia 
lyase (API) enzyme deaminates the phenylalanine in an antiperiplaner manner with loss of 
the B-pro-S hydrogen to produce cinnamic acid.  The hydroxylation and oxidation of 
cinnamic acid give protocatechuic aldehyde.  The condensation of tyramine and 
protocatechuic aldehyde gives the norbelladine precursor.  The phenolic oxidative coupling 
of norbelladine or other biosynthetic precursors produces the different groups of alkaloids 
and in most cases O-methylnorbelladine is the intermediate compound .107,120,149 
 
The first step of lycorine and homolycorine biosynthesis starts from the precursor 
norbelladine.  Norbelladine is methylated to O-methylnorbelladine.  Followed by o-p-
phenolic coupling with cyclisation and formation of a carbon-nitrogen bond to produce 
norpluviine 120 
 
During the lycorine biosynthesis [Scheme 3.2], the hydroxyl group and the adjacent methoxy 
group on the norpluviine A ring combine to form a methylenedioxy group.  Finally 
hydroxylation at C-2 produces lycorine.  In the homolycorine pathway the norpluviine 
undergoes benzylic oxidation at position 7, then ring opening will produce an amino 
aldehyde.150  Rotation about the C11a-C11b bond is then following by hemiacetal formation, 
oxidation and methylation at the nitrogen atom to produce homolycorine.120 
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In the crinine and haemanthamine type alkaloid biosynthesis [Scheme 3.3], the p-p-phenolic 
coupling takes place between the two aromatic rings of the precursor o-methylnorbelladine to 
give an ethanoic bridge between the C-10b and the N at position 5.  Two different series of 
alkaloid, crinine or haemanthamine, can arise depending on the way that precursor is twisted. 
 
Scheme 3.1: Probable pathway to Amaryllidaceae alkaloids.107,120 
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Scheme 3.2: Probable pathway to lycorine and homolycorine alkaloids.120,149,151 
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Scheme 3.3: Probable pathway to crinine and haemanthamine Amaryllidaceae 
alkaloids.151,152 
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 The chemistry of Crinum species 6538 
 C. firmifolium Baker and Ethnobotany 
Eleven species of Crinum are reported to occur in Madagascan, including Crinum firmifolium 
Baker.  The phytochemistry of this species has been investigated.  C. firmifolium has a big 
bulb, 10-14 cm in diameter, with a long neck, leaves are loriformes or slightly lanceolate, 
peduncle is slightly compressed and holding a dense umbel of 8-20 flowers.  Flowers are 
sessile or shortly stalked [Picture 3.2], the fruit is irregularly spherical up to 6 cm, 
indehiscent and contains 3 to 13 seeds per fruit.  This species occurs in three varieties, C. 
firmifolium Var. hygrophilum H. Perr, C. firmifolium Var. geophilum H. Perr. and C. 
firmifolium Var. xerophilum H. Perr.153  Crinum firmifolium is endemic to Madagascar,154 
where it is called vahondrano and kingatsy and it is used externally for the treatment of 
different parasitic skin diseases.111  
 
 
Picture 3.2: Flowers and leaves of Crinum firmifolium155 
 Chemical constituents of the Crinum firmifolium 
In 1996, Razafimbelo et. al, isolated one novel compound 3-hydroxy-8,9-
methylenedioxyphenanthridine (1), seven known alkaloids, trisphaeridine (2), crinamine (3), 
hamayne (4), 6-hydroxycrinamine (5), criwelline (6), ismine (7) and lycorine (8) from whole 
plants of C. firmifolium Var. hygrophilum.156  In addition, the flavouring agent α-ionone (4,7-
megastigmadiene-9-one) (9), vomifoliol (6S, 7E, 9R-6,9-dihydroxy-4,7-megastigmadien-3-
one) (10) and tyramine (4-(2-aminoethyl)phenol) (11) were found in the same species. 111,156  
103 
 
Before that, in 1953, Hungar isolated just one alkaloid, lycorine (8) from Madagascan 
Crinum firmifolium [Figure 3.7]. 
 
 
  R1 R2  R1 R2 
1: 3-Hydroxy-8,9-
methylenedioxyphenanthridine 
H OH 3: Crinamine Me H2 
2: Trisphaeridine H H 4: Hamayne H H2 
   5: 6-Hydroxycrinamine Me OH (Author did not determine 
configuration)  
 
 
6: Criwelline  7: Ismine   
 
 
8: Lycorine 9: α-Ionone (4,7-megastigmadiene-9-one)                    
 
 
10: Vomifoliol (6S, 7E, 9R-6,9-dihydroxy-4,7-
megastigmadien-3-one)  
11: Tyramine (4-(2-aminoethyl)phenol) 
Figure 3.7: Compounds isolated previously from C. firmifolium Var. hygrophilum111,156
104 
 
 Results and discussion of Crinum sp. 6538 
We have been provided with plant material labelled Crinum sp. 6538.  We are waiting for 
flowering over this summer to confirm whether it is C. firmifolium Var. hygrophilum, or a 
new species.  Plant material was collected under permit in Madagascan and propagated in a 
green house in Austria.  The objective of this study was to compare the reported chemical 
constituents of C. firmifolium Var. hygrophilum with those of Crinum sp. 6538.  Secondly, 
this species was investigated to obtain experience working with Amaryllidaceae alkaloids 
before investigating the other two new Crinum species, Crinum hardyi Lehmiller and Crinum 
species 2 5629, which have not been investigated before. 
 
Picture 3.3 shows the bulbs of Crinum sp. 6538, which were used in this study.  The 
phytochemical analysis of the hexane and ethanol extracts of the bulbs yielded a new 
alkaloid, the 6,7,11b,11c-didehydrolycorinium salt (CF.2) with six known alkaloids, lycorine 
(CF.1), hippadine (CF.3), hippeastrine (CF.4), masonine (CF.5), crinine (CF.6) and the 
ammonium salt of crinine (CF.7) [Figure 3.8].   
 
 
 
Picture 3.3: Bulbs of Crinum sp. 6538 
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Figure 3.8: Compounds isolated from the hexane and ethanol extract of Crinum sp. 6538 
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3.3.3.1 Structure elucidation of Compound CF.1: lycorine   (Appendices 132-141) 
 
Figure 3.9: Structure of compound CF.1: lycorine 
Compound CF.1 was isolated as a white crystalline compound from the ethanol extract of the 
bulbs of Crinum sp. 6538 and was found to be the known alkaloid called lycorine.  It has 
been isolated previously from C. firmifolium var hygrophilum,156 and from many other 
sources such as Crinum macowanii157 and Brunsvigia littoralis (Amaryllidaceae).158 
 
The LCMS for compound CF.1 gave a [M + H]+ ion at m/z 288.2 which indicated a 
molecular formula of C16H17NO4 for the compound.  A double bond equivalence of nine was 
calculated for this compound.  The FTIR spectrum showed absorptions bands at 3432 cm-1 for 
an OH stretch, 2921 and 2850 cm-1 for C-H stretches.77 
 
The 1H NMR spectrum showed two singlet proton resonances at δH 6.65 and δH 6.90 which 
corresponded to the carbon resonances δC 108.4 and δC 106.4 in the HSQCDEPT spectrum 
and were attributed to H-8 and H-11 respectively.  The H-11 proton resonance usually 
appears at a lower field than the H-8 proton resonance as it is near to the unsaturated C-
ring.138  These two proton resonances H-8 and H-11 showed correlations with the C-7 (δC 
58.0) and C-11b (δC 41.5) resonances respectively and both showed correlation with the four 
fully substituted aromatic carbon resonances at δC 129.9 (C-7a), δC 130.5 (C-11a), δC 147.7 
(C-9) and δC 148.3 (C-10) in the HMBC spectrum.  A broad singlet integrating to two protons 
at δH 5.92 in the 1H NMR spectrum was assigned to protons of the methylenedioxy group 
attached to the A-ring due to correlations seen in the HMBC spectrum with two aromatic ring 
carbon resonances at δC 147.7 (C-9) and δC 148.3 (C-10).  The broad singlet proton resonance 
at δH 5.55 which corresponded to the olefinic carbon resonance at δC 119.3 was assigned as 
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H-3.  The C-3 resonance showed correlations with the H-1 (δH 4.47) resonance in the HMBC 
spectrum [Figure 3.9 and Table 3.2]. 
 
The COSY spectrum showed coupling between H-11c (δH 2.89), H-11b (δH 2.72), H-1 (δH 
4.47), H-2 (δH 4.18) and H-3 (δH 5.55) resonances.  The J11b,11c of 10.7 Hz indicated a trans 
B/C ring junction in Compound CF.1.120 
 
In the NOESY spectrum, the H-1 proton resonance showed a correlation with the H-11b 
resonance which showed a further correlation with the H-7β resonance and were all assigned 
the β-orientation.  On the other hand, the H-11c proton resonance showed a correlation with 
the H-7α resonance which, in turn, showed a further correlation with the H-5α resonance.  
The proton resonances at δH 3.33 and δH 4.12 were assigned to H-5β and H-7β respectively, 
while the proton resonances at δH 2.44 and δH 3.54 were assigned to H-5α and H-7α 
respectively due to the deshielding effect of the cis-lone pair of electrons of the nitrogen on β-
proton at position 5 and 7.120  The absolute configuration of the B/C ring fusion was 
confirmed by using circular dichroism.  The CD spectrum of the compound CF.1 showed a 
positive Cotton effect at 246 nm (23.80) and a negative Cotton effect at 295 nm (-7.58) 
indicated that the B/C ring fusion was in the trans-1 correlation, when the H-11b and H-11c 
are in the β and α-orientation respectively.159  The NMR data were compared with the 
literature values in Table 3.2.160  The specific rotation for compound CF.1 was determined to 
be +50.0 in ethanol (literature +55.0 in water).161 
 
Lycorine has been shown to exhibit significant bioactivity, for example, it showed 
antimalarial activity against two Plasmodium falciparum strains, D 10 and FAC8, with IC50 
values 0.62 and 0.7 µg/ml respectively.158  Moreover, it showed strong cytotoxicity against 
human tumour cell lines HL-60, 6T-CEM, LOVO and A549 with IC50 values 0.17, 1.42, 0.59 
and 0.65 µg/ml respectively.162 
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Table 3.2: NMR data for compound CF.1: lycorine in CD3OD compared against 
literature reference values 
No. 13C NMR 
(125 Hz) 
D3OD 
13C NMR 
(75 MHz) 
CD3OD160 
1H NMR  
(500 MHz) 
CD3OD 
1H NMR  
(300 MHz) 
CD3OD160 
HMBC 
 (H      C) 
COSY NOESY 
1 72.1 CH* 73.1  4.47 brs 
W1/2=4.9 Hz 
4.48 s 2, 3, 11b, 11c 2, 11b 11b 
2 73.3 CH* 71.9 4.18 brs 
W1/2=7.4 Hz 
4.20 brs - 3 3 
3 119.3 CH 119.1 5.55 brs 
W1/2=7.4 Hz 
5.50 brs - 2 2 
3a 143.9 C 143.6 - - - - - 
4α 29.5  CH2 29.2 2.67 m 2.65 m 3a 4β, 5α, 
5β 
5α 
4β 2.60 m 2.65 m 3a 4α, 5α, 
5β 
5α, 5β 
5α 54.9 CH2 54.5 2.44 m 2.48 dd J=17.7, 
8.7 Hz 
4, 7 4, 5 4α, 4β, 
5β, 7α 
5β 3.33 m 3.38 m  3a, 11c 4, 5 4β, 5α 
7α 58.0 CH2 57.5 3.54 d J=14.2 Hz 3.57 d J=14.2 Hz 5, 7a, 11a  5α, 11c 
7β 4.12 d J=14.2 Hz 4.15 d J=14.2 Hz 7a, 8, 11a, 11c 7B - 
7a 129.9 C 130.4 - - - - - 
8 108.4 CH 108.2 6.65 s 6.67 s 7, 7a, 10  - 
9 148.3 C 148.2 - - - - - 
10 147.7 C 147.7 - - - - - 
11 106.2 C 106.0 6.90 s 6.91 s 7a, 9, 11a, 11b - - 
11a 130.6 C 129.7 - - - - - 
11b 41.5 CH  41.3 2.72 d J=10.7 Hz 2.70 m 7a, 11c 1, 11c 1 
11c 62.6 CH 62.5 2.89 d J=10.7 Hz 2.93 d J=11.2 Hz - 11b,  7α 
OCH2O 102.4 102.2 5.92 brs 
W1/2=4.4 Hz 
5.94 s 9, 10 - - 
*The 13C NMR chemical shifts have been corrected by using HMBC and COSY correlations 
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3.3.3.2 Structure elucidation of Compound CF.2: 6,7,11b,11c-didehydrolycorinium salt 
(Appendices 142-150) 
 
Figure 3.10: Structure of compound CF.2: 6,7,11b,11c-didehydrolycorinium salt 
Compound CF.2 was isolated as a yellow solid material from the ethanol extract of the bulbs 
of Crinum sp. 6538 and was found to be a new lycorine-type alkaloid. 
 
The HRMS spectrum of compound CF.2 gave a [M]+ ion at m/z 284.0911 which indicated a 
molecular formula of C16H14NO4 for the compound.  The FTIR spectrum showed absorptions 
bands at 3343 cm-1 for an OH stretch, 2920 cm-1 for C-H stretches, 1609 cm-1 for double bond 
stretches, 1263 cm-1 for C-O stretches and 1034 cm-1 for C-N bending.77 
 
The 13C NMR spectrum of compound CF.2 showed sixteen carbon resonances including two 
oxymethine carbon resonances, one methylenedioxy group carbon resonance, two methylene 
group carbon resonances and eleven double bond carbon resonances seven of them are fully 
substituted carbon resonances and four methine carbon resonances [Figure 3.10 and Table 
3.3]. 
 
The 1H NMR spectrum showed a lycorine type structure with some modifications on the B 
ring.  The most downfield proton occurred at δH 9.35 was assigned to H-7 due to its 
correlations with the C-5 (δC 57.3), C-7a (δC 139.5), C-8 (δC 106.2), C-11a (δC 128.6) and C-
11c (δC 141.4) resonances in the HMBC spectrum.  The deshielding of the H-7 is due to the 
iminium salt effect,163 or nitrogen quaternization effect.164  The two singlet proton resonances 
at δH 7.65 and δH 7.78 were assigned to H-8 and H-11 respectively, because of their 
correlations in the HMBC spectrum with the carbon resonances at δC 142.3 (C-7) and δC 
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126.7 (C-11b) respectively and between both and the fully substituted aromatic carbon 
resonances at δC 139.5 (C-7a), δC 153.1 (C-9), δC 158.8 (C-10) and δC 128.6 (C-11a).  A broad 
singlet integrating to two protons at δH 6.38 in the 1H NMR spectrum showed correlations 
with the C-9 (δC 153.1) and C-10 (δC 158.8) resonances in the HMBC spectrum.  Therefore, it 
was assigned to protons of the methylenedioxy group attached to ring A.  The broad singlet 
proton resonance at δH 6.45, which corresponded to the olefinic carbon resonance at δC 127.9, 
was signed as C-3 as it showed correlations in the HMBC spectra with the H-1 resonance. 
 
The COSY spectrum showed coupling between the H-1 (δH 5.35), H-2 (δH 4.60) and H-3 (δH 
5.55) resonances and between the two H-4 (δH 3.31) and two H-5 (δH 5.02) resonances.  The 
J1, 2 of 2.2 Hz indicated the same configuration as in lycorine (CF.1).  A search for the 
structure in Scifinder and Dictionary of Natural Products showed that this alkaloid has not 
been reported before.  The NMR data of compound CF.2 was compared with compound 8-O-
demethylvasconine, the only compound in the literature with 6,7,11b,11c double bonds and a 
quaternary nitrogen [Figure 3.11].163  The specific rotation for compound CF.2 was 
determined to be +20.0 in methanol 
 
. 8- 8  
Figure 3.11: Structure of compound 8-O-demethylvasconine 
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Table 3.3: NMR data for compound CF.2: 6,7,11b,11c-didehydrolycorinium salt in 
CD3OD compared against 8-O-demethylvasconine reference values 
No. 13C NMR 
(125 MHz) 
CD3OD 
13C NMR 
(50 MHz) 
CD3OD163 
1H NMR 
(500 MHz) 
CD3OD 
1H NMR 
(500 MHz) 
CD3OD163 
HMBC 
(H      C) 
COSY NOESY 
1 69.2 CH 119.4 5.30 d J=2.2 Hz 7.95 2, 3, 11b, 11c 2 - 
2 72.2 CH  130.8 4.60 dd J=2.2, 
4.9 Hz 
7.67 - 1, 3 3 
 
3 127.9 CH  123.7 6.45 dt J=2.2, 
4.9 Hz 
7.52 - 2, 4 2 
3a 134.3 C 137.1 - - - - - 
4 26.7 CH2 28.0 3.31 m 3.64  3, 5 5 
5 57.3 CH2 55.7 5.02 m 4.96 4, 7 4 4 
7 142.2 CH 142.2 9.35 s 8.85 5, 7a, 8, 11a, 11c - - 
7a 139.5 C 123.7 - - - - - 
8 106.2 CH 112.9 7.63 s 6.92 7, 7a, 9, 10 - - 
9 153.1 C 161.7 - - - - - 
10 158.8 C 161. - - - - - 
11 101.1 CH 100.8 7.78 s 7.21 9, 10, 11a, 11b   
11a 128.6  C 124.2 - - - - - 
11b 126.7  C 123.7 - - - - - 
11c 141.3 C 134.9 - - - - - 
OCH2O 105.8 - 6.38 s - 9, 10 - - 
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3.3.3.3 Structure elucidation of Compound CF.3: hippadine (Appendices 151-157) 
 
Figure 3.12: Structure of compound CF.3: hippadine 
Compound CF.3 was isolated as a yellow material from the hexane extract of the bulbs of 
Crinum sp. 6538 and was found to be the known lycorine-type alkaloid called hippadine.  It 
has been isolated previously from different sources such as, Ammocharis coranica,165 Crinum 
latifolium166 and Crinum macowanii (Amaryllidaceae).167 
 
The LC-MS spectrum of compound CF.3 gave a [M+H]+ ion at m/z 264.4 which indicated a 
molecular formula of C16H9NO3 for the compound.  A double bond equivalence of thirteen 
was calculated for this compound.  The FTIR spectrum showed absorptions bands at 2918 
and 2849 cm-1 for C-H stretches, 1738 cm-1 for a carbonyl group stretch, 1675 cm-1 for 
double bond stretches, 1250 cm-1 for C-O stretches and 1313 cm-1 for C-N bending.77 
 
The 1H NMR spectrum showed two singlet proton resonances at δH 8.00 and δH 7.68 for the 
para-oriented aromatic protons resonances, H-8 and H-11 respectively.  The deshielding of 
H-8 is because of the lactam carbonyl group in ring-B.142  A broad singlet integrating to two 
protons at δH 6.17 in the 1H NMR spectrum was assigned to the methylenedioxy group 
protons attached to ring A due to its correlations in the HMBC spectrum with two aromatic 
ring carbon resonances at δC 148.8 (C-9) and δC 152.8 (C-10) [Figure 3.12 and Table 3.4]. 
 
The COSY spectrum showed coupling between H-1 (δH 7.93, J = 7.9 Hz), H-2 (δH 7.48 J = 
7.7) and H-3 (δH 7.76, J = 7.9 Hz) and between the H-4 (δH 6.90) and H-5 (δH 8.05) doublet 
proton resonances. 
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Although the 13C NMR spectrum did not show the C-7 cyclic amide group carbon resonance 
nor the C-11c resonances they were detected at δC 158.4 (C-7) and δC 131.1 (C-11c), in the 
HMBC spectrum, and showed correlations with the H-8 (δH 8.00) and with the H-1 (δH 7.93), 
H-3 (δH 7.76) and H-4 (δH 6.90) resonances respectively.  The NMR data compared well with 
the literature values.168 
 
Hippadine has been shown to have antitumor activity against the S-180 (mouse ascites tumor) 
cell line, and to inhibite significantly male rats’fertility.138  However, it did not show any 
activity against the cholinesterase enzyme.169 
Table 3.4: NMR data for compound CF.3: hippadine in CDCl3 compared against 
literature reference values 
No 13C NMR 
(125 MHz) 
CDCl3 
13C NMR 
CD3Cl3168 
1H NMR 
(500 MHz) 
CDCl3 
1H NMR 
CDCl3168 
HMBC 
(H      C) 
COSY 
1 118.6 CH 118.20 7.93 d J=7.9 Hz 7.87 dd J=7.6, 1.0 Hz 3, 11a, 11c 2 
2 124.2 CH  123.82 7.48 t J=7.7 Hz 4.44 t J=7.6, 7.55 Hz 3a, 11b 1, 3 
3 122.8 CH  122.42 7.76 d J=7.7 Hz 7.33 dd J=7.6, 1.0 Hz 1, 11c 2 
3a 128.6 C 128.28 - - - - 
4 111.0 CH2 110.59 6.90 d J=3.6 Hz 6.88 d J=3.66 Hz 3a, 5, 11c 5 
5 123.8 CH2 123.34 8.05 d J=3.6 Hz 8.03 d J=3.66 Hz 3a, 4 4 
7 158.4 C 157.95 - - -  
7a 122.6 C 131.51 - - - - 
8 108.3 CH 107.84 8.00 s 7.95 s 7, 11a  
9 148.8 C 148.37 - - - - 
10 152.8 C 152.45 - - - - 
11 102.0 CH 101.55 7.68 s 7.61 s 7a, 11b  
11a 131.9 C 119.58 - - - - 
11b 116.9 C 116.56 - - - - 
11c 131.1 C 130.85 - - - - 
OCH2O 102.5 CH   102.11 6.17 s - 9, 10 - 
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3.3.3.4 Structure elucidation of Compound CF.4: hippeastrine (Appendices 158-169) 
 
Figure 3.13: Structure of compound CF.4: hippeastrine 
 
Compound CF.4 was isolated as a white crystalline compound from the ethanol extract of the 
bulbs of Crinum sp. 6538 and was found to be the known homolycorine-type alkaloid called 
hippeastrine.  It has been isolated previously from many sources such as Amaryllis 
belladonna L,132 Crinum latifolium L.142 and Lycoris radiate Herb (Amaryllidaceae).170 
 
The LCMS spectrum of compound CF.4 gave a [M + H]+ ion at m/z 316.3 which suggested a 
molecular formula of C17H17NO5 for the compound.  A double bond equivalence of ten was 
calculated for this compound.  The FTIR spectrum showed absorptions bands at 3468 cm-1 for 
an OH stretch, 2922 and 2852 cm-1 for C-H stretches, 1726 cm-1 for a carbonyl group stretch, 
1614 cm-1 for double bond stretches, 1481 cm-1 for methylene bending, 1225 cm-1 for C-O 
stretches and 1033 cm-1 for C-N bending.77 
 
The 13C NMR and DEPT spectra of compound CF.4 showed seventeen carbon resonances, 
including two oxymethine carbon resonances, one methylenedioxy group carbon resonance, 
one N-methyl group carbon resonance, two methylene group carbon resonances, two methine 
group carbon resonances and nine double bond carbon resonances.  Seven of them were fully 
substituted carbon resonances, one with methine carbon resonance and one a lactone group 
carbon resonance [Figure 3.13 and Table 3.5]. 
 
The 1H NMR spectrum showed two singlet proton resonances at δH 7.41 and δH 7.05 for the 
para-oriented aromatic protons resonances, H-8 and H-11, respectively.  The deshielding of 
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H-8 is because of the lactone carbonyl group in ring-B.142  A broad singlet integrating to two 
protons at δH 6.12 in the 1H NMR spectrum was assigned to the methylenedioxy group proton 
resonances attached to ring A, due to its correlations in the HMBC spectrum with aromatic 
ring carbon resonances at δC 149.8 (C-9) and δC 154.0 (C-10).   
 
The lactone group carbon resonance at δC 166.7 was assigned to C-7 as it showed correlation 
in the HMBC spectrum with the H-8 (δH 7.41) proton resonance.  The oxymethine proton 
resonance at δH 4.58 (H-5a) showed correlations with the olefinic carbon resonance at δC 
120.4 (C-4), oxymethine carbon resonance at δC 68.1 (C-5) and methine carbon resonance at 
δC 68.3 (C-11c) in the HMBC spectrum.  The double bond carbon resonances at δC 145.4 and 
δC 120.4 were assigned as C-3a and C-4 respectively as they showed correlations with the H-
2 (δH 3.19) and H-5a (δH 4.58) proton resonances in the HMBC spectrum.  The N-methyl 
proton resonance showed HMBC correlations with the C-2 (δC 57.3) and C-11c (δC 68.5) 
carbon resonances.   
 
The COSY spectrum showed coupling between H-11c (δH 2.63), H-11b (δH 2.88), H-5a (δH 
4.58), H-5 (δH 4.27) and H-4 (δH 6.68) resonances, and between the 2H-2 (δH 3.26 and δH 
2.37) and 2H-3 (δH 2.60) resonances. 
 
The large coupling constant between the H-11b and H-11c proton resonance (J=9.6 Hz) 
confirmed a trans-diaxial relationship.120  Moreover, the small coupling constant between H-
11b and H-5a (J = 2.2 Hz) and a NOESY correlation seen between them, confirmed a cis B/C 
ring junction in compound CF.4.120  The proton resonances at δH 3.19 and δH 2.33 were 
assigned to H-2α and H-2β respectively due to the deshielding effect of the cis-lone pair of 
electrons of the nitrogen on H-2α.120  Although the substituent at position 5 is usually in the 
α-position,120 the NOESY spectrum did not show any correlation between the H-5 and H-11c 
resonances.  Therefore, compound CF.4 was acetylated.  The 1H NMR spectrum of the 
hippeastrine acetate showed a downfield shift of H-5 from to δH 4.39 to δH 5.44 in CDCl3 and 
the appearance of the acetate methyl group proton resonance δH 2.06.  However, no 
correlation between H-5 and H-11c of the acetate was observed in the ROESY spectrum.  
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This absolute configuration of B/C ring had to be confirmed by using circular dichroism.  The 
CD spectrum of the compound CF.4 showed positive Cotton effects at 254 nm (26.51) and 
302 nm (0.41) and negative Cotton effects at 232 nm (-120.74) and 275 (-98.54) indicated 
that the B:C ring fusion was in the cis-3 configuration, when the H-5a and H-11b are in the α-
orientation.159,142  In order to confirm the CF.4 assignment the 1H NMR and 13C NMR 
spectrum were rerun in CDCl3 to compare with literature data of hippeastrine and it was 
found comparable.171  The specific rotation for acetylated compound CF.4 was determined to 
be +140.0 in chloroform (the literature value is +142.0 in ethanol).171 
 
Previous research showed that hippeastrine showed antifungal activity against Candida 
albicans with a MIC value 25 µg/ml.132  However, it did not show any significant inhibition 
of acetylcholinesterase (AChE) in vitro.172  
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Table 3.5: NMR data for compound CF.4: hippeastrine in CD3OD and CDCl3 
compared against literature reference values 
No. 13C NMR 
(125 MHz) 
CD3OD 
13C NMR 
(125 MHz) 
CDCl3 
13C NMR 
(125 MHz) 
CDCl3
171 
1H NMR 
(500 MHz) 
CD3OD 
1H NMR 
(500 MHz) 
CDCl3
 
1H NMR 
(500 MHz) 
CDCl3 
171 
HMBC 
(H      C) 
COSY NOESY 
NCH3 43.8 CH3 43.7 42.9 2.05 s 2.06 s  2.03 s 2, 11c - - 
2α 57.3 CH2 56.3 55.9 3.19 dt 
J=9.9, 2.3 
Hz 
3.15 m 3.13 ddd 
J=3.0, 8.0, 
10.0 Hz 
3a, 1, 11c  3, 2β 2β, 3 
 
2β 2.33 q 
J=9.9 Hz 
2.53 q  
J=9.5 Hz 
2.23 ddd 
J=9.0, 9.0, 
10.0 Hz 
3, 1 3, 2α 2α, 11c 
3 28.8 CH2 28.1 27.3 2.58 m 2.52 m 2.48 m - 2α, 2β 2α 
3a 145.4 C  142.4 - - - - - - 
4 120.4  CH 118.7 119.4 5.68 brs 
W1/2=7.36 
Hz 
5.67 s 5.63 br s - 5, 11c 5 
5 68.1 CH 67.2 66.2 4.27 brs 
W1/2=7.23 
Hz 
4.39 m 4.38 br s  - 4, 5a 4, 5a 
5a 84.3 CH 82.3 82.2 4.58 brs 
W1/2=5.04 
Hz 
4.60 brs  4.58 br s  4, 5, 11c 5, 11b 5, 11b 
7 166.7 C 164.9 165.0 - - - - - - 
7a 119.6 C 118.4 118.0 - - - - - - 
8 110.4 CH 110.1 109.8 7.41 s 7.48 s 7.45 s 7, 7a, 9, 
10, 11a 
- - 
9 149.8 C 148.2 148.0 - - - - - - 
10 154.0 C 152.1 151.9 - - - - - - 
11 109.9 CH 108.9 108.5 7.05 s 6.95 s 6.92 s 7a, 9, 10, 
11a, 11b 
- 11b 
11a 140.9 C 139.5 138.8 - - - - - - 
11b 40.9 CH  40.1 38.4 2.88 dd 
J=9.6, 2.2 
Hz 
2.87 brd 
J=9.5 Hz 
2.85 dd 
J=2.5, 9.5 Hz 
5, 11, 
11c, 11a 
11c, 5a 11, 5a,  
11c 68.5 CH 67.3 67.1 2.63d  
J= 9.6 Hz 
2.65 d  
J=9.4 Hz 
2.62 d J=9.5 
Hz 
- - 1, 2B,   
OCH2O 104.1 CH2 102.3 102.1 6.12 s 6.08 d  
J=5.7 Hz 
6.04 2d J= 
1.5 Hz 
9,10 -  
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3.3.3.5 Structure elucidation of Compound CF.5: masonine (Appendices 170-179) 
 
 
 
Figure 3.14: Structure of compound CF.5: masonine 
Compound CF.5 was isolated as a yellow crystalline compound from the ethanol extract of 
the bulbs of Crinum sp. 6538 and was found to be the known homolycorine-type alkaloid 
called masonine.  It has been isolated previously from Nerine masonorum,173 Narcissus 
pseudonarcissus174 and Narcissus serotinus (Amaryllidaceae).175 
 
The LCMS spectrum of compound CF.5 gave a [M + H]+ ion at m/z 300.3 which indicated a 
molecular formula of C17H17NO4 for the compound.  A double bond equivalence of ten was 
calculated for this compound.  The FTIR spectrum showed absorptions bands at 3437 cm-1 for 
an OH stretch, 2919 and 2850 cm-1 for C-H stretches, 1717 cm-1 for a carbonyl group stretch , 
1482 cm-1 for double bond stretches in aromatic ring, 1255 cm-1 for C-O stretches and 1034 
cm-1 for C-N bending.77 
 
The 13C NMR and DEPT spectra of compound CF.5 showed seventeen carbon resonances, 
including one oxymethine carbon resonances, one methylenedioxy group carbon resonance, 
one N-methyl group carbon resonance, three methylene group carbon resonances, two 
methine group carbon resonances and nine olefinic carbon resonances seven of them were 
fully substituted carbon resonances, one a methine carbon resonance and one lactone group 
carbon resonance [Figure 3.14 and Table 3.6]. 
 
The NMR data of CF.5 showed similarity with those of CF.4 but one oxymethine group 
carbon resonance was absent and an extra methylene group carbon resonance was present.  
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The extra methylene carbon resonance at δC 32.2 was assigned as C-5 due to coupling seen in 
the COSY spectrum between H-11c (δH 2.71), H-11b (δH 2.75), H-5a (δH 4.83), 2H-5 (δH 2.68 
and 2.51) and the H-4 (δH 5.58) proton resonances. 
 
In the NOESY spectrum, the correlation between the H-11b and H-5a resonance confirmed a 
cis B/C ring junction in compound CF.5.  The proton resonances at δH 3.17 and δH 2.32 were 
assigned to H-2α and H-2β respectively due to the deshielding effect of the cis-lone pair of 
electrons of the nitrogen on the H-2α.120  The 2H-5 resonances could be distinguished as the 
H-5β (δH 2.51) showed a correlation in the NOESY spectrum with the H-11c (δH 2.71) proton 
resonance.  The absolute configuration of B/C ring fusion was confirmed using circular 
dichroism.  The CD spectrum of the compound CF.5 showed a positive Cotton effect at 255 
nm (56.85) and 312 nm (11.85) and negative Cotton effect at 230 nm (-110.98) and 276 (-
62.06) indicating that the B/C ring fusion was cis-3 configuration, when the H-5a and H-11b 
are in the α-orientation.159  The specific rotation for acetylated compound CF.5 was 
determined to be +50.0 in methanol (literature is +55.6 in chloroform).174 
 
Literature values for the NMR data were reported in CDCl3 but we found that CF.5 did not 
dissolve completely in the solvent.  However, values are still comparable [Table 3.6].174 
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Table 3.6: NMR data for compound CF.5: masonine in CD3OD compared against 
literature reference values in and CDCl3 
 
No. 
13C NMR 
(125 MHz) 
CD3OD 
13C NMR 
(100 MHz) 
CD3Cl3174 
1H NMR (500 
MHz) 
CD3OD 
1H NMR (400 
MHz) CD3Cl3174 
HMBC 
(H      C) 
COSY NOESY 
NCH3 43.7 CH3 43.5 2.05 s 2.06 s  2, 11c - 11, 11c 
2α 57.4 CH2 56.3 3.17 td J=2.3, 
9.5 Hz 
3.18 ddd 
J=4.2, 6.3, 7.4 Hz 
11c  2β, 3 2β 
 
2β 2.27 dd  
J=9.2, 18.7 
Hz 
2.27 dd  
J=9.2, 18.7 Hz 
- 2α, 3 2α, 3 
3 28.7 CH2 27.9 2.53 m 2.52 br m 2.48 3a 2α, 2β 2α 
3a 141.1 C 140.2 - - - - - 
4 117.5 CH 115.6 5.58 brs 
W1/2=7.52 Hz 
5.50 br d  
J=2.2 Hz 
- 5β 5β 
5α 32.2 CH2 31.1 2.68 m 2.62 m J=2.9 Hz 
 
- 5β, 5a 5β 
5β 2.51 m 2.58 m  
J=2.9 Hz 
- 4, 5α 4, 5α, 
11c 
5a 79.1 CH 77.3 4.83 m 4.75 m  
J=2.2, 2.1 Hz 
- 5α, 11b 11b  
7 167.1 C 165.4 - - - - - 
7a 119.6 C 118.5 - - - - - 
8 110.2 CH 109.7 7.42 s 7.49 s 7, 7a, 9, 
10, 11a 
- - 
9 153.8 C 151.8 - - - - - 
10 149.6 C 147.8 - - - - - 
11 109.8 CH 108.6 7.02 s 6.96 s 7a, 9, 10, 
11a, 11b 
- 1, 11b 
11a 141.2 C 139.7 - - -  - 
11b 44.5 CH  43.8 2.75 dd  
J=1.9, 9.9 Hz 
2.72-2.76 m 
J=1.6, 5.2 Hz 
11c 11c, 5a 11, 5a 
11c 68.3 CH 66.8 2.71 m 2.72-2.76 m 
J=1.6, 5.2 Hz 
- - 1 
OCH2O 104.0 CH2 102.0 6.11 s 6.07 dd  
J=0.9, 4.7 Hz 
9,10 - - 
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3.3.3.6 Structure elucidation of Compound CF.6: crinine (Appendices 180-188) 
 
Figure 3.15: Structure of compound CF.6: crinine 
Compound CF.6 was isolated as a white material from the ethanol extract of the bulbs of 
Crinum sp. 6538 and was found to be the known crinine.  It has been isolated previously from 
different sources such as, Ammocharis tinneana,176 Boophane disticha135 and Crinum 
macowanii (Amaryllidaceae).157  
 
The LCMS spectrum of compound CF.6 gave a [M + H]+ ion at m/z 272.5 which suggested a 
molecular formula of C16H17NO3
 for the compound.  A double bond equivalence of nine was 
calculated for this compound.  The FTIR spectrum showed absorptions bands at 3435 cm-1 for 
an OH stretch, 2921 and 2851 cm-1 for C-H stretches, 1461 cm-1 for methylene bending , 
1284 cm-1 for C-O stretching and 1004 cm-1 for C-N bending.77 
 
The 1H NMR spectrum showed two singlet proton resonances at δH 6.52 and δH 6.86 for the 
para-oriented aromatic protons resonances, H-7 and H-10 respectively.  The H-10 proton 
resonance usually occurs as sharper, longer and at a lower field singlet than the H-7 proton 
resonance as it is near to the diamagnetic shift of unsaturated C-ring.177  A broad doublet 
integrating to two protons at δH 5.92 in the 1H NMR spectrum was assigned to protons of the 
methylenedioxy group attached to ring A.  The COSY spectrum showed coupling between H-
1 (δH 5.56) and H-2 (δH 5.99) proton resonances, and then sequential coupling between the H-
2 (δH 5.99), H-3 (δH 4.38), 2H-4 (δH 2.17 and 1.78) and H-4a (δH 3.54) resonances [Figure 
3.15 and Table 3.7]. 
 
The coupling constants between J1,2 and J2,3 are used to determine the configuration of the C-
3 substituent in relation to the 5,10b-ethane bridge.  A cis relationship between the C-3 
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substituent and the 5,10b-ethane bridge is shown by a small coupling constant (J2,3 ~ 0-1.5 
Hz) with allylic coupling seen between the H-1 and H-3 proton resonance (J1,3~1-2 Hz) and 
the H-2 resonance remains a doublet as the dihedral angle between H-2 and H-3 is 
approximately 900.  A larger J2,3 coupling constant (J2,3= 5.0 Hz) with undetectable coupling 
between H-1 and H-3 and the splitting of H-2 into a doublet of doublets reflects a trans 
relationship between the C-3 substituent and 5,10b ethane bridge as the dihedral angle 
between H-2 and H-3 is approximately 300.120,177,178  Compound CF.6 was assigned a trans 
orientation between the ethane bridge and the hydroxyl group on C-3 due to the splitting of 
H-2 into a doublet of doublets with coupling constants of 10.0 Hz (J1,2) and 5.4 Hz (J2,3). 
 
The proton resonances at δH 4.52 and δH 3.54 were assigned as H-6α and H-12exo 
respectively due to the deshielding effect of the cis-relation with the lone pair electrons of the 
nitrogen.179  Moreover, the NOESY spectrum showed the correlations between the H-6α and 
H-4a proton resonances, and between the H-6β and H-12endo proton resonances to confirm 
this assignment.  The NOESY spectrum showed correlations also between the H-4β proton 
resonance and H-3, H-11exo and H-12exo proton resonances which matched the correlations 
seen in the literature NMR data.180  The absolute configuration of the 5,10-ethane bridge was 
determined by using circular dichroism.  The CD spectrum of compound CF.6 showed 
positive Cotton effect at 244 nm (35.66) followed by a negative Cotton effect at 298 nm (-
4.19) indicated that the 5, 10-ethanobridge was in the β-configuration.159  The NMR data of 
compound CF.6 was found comparable with the literature values for crinine.178  The specific 
rotation for compound CF.6 was determined to be -12.0 in methanol (literature -9.0 in 
ethanol).178 
 
Previous research showed significant antiproliferative effects of crinine with IC50 of 14.04 
µM against HL-60/Dox human tumour cell lines.181 In addition, it showed weak inhibition of 
acetylcholinesterase with IC50 value of 461 µM.
135 
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Table 3.7: NMR data for compound CF.6: crinine in CDCl3 compared against literature 
reference values 
No. 13C NMR 
(125 MHz) 
CDCl3
 
13CNMR 
(50. MHz) 
CDCl3
178 
1H NMR (500 MHz) 
CDCl3 
1H NMR (300 
MHz) CDCl3 
HMBC 
(H      C) 
COSY NOESY 
1 131.7 CH 131.0 6.56 d J=10.0 Hz 6.59 d J=10.0 Hz 3, 4a, 10b, 0a  2 - 
2 127.9 CH 128.0 5.99 dd J=5.4, 10.0 
Hz 
5.96 dd J=5.4, 
10.0 Hz 
 3, 4, 10b 1, 3 3 
 
3 63.9 CH 63.3 4.38 m 4.33 m 1, 2, 4a 2, 4β 2, 4β 
4α 32.3 CH2 32.3 2.17 brd J=13.5 Hz 2.06 brd J=13.5 
Hz 
3, 4a, 10b 4a, 4β 4β, 4a 
4β 1.78 dt J=4.2, 13.5, 
Hz 
1,74 ddd J=4.2, 
13.5, 13.5 Hz 
3, 4a, 10b 3, 4a, 4α 3, 4α, 
11exo, 
12exo 
4a 63.4 CH 62.9 3.54 m* 3.42 dd J=3.9, 
13.5 Hz 
11, 6 4α, 4β 4α, 6α, 
12exo 
6α 61.9 CH2 61.5 4.52 d J=16.6 Hz 4.41 d J=16.8 Hz 6a, 7,  10a, 12 6β 4a, 7 
6β 3.89 d J=16.6 Hz 3.78 d J=16.8 Hz 4a, 6a, 7, 10a, 
12 
6α 7, 
12endo 
6a 124.4 C 125.0 - - - - - 
7 106.9 CH 106.9 6.52 s 6.48 s 6,  8, 9, 10a - 6α, 6β 
8 146.5 C 145.8 - - - - - 
9 146.2 C 146.3 - - - - - 
10 103.2 CH 102.9 6.86 s 6.85 s 6a, 8, 9, 10b - - 
10a 137.3 C 137.8 - - - - - 
10b 44.6 C 44.3 - - - - - 
11endo 43.7 CH2 43.6 2.24 ddd  J=4.0, 
8.5, 12.5 Hz 
2.19 ddd J=3.7, 
8.7, 12.5 Hz 
4a, 10a, 10b 11exo, 
12endo, 
12exo 
11exo, 
12endo 
11exo 2.01 ddd J=6.0, 
10.0, 12.5 HZ 
1.94 ddd J=6.3, 
10.8, 12.5 Hz 
1, 10a, 10b, 12 11endo, 
12endo, 
12exo 
11endo, 
4β 
12endo 53.6 CH2 53.1 2.99 ddd J=6.0, 
8.5, 12.5 Hz 
2.91 ddd J=6.3, 
8.7, 12.8 Hz 
- 11endo, 
11exeo, 
12exo 
6β, 
11endo, 
12exo 
12exo 3.54 m*  3.36 brd J=12.8 
Hz 
6 11endo, 
11exo, 
12endo 
4β, 
12endo 
OCH2O 101.2 CH2 100.8 5.92 brd J=7.0 Hz 5.89d-5.91d J=1.2 
Hz 
8, 9 - - 
*Refer to overlapped proton resonances 
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3.3.3.7 Structure elucidation of Compound CF.7: the ammonium salt of crinine 
(Appendices 189-199) 
 
 
Figure 3.16: Structure of compound CF.7: the ammonium salt of crinine 
Compound CF.7 was isolated as a yellow powder from the ethanol extract of the bulbs of 
Crinum sp. 6538 and was found to be the ammonium salt of crinine.  Compound CF.7 has not 
been reported previously, although the isolation of salt is determined by the extraction 
procedure used. 
 
The LCMS spectrum of compound CF.7 gave a [M]+ ion at m/z 272.3 which suggested a 
molecular formula of C16H18NO3
+ for the protonated alkaloid.  The mass spectrum was 
consistent with an alkaloid of the crinine type.178  
 
The 1H NMR spectrum showed the two aromatic proton resonance at δH 6.55 and δH 6.87, 
which were assigned to H-7 and H-10 respectively.  A proton resonance at δH 5.96 was 
assigned to proton of the methylenedioxy group attached to the A ring.  The two olefinic 
proton resonance at δH 6.45 and δH 6.06 were assigned to H-1 and H-2 respectively and 
multiple proton resonance δH 4.45 was assigned to H-3.  The remaining proton and carbon 
resonances were assigned with reference to 2D NMR spectra.  The NMR spectra correlations 
indicated that compound CF.7 was crinine.  However, a comparison with the 1H and 13C 
NMR data of literature reference values,178 and compound CF.6, which was identified as 
crinine, revealed a number of discrepancies.  The H-4a (δH 3.91), 2H-6 (δH 4.75 and 4.10) and 
2H-12 (δH 3.18 and 3.89) proton resonances were shifted downfield when compared with the 
NMR data of crinine whose resonances for H-4a was δH 3.54, 2H-6 was δH 4.52 and 3.89 and 
2H-12 was δH 2.99 and 3.54, most of the carbon resonances values were significantly 
125 
 
changed.  This indicated that a quaternary nitrogen atom was present [Figure 3.16 and Table 
3.8]. 
 
The 1H NMR spectra for quaternary salts are close matches those of the N-oxides of the 
compounds.151  However, the lack of a 10 ppm downfield shift for the carbon directly 
attached to the nitrogen atom in the 13C NMR spectra,151 helped to rule out this option and 
indicated that compound CF.7 was an ammonium salt [Figure 3.16].  In order to confirm the 
identity of compound CF.7 as the ammonium salt of crinine, it was treated with 4M NaOH.  
The 1H and 13C NMR spectra of the product exactly matched those of crinine [Figure 3.17].  
The specific rotation for compound CF.7 was determined to be -15.7 in methanol 
 
Figure 3.17: 1H NMR spectrum for compound CF.7 in CDCl3 before and after addition 
of 4 M NaOH 
` 
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Table 3.8: NMR data for compound CF.7: the ammonium salt of crinine in CDCl3 
compared against free base and literature reference values of crinine 
No. 13C NMR 
(125 
MHz) 
CDCl3
 
13CNMR 
(125 
MHz) 
CDCl3* 
13CNMR 
(50. 
MHz) 
CDCl3 
178 
1H NMR 
(500 MHz) 
CDCl3 
1H NMR 
(500 
MHz) 
CDCl3* 
1H NMR 
(300 MHz)  
CDCl3
178 
HMBC 
(H      C) 
COSY NOESY 
1 128.7 CH 132.7 131.0 6.45 d 
J=10.1 Hz 
6.59 d 
J=10.0 
Hz 
6.59 d 
J=10.0 Hz 
3, 4a, 10b, 
11 
2 - 
2 129.1 CH 127.6 128.0 6.06 dd 
J=5.3, 10.0 
Hz 
5.96 dd 
J=5.2, 
10.0 Hz 
5.96 dd 
J=5.4, 10.0 
Hz 
1, 3, 4, 
10b 
1, 3 3 
 
3 62.5 CH 64.4 63.3 4.45 m 4.35 m 4.33 m 1, 2, 4a 2, 4β 2, 4β 
4α 30.9 CH2 32.9 32.3 2.6 brd 
J=13.5 Hz 
1.99 brd 
J=13.5 
Hz 
2.06 brd 
J=13.5 Hz 
3, 4a, 10b 3, 4a, 
4β 
4β, 4a 
4β 1.85 td 
J=4.1, 13.2 
Hz 
1.74 td 
J=4.1, 
13.2 Hz 
1,74 ddd 
J=4.2, 13.5, 
13.5 Hz 
3, 4a, 10b 3, 4α, 
4a, 
3, 4α, 
11exo, 
12exo 
4a 64.4 CH 63.0 62.9 3.91 dd 
J=3.9, 13.5 
Hz 
3.41 m 3.42 dd 
J=3.9, 13.5 
Hz 
4, 10b, 11, 
6, 3 
4α, 4β 4α, 6α, 
12exo 
6α 60.1 CH2 62.7 61.5 4.75 d 
J=16.1 Hz 
4.41 d 
J=16.9 
Hz 
4.41 d 
J=16.8 Hz 
6a, 7, 8, 
10a, 12 
6β 4a, 7 
6β 4.1 d J=16.1 
Hz 
3.78 d 
J=16.8 
Hz 
3.78 d 
J=16.8 Hz 
4a, 6a, 7, 
10a, 12 
6α 7, 
12endo 
6a  126.6 125.0  - - - - - 
7 107.4 CH 107.2 106.9 6.55 s 6.49 s 6.48 s 6, 6a, 8, 9, 
10a 
- 6α, 6β 
8 147.0 C 146.0 145.8 - - - - - - 
9 147.9 C 146.4 146.3 - - - - - - 
10 103.6 CH 103.0 102.9 6.87 s 6.85 s 6.85 s 6a, 8, 9, 
10b 
-  
10a 135.5 C 138.5 137.8 - - - - - - 
10b 45.1 C 44.2  44.3 - - - - - - 
11endo 41.8 CH2 44.5 43.6 2.16 ddd 
J=4.4, 8.7, 
12.2 Hz 
2.18 ddd 
J=4.4, 
8.7, 12.2 
Hz 
2.19 ddd 
J=3.7, 8.7, 
12.5 Hz 
4a, 10b, 12 11exo, 
12endo, 
12exo 
11exo, 
12endo 
11exo 2.33 ddd 
J=6.3, 10.8, 
12.2 Hz 
1.92 ddd 
J=6.3, 
10.8, 12.2 
Hz 
1.94 ddd 
J=6.3, 10.8, 
12.5 Hz 
10b, 12 11endo, 
12endo, 
12exo 
11endo, 
4β 
12endo 52.8 CH2 55.8 53.1 3.18 ddd 
J=6.3, 8.7, 
12.8 Hz 
2.90 ddd 
J=6.3, 
8.7, 12.8 
Hz 
2.91 ddd 
J=6.3, 8.7, 
12.8 Hz 
4a, 6, 10b, 
11 
11endo, 
11exo, 
12endo 
6β, 
11endo, 
12exo 
12exo 3.89 m 3.37 m 3.36 brd 
J=12.8 Hz 
6, 10b, 11 11endo, 
11exo, 
12endo 
4β, 
12endo 
OCH2O 101.7 CH2 101.0 100.8 5.97d - 5.96 
d J=1.3 Hz 
5.89d-
5.91d, 
J=1.3 Hz 
5.89d-5.91d 
J=1.2 Hz 
8, 9 - - 
*NMR data of free base after hydrolysis.  
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 The chemistry of Crinum hardyi Lehmiller 
The phytochemistry of Crinum hardyi Lehmiller collected in Madagascar, has not been 
investigated previously. 
 Result and discussion of the phytochemical analysis of C. hardyi  
One new alkaloid 6,7,11b,11c-didehydrolycorinium salt (CH.5) and four known alkaloids: 6-
hydroxycrinamine (CH.1), crinine (CH.2), the ammonium salt of crinine (CH.3) and lycorine 
(CH.4) were isolated from bulbs of C. hardyi [Figure 3.18].  Picture 3.4 shows the bulbs of 
C. hardyi which were used in this study. 
 
 
Figure 3.18: Compounds isolated from the ethanol extract of C. hardyi 
  
Picture 3.4: Bulbs of Crinum hardyi 
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3.4.1.1 Structure elucidation of Compound CH.1: 6-hydroxycrinamine         
(Appendices 200-209) 
 
Figure 3.19: Structure of compound CH.1: 6-hydroxycrinamine 
Compound CH.1 was isolated as a white crystalline compound from the ethanol extract of the 
bulbs of C. hardyi and was found to be the known haemanthamine-type alkaloid called 6-
hydroxycrinamine [Figure 3.19].  It has been isolated previously from Boophane disticha,135 
Brunsvigia orientalis179 and Crinum delagoense.144 
 
The LCMS spectrum of compound CH.1 gave a [M]+ ion at m/z 317.4 which suggested a 
molecular formula of C17H19NO5 for the compound.  A double bond equivalence of nine was 
calculated for this compound.  The FTIR spectrum showed absorptions bands at 3397 cm-1 for 
an OH stretch, 2923 cm-1 for C-H stretches, 1483 and 1357 cm-1 for methylene and methyl 
bending, 1247 cm-1 for C-O stretching and 1066 cm-1 for C-N bending.77 
 
The NMR data showed doubling up of some proton and carbon resonances, which is typical 
of mixture of C-6 epimers which are in equilibrium in solution and not possible to separate 
.120  The resonances of one epimer are, however, more dominant with a ratio of 
approximately 3:1, and these were used in the structural elucidation of this compound. 
 
The 1H NMR spectrum showed two singlet proton resonances at δH 6.79 and δH 6.88 for the 
para-oriented aromatic protons resonances H-7 and H-10 respectively due to their 
correlations seen in the HMBC spectrum with C-6 (δC 89.1) and C-10b (δC 52.0) resonances 
respectively.  The COSY spectrum showed coupling between H-1 (δH 6.30, dd, J=2.2, 10.5 
Hz), H-2 (δH 6.11, d J=10.5 Hz), H-3 (δH 4.09), 2H-4 (δH 2.16 and 2.02) and H-4a (δH 3.58 dd 
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J=3.9 and 14.0) resonances.  The chemical shifts indicated a 1,2-double bond and the 
presence of an oxygenated substituent at C-3.  A methoxy group (δH 3.43) was placed as C-3 
[Table 3.9]. 
 
The oxymethine carbon resonance at δC 89.1 for the major epimer (87.0 for the minor epimer) 
which corresponding to a singlet proton resonance at δH 5.00 in the HSQC spectrum was 
assigned as C-6 due to its correlation in the HMBC spectrum with the C-4a (δC 61.6), C-6a 
(δC 129.3), C-7 (δC 110.4), C-10a (δC 138.6), C-12 (δC 59.0) resonances.  Another oxymethine 
carbon resonance at δC 79.6 was assigned as C-11 because of its correlations with the C-4a, 
C-10a, C-12 resonances in the HMBC spectrum. 
 
As with compound CF.6, the coupling constants J1,2 and J2,3 and splitting pattern show 
whether the C-3 substituent and the 5,10b ethane-bridge are cis or trans to each other.  A very 
small J2,3 and doublet resonance for H-2 reflects a cis relationship between C-3 substituent 
and 5,10b ethane-bridge as the dihedral angle between H-2 and H-3 is approximately 
900.120,177,178  The H-2 resonance of compound CH.1 was found to be doublet, indicating a cis 
orientation between ethane bridge and the methoxy substituent at C-3. 
 
The NOESY spectrum was used to assign the relative configuration of compound CH.1. It 
showed correlations between the H-4a proton resonance and H-3 and H-4β resonances (δH 
2.02) which, in turn, showed a correlation with the H-12exo (δH 3.45) proton resonances.  
The H-4α (δH 2.16) resonance showed correlations with the H-12endo (δH 3.20) resonance.  
The NOESY spectrum showed correlations also between the H-1 (δH 6.30) and the H-10 (δH 
6.88) and the H-1 and the H-11 (δH 3.90) resonances which confirmed the position of the 
hydroxyl substituent at C-11.179  Adewusi et al. reported two epimers of 6-hydroxycrinamine 
in a ratio of 3:1, and showed the difference in the 13C NMR shifts between them.135  The 13C 
NMR values for C-6, C-10a and C-12 showed downfield shifted for 6α-hydroxycrinamine at 
δC 88.4, δC 136.2 and δC 58.1 respectively compared with δC 85.9, δC 134.9 and δC 52.1 
respectively for 6β-hydroxycrinamine.135  This showed that the major epimer present in CH.1 
was 6α-hydroxycrinamine 
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The absolute configuration of the 5,10-ethanobridge was confirmed using circular dichroism 
spectroscopy.  The CD spectrum of compound CH.1 showed a positive Cotton effect at 292 
nm (10.10) followed by a negative Cotton effect at 248 nm (-4.00) indicated that the 5,10-
ethanobridge was in the α-configuration.159  The NMR data of compound CH.1 was found 
comparable with the literature values for 6-hydroxycrinamine. The specific rotation for 
compound CH.1 was determined to be +45.0 in the chloroform (literature value +40.0 in 
chloroform).179 
 
6-Hydroxycrinamine has shown acetylcholinesterase inhibitory activity with the IC50 value 
445 µM, and was found to be toxic to neuroblastoma cells.135  
 
Table 3.9: NMR data for compound CH.1: 6-hydroxycrinamine in CD3OD compared 
against literature reference values 
No. 13C NMR 
(125 MHz) 
CD3OD
 
13CNMR 
(100 MHz) 
CD3OD
182 
1H NMR 
(500 MHz) 
CDCl3 
1H NMR 
(400 MHz) 
CD3OD
182 
HMBC 
(H      C) 
COSY NOESY 
1 125.7 CH 125.75 6.30 dd J=2.2, 
10.5 Hz 
6.28 dd J=2.2, 10.3 
Hz 
2, 3, 4a, 
10a, 10b  
2, 3 10, 11 
2 134.6 CH 134.37 6.11 d J=10.5 Hz 6.09 d J=10.3 Hz 1, 4, 10b 1, 3, 4α 3 
3 77.9 CH 77.87 4.09 m 4.07 m 1, 2, OMe 2, 4α, 4β 2, 4a, 4β  
4α 30.4 CH2 30.41 2.16 m 2.12 m 3, 4a, 10b 3, 4α, 4β 4β, 12endo 
4β 2.02 m 2.00 m 2, 3, 4a, 10b 3, 4α 3, 4a, 4α, 
12exo. OMe 
4a 61.6 CH 61.80 3.58 dd J=3.9, 
14.0 Hz 
3.65 dd J=4.0, 13.6 
Hz 
3, 4, 6, 10a, 
11, 12  
4α, 4β 3, 4β 
6 89.1 CH 88.94 5.00 s 4.96 s 4a, 6a, 7, 
10a, 12 
 7, OMe 
6a 129.3 C 129.22 - - - - - 
7 110.4 CH 110.29 6.79 s 6.75 s 6, 8, 9, 10, 
10a 
6 6 
8 148.0 C 149.24 - - - - - 
9 149.6 C 147.69 - - - - - 
10 104.0 CH 103.77 6.88 s 6.84 s  6a, 7, 8, 9, 
10b 
- 1, 11 
10a 138.6 C 138.52 - - -   
10b 52.0 C 51.81 - - - -  
11 79.6 CH 79.61 3.90 dd J=3.5, 7.4 
Hz 
3.85 m 4a, 10a, 12 12exo, 
12endo 
1, 10 
12exo 59.0 CH2 58.92 3.45 dd* J=3.4, 
14.0 Hz 
3.15 dd J=3.6, 14.3 
Hz 
4a, 10b, 6, 
11,  
11, 12endo 4β  
12endo 3.20 dd J=3.4, 
14.0 Hz 
3.43 dd J=3.3, 6.2 
Hz 
6, 11 11, 12exo 4α, OMe 
OCH2O 102.7 CH2 102.43 5.94 brs W1/2=5.84 
Hz 
5.89 s 8, 9 - - 
OMe 56.0 CH3 55.81  3.43 s* 3.39 s 3  6, 12endo 
* Refer to overlapped proton resonances 
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3.4.1.2 Structure elucidation of Compound CH.2: crinine (Appendices 210-216) 
 
Figure 3.20: Structure of compound CH.2: crinine 
Compound CH.2 [Figure 3.20].was isolated as a white solid from the ethanol extract of the 
bulbs of C. hardyi.  It was found to be the known alkaloid crinine, and the same as CF.6 
isolated from Crinum sp. 6538 [section 3.3.3.6].  Compound CH.2 has been isolated 
previously from different sources such as Ammocharis tinneana,176 Boophane disticha135 and 
Crinum macowanii (Amaryllidaceae).157  
 
The LCMS spectrum of compound CH.2 gave a [M + H]+ ion at m/z 272.5 which indicated a 
molecular formula of C16H17NO3 for the compound. 
 
3.4.1.3 Structure elucidation of Compound CH.3: the ammonium salt of crinine 
(Appendices 217-220) 
 
 
Figure 3.21: Structure of compound CH.3: the ammonium salt of crinine 
 
Compound CH.3 was isolated as a yellow solid compound from the ethanol extract of the 
bulbs of C. hardyi and was found to be the ammonium salt of crinine [Figure 3.21].  The 
LCMS, IR, 1H and 13C NMR spectra for compound CH.3 were found to be the same as those 
of compound CF.7 earlier isolated from Crinum sp. 6538.  The description of the structural 
elucidation has been done in the section 3.3.3.7. 
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3.4.1.4 Structure elucidation of Compound CH.4: lycorine (Appendices 221-222) 
 
Figure 3.22: Structure of compound CH.4: lycorine 
Compound CH.4 was isolated as a white crystalline compound from the ethanol extract of 
the bulbs of C. hardyi and was found to be the known alkaloid, lycorine [Figure 3.22], also 
isolated in this work as CF1 from Crinum sp. 6538. [section 3.3.3.1].  Compound CH.4 has 
been reported previously from as Crinum macowanii157 and Brunsvigia littoralis 
(Amaryllidaceae).158 
 
3.4.1.5 Structure elucidation of Compound CH.5: 6,7,11b,11c-didehydrolycorinium 
salt (Appendices 223-226) 
 
 
 
Figure 3.23: Structure of compound CH.5: 6,7,11b,11c-didehydrolycorinium salt  
Compound CH.5 was isolated as a yellow solid compound from the ethanol extract of the 
bulbs of C. hardyi and was found to a new alkaloid, 6,7,11b,11c-didehydrolycorinium salt 
[Figure 3.23] also isolated in this work as CF.2 from Crinum sp. 6538. [section 3.3.3.2] . 
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The LCMS spectrum of compound CH.5 gave a [M+H]+ ion at m/z 284.5 which indicated a 
molecular formula of C16H14NO4 for the compound.  The FTIR spectrum showed absorptions 
bands at 3343 cm-1 for an OH stretch, 2920 cm-1 for C-H stretches, 1609 cm-1 for double 
bond stretches, 1467 cm-1 for methylene bending, 1263 cm-1 for C-O stretches and 1034 cm-1 
for C-N bending. 
 
Table 3.10: NMR data for compound CH.5: 6,7,Hb,Hc-didehydrolycorinium salt in 
CD3OD 
No. 13C NMR 
(125 MHz) 
CD3OD 
1H NMR 
(500 MHz) 
CD3OD 
HMBC 
(H      C) 
COSY NOESY 
1 69.2 CH 5.30 d J=2.0 Hz 2, 3, 11b, 11c 2 - 
2 72.2 CH  4.59 m - 1, 3 3 
 
3 128.0 CH  6.45 m - 2, 4 2 
3a 134.3 C - - - - 
4 26.7 CH2 3.32 m  3, 5 5 
5 57.3 CH2 5.02 m 4, 7 4 4 
7 142.3 CH 9.36 s 5, 7a, 8, 11a, 11c - - 
7a 139.5 C - - - - 
8 106.2 CH 7.64 s 7, 7a, 9, 10 - - 
9 153.1 C - - - - 
10 158.7 C - - - - 
11 101.1 CH 7.80 s 9, 1, 11a, 11b   
11a 128.6  C - - - - 
11b 126.8 C - - - - 
11c 141.7 C - - - - 
OCH2O 105.8 6.39 s 9, 10 - - 
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 The chemistry of Crinum species 5629 
It is thought by our collaborative botanist Dr. Walter Krunch, this may be a new Madagascan 
Crinum species.  He is waiting for bulbs to flower this summer to provide complete 
identification.  Figure 3.24 shows the bulbs of Crinum sp. 5629 that were used in this study. 
 
Figure 3.24: Bulbs of Crinum sp. 5629 
 
 Results and discussion of the phytochemical analysis of C. sp. 5629 
The phytochemical analysis of the ethanol extracts of the bulbs showed that the bulbs 
contained three alkaloids: 6-hydroxy crinamine (CS1), lycorine (CS2) and pseudolycorine 
(CS3) [Figure 3.25]. 
 
Figure 3.25: Compounds isolated from the ethanol extract of Crinum sp. 5629 
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3.5.1.1 Structure elucidation of Compound CS.1: 6-hydroxy crinamine       
(Appendices 227-235) 
 
 
Figure 3.26: Structure of compound CS.1: 6-hydroxy crinamine 
 
Compound CS.1 was obtained after acetylation of an inseparable mixture obtained from the 
ethanol extract that was acetylated in order to separate the components.  It was isolated as a 
white solid and was found to be the diacetate of 6-hydroxy crinamine [Figure 3.26].  6-
Hydroxy crinamine was earlier isolated from Croton hardyi (compound CH.1) [section 
3.4.1.1].   
 
The LCMS spectrum of compound CS.1 gave a [M-OAc]+ ion at m/z 342.6 which suggested 
a molecular formula of C21H23NO7 for the compound.  The NMR data resembled those of 
compound CH.1 earlier isolated from Croton hardyi except for an additional two OAc group 
carbon resonances that appeared due to the acetylation of the compound during the 
purification process.  Acetylation was indicated by resonances at δC 170.7 and 21.7 and δC 
170.4 and 21.5 in the 13C NMR spectrum and the hydroxy groups at C-11exo and C-6 had 
been acetylated as expected.  The H-6 and H-11 proton resonances in compound CS.1 were 
found more downfield at δH 6.12 and δH 4.91 respectively compared to compound CH.1 
where they occurred at δH 5.00 and δH 3.90 respectively.   
 
The absolute configuration of the 5,10-ethane bridge was determined by using circular 
dichroism spectroscopy.  The CD spectrum of compound CS.1 showed positive Cotton effect 
at 293 nm (6.0) followed by a negative Cotton effect at 250 nm (-2.3) indicated that the 5,10-
ethane bridge was in the α-configuration.159 
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As for compound CH.1, the coupling constants J1,2 and J2,3 and splitting pattern show when 
the C-3 substituent and the 5,10b ethane-bridge are cis or trans to each other.  A very small 
J2,3 and doublet resonances for H-2 reflects a cis relationship between C-3 substituent and 
5,10b ethane-bridge as the dihedral angle between H-2 and H-3 is approximately 900.120,177,178  
The H-2 resonance of compound CS.1 was found to be doublet, indicating a cis orientation 
between ethane bridge and the methoxy substituent at C-3.  The H-6 (δH 6.12) proton 
resonances was assigned in the β-orientation.  Firstly, due to its correlation with the H-12 (δH 
3.47) proton resonance in the NOESY spectrum, secondly, The 13C NMR values for C-10a 
and C-12 showed downfield shifted for 6α-hydroxycrinamine at δC 137.0 and δC 55.8 
respectively compared with δC 134.9 and δC 52.1 respectively for 6β-hydroxycrinamine.135  
This showed that the major epimer present in CS.1 was 6α,11exo-diacetoxy crinamine.  The 
specific rotation for compound CS.1 was determined to be +130 in chloroform. 
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Table 3.11: NMR data for compound CS.1: diacetate 6-hydroxy crinamine in CDCl3 
compared against literature reference values 
No. 13C NMR  
(125 MHz) CDCl3 
1H NMR 
(500 MHz) CDCl3 
HMBC 
(H      C) 
COSY NOESY 
1 123.5 CH 6.12 m*  3, 4a  2 10 
2 133.9 CH 6.03 d J=9.9 Hz - 1 - 
 
3 76.2 CH 4.00 m - 4A, 4B OMe  
4A 29.6 CH2 2.10 m - 3, 4a, 
4B 
- 
4B 1.98 m - 3, 4a, 
4A 
- 
4a 62.1CH 3.48 m 6  4A, 4B - 
6 87.1 CH 6.12 m* 4a, 6a, 7, 10a, 
12, OAc2 
- 12 
6a 124.9 C - - - - 
7 108.8 CH 6.65 s 6, 8, 9, 10a - - 
8 147.1 C - - - - 
9 148.7 C - - - - 
10 103.8 CH 6.87 s 6a, 8, 9, 10b - - 
10a 137.0 C - -  - 
10b 50.3 C - - - - 
11 79.0 CH 4.91 m  - 12 - 
12 55.8 CH2 3.47 m 4a, 6  11 - 
OCH2
O 
101.6 CH2 5.94 dbr W1/2=3.5 Hz 8, 9 - - 
OMe 56.0 CH3 3.41 s 3 - - 
OAc1  170.7 C - - - - 
OAc2 170.4 C  - - - 
MeAc 21.5 CH3 2.14 OAc2 - - 
MeAc 21.7 CH3 2.03 OAc1 - - 
* Refer to overlapped proton resonances 
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3.5.1.2 Structure elucidation of Compound CS.2: lycorine(Appendices 236-238) 
 
Figure 3.27: Structure of compound CS.2: lycorine 
Compound CS.2 was isolated as a white crystalline compound from the ethanol extract of the 
bulbs of C. species and was found to be a known alkaloid called lycorine [Figure 3.27].  
Compound CS.2 has been reported previously from as Crinum macowanii157 and Brunsvigia 
littoralis (Amaryllidaceae).158  NMR spectra for compound CS.2 were found to be the same 
as those of compound CF.1 earlier isolated from Crinum sp. 6538 [section 3.3.3.1]. 
 
3.5.1.3 Structure elucidation of Compound CS.3: pseudolycorine (Appendices 239-247) 
 
 
Figure 3.28: Structure of compound CS.3: pseudolycorine 
Compound CS.2 was isolated as a yellow material from the ethanol extract of the bulbs of C. 
species and was found to be the known alkaloid called pseudolycorine.  Pseudolycorine has 
been reported previously from Narcissus requienii,183 and Narcissus tazetta 
(Amaryllidacea).184 
 
The HRMS spectrum of compound CS.3 gave a [M + H]+ ion at m/z 290.1387 which 
indicated a molecular formula of C16H19NO4 for the compound.  A double bond equivalence 
of eight was calculated for this compound.  The FTIR spectrum showed absorptions bands at 
3391 cm-1 for an OH stretch, 2922 cm-1 for C-H stretches and 1015 cm-1 for C-N bending.77 
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The NMR spectra showed similarity with the lycorine alkaloids CF.1 and CS.2 but with the 
absence of a methylenedioxy group resonance and presence of a methoxy group proton 
resonance at δH 3.84.  The two singlet proton resonances at δH 6.74 and δH 6.88 were assigned 
to H-8 and H-11 respectively.  These two proton resonances H-8 and H-11 showed 
correlations with the C-7 (δC 57.6) and C-11b (δC 41.0) resonances respectively, and with the 
two fully substituted carbon resonances C-9 (δC 147.9) and C-10 (δC 146.7) in the HMBC 
spectrum.  The methoxy group proton resonances at δH 3.84 showed a correlation with the 
fully substituted C-9 carbon resonances at δC 147.9 in the HMBC spectrum.  The olefinic 
carbon resonance δC 119.4 which corresponded to the singlet proton resonances at δH 5.57 
was signed as C-3 as it showed a correlation in the HMBC with the H-1 (δH 4.49) resonance 
[Figure 3.9 and Table 3.2]. 
 
A sequence of coupled resonances were seen in the COSY spectrum between H-11b (δH 
2.73), H-1 (δH 4.49), H-2 (δH 4.17) to H-3 (δH 5.57).  The H-11b (δH 2.73) showed coupling 
in the COSY spectrum with the H-11c (δH 2.91) resonance with coupling constant 
J11b,11c=11.0 Hz indicated a trans B/C ring junction in the Compound CS.3.
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The proton resonances at δH 3.33 and δH 4.12 were assigned to H-5β and H-7β respectively, 
while the proton resonances at δH 2.44 and δH 3.54 were assigned to H-5α and H-7α 
respectively due to the deshielding effect of the cis-lone pair of electrons of the nitrogen on 
the β-proton at positions 5 and 7.120  In the NOESY spectrum the H-1 proton resonance 
showed a correlation with the H-11b resonance which showed further correlation with H-7β 
and were all assigned as β.  On the other hand the H-11c proton resonance showed a 
correlation with the H-7α resonances, which, in turn showed a further correlations with the 
H-5α resonance and were all assigned as α orientation.  The specific rotation for compound 
CS.1 was determined to be [α]23 D -66.5 in ethanol (literature value-57 in the ethanol.185 
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Previous research had shown that pseudolycorine showed inhibitory activity against different 
cancer cell lines A549, OE21, Hs683, U373 and B16F10 with IC50 values 7.5, 7.7, 7.9, 7.8 
and 7.5 µM respectively.185 
 
Table 3.12: NMR data for compound CS.3: pseudolycorine in CD3OD compared against 
literature reference values 
  
No. 
13C NMR 
(125 MHz)  
CD3OD 
13C NMR (50.3 
MHz)  
CDCl3:CD3OD
 
1H NMR 
(500 MHz) 
CD3OD 
1H NMR 
(200 MHz) 
In CDCl3:CD3OD  
HMBC 
(H      C) 
COSY NOESY 
1 72.1 CH 70.7 4.49 brs 
W1/2=5.0 
Hz 
4.85 br s 2, 3, 11c 2, 11b 2, 11, 
11b 
2 73.3 CH  71.83 4.17 m 4.50 t J=1.6 Hz - 1, 3 1, 3 
 
3 119.4 CH 
747 
118.57 5.57 brs 
W1/2=7.40 
Hz 
5.60 t J=2.4 Hz - 2, 11c 2 
3a 143.9 C 141.71 -  -   
4 29.4 CH2 28.34 2.64 m 2.6-2.7 m 3a 5α, 5β  
5 54.9 CH2 53.93 3.34 m 2.6-2.7 m - 4, 5  
2.49 m 3.37 dd J=9.6, 2.4 
Hz 
7 4, 5  
7 57.61 CH2 56.38 4.17 d 
J=13.8 Hz 
3.68 br 14.4 7a, 8, 11c 7, 8 - 
3.59 d 
J=13.8 Hz 
4.16 d J=14.4 Hz 7a, 5 7  
7a 128.1.5 C 127.35 -  - - - 
8 111.9 CH 110.49 6.74 s 6.71 s 7, 8, 9, 
11a 
- - 
9 147.9 C 146.19 -  - - - 
10 146.7 C 145.11 -  - - - 
11 112.9 CH 111.32 6.88 s 6.89 s 7a, 8, 9, 
11b 
- 1 
11a 128.9  C 126.52 -  - -  
11b 41.00 CH 39.41 2.73 d 
J=11.0 Hz 
2.74 br d J=11.2 
Hz 
7a, 11a, 
11c 
1, 11c 1 
11c 62.7 CH 61.41 2.91 d 
J=11.0 Hz 
3.02 br d J=11.2 
Hz 
- 3, 11b  
OCH3 56.6 CH3 56.11 3.84 s 3.84 s 9 - 8 
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 Conclusion 
This chapter described the phytochemistry of three Madagascan Crinum species belonging to 
the Amaryllidaceae family: Crinum sp. 6538, Crinum hardyi Lehmiller and Crinum sp. 5629.   
Isolated compounds are given in Figure 3.29. 
 
Figure 3.29: Compounds isolated from Crinum sp. 6538 (CF.1-CF.7), Crinum hardyi 
(CH.1-CH.5) and Crinum sp. 5629 (CS.1-CS.3) 
The objective of the study of Crinum sp. 6538, cultivated in a green house in Austria was to 
compare its chemical constituents to that of Crinum firmifolium Var. hygrophilum H. Perr 
that was collected from Madagascar.  The compounds isolated previously from Crinum 
firmifolium Var. hygrophilum are eight alkaloids, lycorine, 3-hydroxy-8,9-
methylenedioxyphenanthridine, trisphaeridine, crinamine, 6-hydroxycrinamine, hamayne, 
criwelline, and ismine along with the isoquinoline alkaloid precursor tyramine and two 
isoprenoids, α-ionone and vomifoliol.111,156,161  In this study the phytochemical analysis of the 
hexane and ethanol extracts of the bulbs of Crinum sp. 6538 yielded a new alkaloid 
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6,7,Hb,Hc-didehydrolycorinium salt (CF.2) with six known alkaloids, lyocrine (CF.1), 
hippadine (CF.3), hippeastrine (CF.4), masonine (CF.5), crinine (CF.6) and the ammonium 
salt of crinine (CF.7) [Figure 3.8].  Lyocrine (CF.1), hippadine (CF.3), hippeastrine (CF.4) 
and crinine (CF.6) have been isolated from other Crinum species,142,157,166,167 while masonine 
(CF.5) has been isolated from Nerine masonorum,173 and different Narcissus species.174,175  
Therefore, the report of masonine is the first report from a Crinum species.  Compound 
(CF.7) the ammonium salt of crinine, has not been reported before.  The hexane extract of the 
bulbs of Crinum sp. 6538 gave a mixture of cycloartane triterpenoids.  These cycloartanes 
could not be fully purified, so they have not been discussed in this thesis.  Cycloartanes have 
been reported from the Amaryllidaceae previously.165  
 
The chemical constituents of the ethanol extract of the bulbs of Crinum hardyi Lehmiller 
have not been investigated before.  In this study the ethanol extracts of the bulbs of C. hardyi 
yielded the new 6,7,Hb,Hc-didehydrolycorinium salt (CH.5) and four known alkaloids: 6-
hydroxycrinamine (CH.1), crinine (CH.2), the ammonium salt of crinine (CH.3) and lycorine 
(CH.4).  The four isolated alkaloids have been reported from Crinum sp. 6538 but not 6-
hydroxycrinamine (CH.1).  6-Hydroxycrinamine (CH.1) has been isolated from the Crinum 
genus and other Amaryllidaceae genera as a mixture of C-6 epimers which are in equilibrium 
in solution and not possible to separate.120  However, the resonances of one epimer are more 
dominant with a ratio of 3:1, and these were used in the structural elucidation of this 
compound.  It was found that the major epimer was 6α-hydroxy, which agreed with the report 
of Adewusi et al. who isolated mixture of the two epimers in same ratio with 6α-
hydroxycrinamine as the predominant one.135  The occurrence of α and β 5,10-ethanobridge 
compounds (CH.1 and CH.2 respectively) in the same species has been reported from 
Boophane disticha135 and Brunsvigia orientalis (Amaryllidaceae family).179 
 
The chemical constituents of the ethanol extract of the bulbs Crinum sp. 5629 yielded just 
three compounds, 6-hydroxy crinamine (CS.1), lycorine (CS.2) and pseudolycorine (CS.3).  
6-Hydroxy crinamine (CS.1) was isolated after acetylation of an inseparable mixture.  The 
acetylation of this compound showed that the major epimer present in CS.1 was 6α, 11exo-
diacetylcrinamine.  Pseudolycorine CS.3 has been reported to occur in Crinum species,118,138  
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In general, lycorine (CF.1, CH.4, CS.2) is a common alkaloid of three Crinum species.  
Besides the 6,7,Hb,Hc-didehydrolycorinium salt, crinine, the ammonium salt of crinine and 
6-hydroxycrinamine were isolated from two Crinum species.  This indicates that three 
investigated Crinum species have a degree of variation in their chemical constituent.  
 
Table 3.13: Distribution of isolated alkaloids between the three investigated Crinum 
species 
Alkaloid  Crinum sp. 6538 Crinum hardyi Crinum sp. 5629 
Lyocrine √ √ √ 
6,7,Hb,Hc-Didehydrolycorinium salt √ √ X 
Hippadine √  X 
Pseudolycorine X X √ 
Hippeastrine √ X X 
Masonine √ X X 
Crinine √ √ X 
Ammonium salt of crinine √ √ X 
6-Hydroxy crinamine X √ √ 
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 Chapter 4: The Phytochemistry of Toona sinensis [Meliaceae family] 
 Introduction to Toona sinensis [Meliaceae family] 
 Botanical aspects of T. sinensis 
Toona sinensis M. Roem belongs to the Meliaceae family.186  The Meliaceae family 
constitutes trees or shrubs that are widely distributed in the tropics and subtropics, with rare 
representation in the temperate zones.186  A molecular phylogenetic study of the Meliaceae 
family using DNA sequence data of plastid and nuclear genes proposed splitting the 
Meliaceae family, which includes 50 genera and approximately 575 species, into two 
subfamilies, the Melioideae and Swietenioideae.186,187  T. sinensis is placed into the Cedrelea 
tribe of the Swietenioideae subfamily.188  This tribe is split into two genera, Cedrela and 
Toona.188  The Toona genus was originally classified as part of the Cedrela genus by 
Endlicher (1840), then it was separated into two genera by Roemer in 1846, due to some 
differences in morphological features.189,190  Toona sinensis was originally classified as 
Cedrela sinensis by Jussieu (1830).189 
 
Plants of the Toona M. Roem genus are deciduous or semi-evergreen trees growing up to 50 
m high, whose flowers are usually unisexual, with a 5-1 locular ovary and a woody 
septifragal capsule fruit, which opens from the apex.186  The Toona genus is distributed from 
Pakistan to China and Australia, and it is composed of 4 or 5 species.186  T. sinensis is the 
only species which can be planted in the temperate zones, its seeds are winged at one end, its 
male stamens are alternate, and its leaflets are serrate to serrulate,189 while in other species 
the seeds are winged at two ends, their male stamens arise from androgynophore and their 
leaflets are entire.186  T. sinensis M. Roem (syn. Cedrela sinensis A. Juss), commonly known 
as the Chinese mahogany, Chinese toon and red toon, is widely distributed in eastern and 
south-eastern Asia from India, Nepal, China, Burma, Thailand, Malaysia and Java to 
Europe.189,190  It is cultivated in different parks and gardens including the garden of the Royal 
Horticultural Society garden at Wisley in Surrey, England.189 
 Ethnobotany and biological screening of Toona sinensis 
Different parts of T. sinensis are used in traditional Chinese medicine.  The stem bark is used 
as an astringent and depurative, the fruits are used to treat eye infections, the leaves are used 
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to treat dysentery, heliosis, vomiting, enteritis and itching and the roots are used as a 
corrective for amenorrhea.189,191,192 
 
Pharmacological and clinical studies of plant extracts and compounds isolated from T. 
sinensis have been undertaken previously.  It was reported that the DPPH scavenging 
activities of the water extracts from T. sinensis bark, roots and leaf were more than 80% at a 
concentration of 0.625 mg/ml, which was comparable to 0.1 mg/ml vitamin C, and mice fed 
with any of these three extracts showed less amyloid -protein accumulation in the brain 
tissue than the control group, which could improve working memory.193  The 
supplementation of food with an aqueous extract of T. sinensis showed a decrease of the 
reactive oxygen species (ROS) and restored the function and motility of sperm in rats under 
oxidative stress.194  It was also reported that the leaf extract of T. sinensis improved the 
enzyme activities of catalase, peroxidase and copper/zinc superoxide dismutase in the liver of 
rats under oxidative stress induced by H2O2.
195  It was found that the flavonoids, gallic acid, 
methyl gallate, trigallic acid and gallotannins like quercetin-3-O--D-glucopyranoside were 
the main cause of antioxidant activity of T. sinensis.192 
 
It was observed that rutin extracted from T. sinensis acted as an immunostimulant for the 
white shrimp Litopenaeus vannamei against the pathogen Vibrio alginolyticus at doses of 20 
and 50 µg/ml by increasing phenoloxidase activity.196  The anti-inflammatory effects of the T. 
sinensis compound, gallic acid, was exhibited by inhibition of LPS-induced inflammation in 
nuclear factor–kB transgenic mice.197  Furthermore, betulonic acid and 3-oxours-12-en-28-
oic acid, which were isolated from T. sinensis, showed antitumor activities by induction of 
cancer cell apoptosis with ratios of 27.3% and 24.5% at 20 µM after 72 h of treatment.  Both 
of these two compounds showed antiproliferative activities against PC3 with the IC50 values 
26.5 and 21.9 µM respectively, and against MGC-803 with the IC50 values of 17.7 and 13.6 
µM.198  The seed essential oil of Cedrela sinensis has been reported to show moderate anti-
bacterial activity against Staphylococcus aureus ATCC 25925, Bacillus subtilis ATCC 9372, 
Pseudomonas aeruginosa ATCC 25916, Escherichia coli ATCC 25922 with the MIC values 
between 192 to 390 µg/ml.199 
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 Chemical constituents of Toona sinensis: 
The main phytochemical characteristic of the Meliceae family is the presence of tetracyclic 
triterpenes including distinctive nortriterpenoids (limonoids).  The limonoids have been 
shown to have insecticidal properties.186 
 
Previous phytochemical investigations on T. sinensis have reported the presence of 
triterpenoid compounds (1-40) [Figure 4.1], tetranortriterpenoids (41-46) [Figure 4.2], 
lignans and norlignans (47-50) [Figure 4.3], flavonoids and biflavonoids (51-59) [Figure 
4.4] and other compounds (60-65) [Figure 4.5].191,200-204 
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 21 
21 R 
22 S 
 3 21 24 
18 -H R S 
19 -H S S 
20 -H S ND 
 3 
23 -H 
24 -H 
 21 24 R 
31 S R H 
32 R S Me 
 3 21 24 R 
1 -H R S H 
2 -H S S H 
3 -H R ND H 
4 -H R S Me 
5 -H S ND Me 
6 -H R  Me 
 3 21 24 R 
7 -H S S H 
8 -H R ND H 
9 -H S S H 
10 -H R ND Me 
11 -H S ND Me 
12 -H R ND Me 
 R1 R2 R3 
13 H H -OMe 
14 Me H -OMe 
15 H OH -OMe 
16 H H H 
17 H OH H 
 
 21 
25 R 
26 S 
  
 3 24 21 R 
27 -H S -H OH 
28 -H ND -H OH 
29 -H ND -H OH 
30 -H ND -H H 
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Figure 4.1: Triterpenoids isolated previously from T. sinensis 
 
 
36 Sapelin E Acetate 37 Grandifoliolenone  38 Bourjotinolone A 
 R 
39  Piscidinol A =O 
40  Hispidol B -OH 
  
33 34 35 
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Figure 4.2:Tetranortriterpenoids isolated previously from T. sinensis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Lignans and norlignans isolated previously from T. sinensis 
 
 
 
41  Azadirone 42  Cedrellin 
  R1 R2 
47 Cedralin A OH H 
48 Cedralin B MeO -D-Glc 
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Figure 4.4: Flavonoids and bioflavonoids isolated from T. sinensis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 4.5: Other compounds isolated from T. sinensis 
 
  R 
57 Quercitrin rhamnose 
58 Rutin rutinose 
  R 
55 Demethoxymatteucinol H 
56 Matteucinol OCH3 
  
  R1 R2 
51 Procyanidin B3 H OH 
52 Procyanidin B4 OH H 
  
  R 
53 Catechin  -H 
54 Epicatchin  -H 
 60   2,6,10,15-Phytatetraene-14-ol   R 
61 Gallic acid H 
62 Methyl gallate CH3 
59      Kaempferol 
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 Result and discussion of Toona sinensis 
The phyotochemistry of the Toona sinensis collected from Asia has been reported.  The 
objective of this study was to compare the chemical constituents of Toona sinensis, naturally 
grown in Asia to this grown on the University of Surrey campus, Guildford, UK.  The 
investigation of this species was to provide me with training in phytochemical techniques.   
The chemical constituents isolated included five triterpenoids, 24-methylencycloartan-3-yl 
acetate (TS.1), 24-methylencycloartan-3-one (TS.2), 23,24,25-trihydroxytirucall-7-en-3-one 
(TS.3), 24-methyltirucalla-8-en-3-ol (TS.4), -amyrin acetate (TS.5), and two flavonoids, 
trans-catechin (TS.6) and cis-epicatechin (TS.7) along with two common phytosterols, 
sitosterol (TS.8) and sitostenone (TS.9). 
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Figure 4.6: Compounds isolated from the dicholoromethane and methanol extract of 
stem bark of Toona sinensis. 
 
153 
 
 Structural elucidation of compound TS.1: 24-methylenecycloartan-3-yl acetate     
(Appendices 248-257) 
 
 
 
 
 
Figure 4.7: Structure of compound TS.1: 24-methylenecycloartan-3β-yl acetate 
Compound TS.1 was obtained from an inseparable mixture from the dichloromethane extract 
of the stem bark of T.sinensis that was acetylated in order to separate the components.  It was 
isolated as a white solid and found to be the known 24-methylencycloartan-3-yl acetate.  24-
Methylencycloartenol has been isolated previously from many sources such as Cedrela 
odorata grafted on T. ciliata (Meliaceae),205 Cirrhopetalum elatum (Orchidaceae),206 
Epidendrum mosenii (Orchidaceae),207 and Euphorbia helioscopia (Euphorbiaceae),208 while 
24-methylencycloartan-3-yl acetate had been reported from Cirrhopetalum elatum 
(Orchidaceae),206 Euphorbia broteri (Euphorbiaceae),209 Microsorium fortune Moore,210 
Polypodium niponicum Baker211 and Pyrrosia petiolosa Christ (Polypodiaceae).212  
 
The LCMS of this compound gave a [M+H]+ ion peak at m/z 483.3768 which indicated a 
molecular formula of C33H54O2.  A double bond equivalence of seven was calculated for this 
compound.  The FTIR spectrum showed absorptions bands at 2940 and 2868 cm-1 for C-H 
stretches, 1734 cm-1 for the carbonyl stretch of an acetate group, 1636 cm-1 for C=C 
stretching and 1243 cm-1 for a C-O stretch.77 
 
The 13C NMR spectrum, displayed thirty-three carbon resonances, including eight methyl, 
twelve methylene, six methine, and seven fully substituted carbons resonances [Figure 
4.7Figure 4.7 and Table 4.1].  The presence of cyclopropyl proton resonances, in the 1H 
NMR spectrum, at H 0.34 and 0.58 (d, J=4.1 Hz) for H-19a and H-19b respectively, 
indicated that TS.1 was a cycloartenol derivative. 
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The proton resonance at H 4.57 (dd, J=10.58, 5.2 Hz), which corresponds to a carbon 
resonance at c 80.9 in the HSQC spectrum, was assigned as H-3 due to its correlation with 
the acetate carbonyl resonance at c 171.2 and with the two methyl carbon resonance at c 
19.5 (C-28) and 15.4 (C-29), in the HMBC spectrum. 
 
The resonance at H 1.62 was assigned as H-17 as it showed correlations, in the HMBC 
spectrum, with two methyl carbons resonances at c 18.2 and 18.5 which were assigned as C-
18 and C-21 respectively.  The 3H-18 resonance (H 0.96 s) showed correlation with two 
quaternary carbons resonances C-13 (c 45.5) and C-14 (c 49.0).  Furthermore, the 3H-21 
resonance at H 0.90 (d, J= 6.5 Hz) showed a correlation with one methylene carbon 
resonance, C-22 (c 35.2), and showed further coupling with the H-20 resonance at H 1.39 in 
the COSY spectrum.  
 
The two doublet methyl group proton resonances (H 1.02 and 1.03, J= 6.8 Hz), were 
assigned to H-26 and H-27, due to coupling with the H-25 resonance (H 2.25 septet, J=6.8 
Hz), seen in the COSY spectrum.  In addition, the H-25 resonance showed a correlation with 
the C-24 resonance (c157.2), in the HMBC spectrum.  The resonances at H 4.66 and 4.72, in 
the alkene region, were assigned to the two H-31 protons which showed correlations with the 
C-25 methine carbon resonance (c 34.0). 
 
The configuration at C-3 was determined from the coupling constants of the H-3 resonance 
which occurred as a doublet of doublets (H 4.57, dd, J=10.58, 5.2 Hz) indicating the -
orientation of H-3.209  In addition, in the NOESY spectrum, the H-3 resonance showed 
correlations with the 3H-28 and H-5 resonances, the H-5 resonance showed a correlation with 
the 3H-28 resonances.  All these protons (H-5, H-30 and H-28) were placed on the -face of 
the molecule on biosynthetic grounds.213  The NMR data compared well with literature 
values.209  
 
A methanol extract of Epidendrum mosenil, that has been reported to contain this compound, 
has been found to possess antinociceptive activity.207 
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Table 4.1: NMR data for compound TS1: 24-methylenecycloartan-3β-yl acetate in 
CDCl3 compared against literature reference values 
No. 13C NMR 
(125 MHz) 
13CNMR 
(50.3 
MHz)209 
in CDCl3
 
1H NMR 
(500 MHz) 
1H NMR 
(200 MHz) 209 
in CDCl3 
HMBC 
(H      C) 
COSY NOESY 
1 31.8 CH2 31.68 1.61 m - 2, 3, 9, 19 1, 2, 2 1, 2, 11 
1 1.25 m - 10 1, 2, 2 1, 2, 11 
2 27.0 CH2 26.87 1.76 m - 1, 10 1, 1, 2, 
3 
1, 2, 3 
2 1.61 m - 3 1, 1, 2, 
3 
1, 2, 
3 80.9 CH 80.75 4.57 dd, 
J=10.6, 5.2 Hz 
4.57 m 
JAX+JBX =15.8 
1, 2, 4, 29, 
O-CO-CH3 
2, 2 1, 2, 5, 30 
4 39.7 C 39.52 - - - - - 
5 47.4 CH 47.25 1.39 m - 4, 6, 10, 19, 29 - 3, 6, 28, 30 
6 21.1 CH2 20.97 1.58 m - - 6, 7 5, 6, 7, 30 
6 0.79 m - 4, 5, 8 6 6 
7 28.4 CH2 28.17 1.92 m - - 6, 7 6, 7 
7 1.29 m - 8,14 7 7, 8, 18, 29 
8 48.0 CH 47.82 1.51 m - 6, 7, 9, 10, 11, 
14, 19, 30 
- 7, 12, 18, 19b 
9 20.4 C 20,25 - - - - - 
10 26.2 C 26.10 - - - - - 
11 26.0 CH2 25.85 1.32 m - 9 11 11 
11 1.10 m - 8,9,19 11 1, 1, 11, 
19a 
12 35.7 CH2 35.59 1.29 m - 13,14 - 8, 17, 18, 21 
13 45.5 C 45.41 - - - - - 
14 49.0 C 48.90 - - - - - 
15 33.1 CH2 32.97 1.62 m - 13, 14, 16 16, 16, 16, 16, 18 
16 26.7 CH2 26.61 1.12 m - 15 15,17 15, 16, 17 
16 1.99 m - 15 15,17 15, 16 
17 52.5 CH 52.34 1.62 m - 13, 14, 18, 21 16, 16 16, 21 
18 18.2 CH3 17.99 0.96 s 0.97 s 13, 14, 17 - 8, 12, 15, 20, 
22 
19a 30.0 CH2 29.76 0.34 d J=4.1 Hz 0.34 d, J= 4.0 
Hz 
1, 8, 9, 10 19b 11, 19b 
19b 0.58 d J=4.1 Hz 0.58 d J= 4.0 
Hz 
1, 5, 8, 9, 10, 11 19a 8, 19a 
20 36.3 CH 36.18 1.40 m - - 21 18, 21 
21 18.5 CH3 18.37 0.90 d J=6.5 Hz 0.90 d, J=6.3 
Hz 
17, 22 20 17 
22 35.2 CH2 35.15 1.14 m - - - 23 
22 1.54 m - - - 18 
23 31.5 CH2 31.41 1.25 m - - - 22 
24 157.2 C 156.94 - - - - - 
25 34.0 CH 33.91 2.25 septet J=6.8 Hz - 24, 26, 31 26, 27 26, 27 
26 22.1 CH3 21.91 1.02 d J=6.8 Hz 1.03 d J= 6.8 
Hz 
24, 25, 27 25 25, 31b 
27 22.2 CH3 22.03 1.03 d J=6.8 Hz 1.03 d J= 6.8 
Hz 
24, 25, 27 25 25, 31b 
28 19.5 CH3 19.35 0.89 s 0.89 s 3, 4 - 5 
29 15.4 CH3 15.17 0.90 s 0.90 s 3, 5 - 7 
30 25.6 CH3 25.47 0.85 s 0.85 s 8 - 3, 5, 6 
31a 106.2 CH2 106.03 4.66 brs W½=4.03 
Hz 
- 25 - - 
31b 4.72 brs W½=3.71 
Hz 
- 25 - 26, 27 
O-CO-CH3 171.2 C 170.90 - - - - - 
O-CO-CH3 21.6 CH3 21.28 2.05 s 2.06 s O-CO-CH3 - - 
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 Structural elucidation of compound TS.2: 24-methylenecycloartan-3-one 
(Appendices 258-267) 
 
 
 
 
 
 
Figure 4.8: Structure of compound TS.2: 24-methylenecycloartan-3-one 
Compound TS.2 was isolated as a white oily material from the dichloromethane extract of the 
stem bark of T. sinensis and was found to be 24-methylenecycloartan-3-one.  It has been 
isolated previously from many species for example, Cedrela odorata grafted on T. ciliata 
(Meliaceae),205 Euphorbia helioscopia (Euphorbiaceae),208 Krameria tomentosa A. St Hill 
(Krameriaceae),214 Larix kaempferi (Pinaceae),215 and Microsorium fortune Moore 
(Polypodiaceae).210 
 
The LCMS of this compound gave a [M+H]+ ion peak at m/z 439.3615 which indicated a 
molecular formula of C31H50O for the compound.  A double bond equivalence of seven was 
calculated for this compound.  The FTIR spectrum showed absorptions bands at 2919 and 
2849 cm-1 for C-H stretches and 1708 cm-1 for the carbonyl stretch of a ketone group.77 
 
Compound TS2 was similar to compound TS1 except that a ketone group was present at C-3 
instead of the acetate group present in compound TS1.  The H-3 resonance present in the 1H 
NMR spectrum of compound TS1 at H 4.57 was missing in compound TS2, but the 13C 
NMR spectrum for TS2 showed a resonance at c 216.9 for ketone group at C-3.  The two H-
2 resonances appeared more downfield at H 2.72 and 2.30 in compound TS2 than in 
compound TS1 (H 1.76 and 1.61).  A comparison of the spectroscopic data for compound 
TS2 with that found in the literature208,214,215  confirmed that compound TS2 was 24-
methylencycloartan-3-one [Figure 4.8 and Table 4.2]. 
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24-Methylenecycloartan-3-one has been reported to show inhibitory effects on the induction 
of Epstein-Barr virus early antigen (EBV-EA) with an IC50 value of 9.2 nM, more potent than 
the references -carotene, retinoic acid and curcumin with IC50 values of 12.7, 15.4 and 10.2 
nM respectively.216 
 
The source of the extra methyl side chain carbons in the triterpenoids is S-
adenosylmethionine (SAM).  The double bond in the side chain C-24 undergoes methylation 
via SAM to give a carbocation.  The carbocation goes through a hydride shift and loss of 
proton from C-24 to give the 24-methylene side-chain [Scheme 4.1].56 
 
 
 
 
Scheme 4.1: Biosynthesis pathway of the extra methyl side chain carbons in the 
triterpenoids56 
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Table 4.2: NMR data for compound TS.2: 24-methylenecycloartan-3-one in CDCl3 
compared against literature reference values 
No. 13C NMR 
(125 MHz) 
13C NMR 
(125 
MHz) 214 
in CDCl3 
1H NMR 
 (500 MHz) 
1H NMR 
(500.1 MHz) 214  
in CDCl3 
HMBC 
(H      
HMBC) 
COSY NOESY 
1 33.7 CH2 33.4 1.86 m 1.85 - 1, 2, 2 1, 2, 2 
1 1.55 m 1.52 - 1, 2, 2  1, 2, 11, 
19b 
2 37.7 CH2 37.4 2.30 ddd J=14.1, 4.1, 
2.7 Hz 
2.28 - 1, 1, 2 1, 1, 2 
2 2.72 dt J=13.9, 6.4 
Hz 
2.70 ddd J=2.2, 
6.6, 14.1 Hz 
1,3 1, 1, 2 1, 2, 19b, 29 
3 216.9 C 217.5 - - - - - 
4 50.5 C 50.2 - - - - - 
5 48.7 CH 48.4 1.71 dd J=12.3, 4.3 
Hz 
1.66 4, 6, 9, 10, 28, 
29 
6 28 
6 21.7 CH2 21.5 1.55 m 1.51 5, 10 6, 7, 7 6, 7, 28 
6 0.95 m 0.91 - 5, 6, 7 6, 7 
7 26.1 CH2* 25.8 1.13 m 1.10 8, 9, 14 6, 7, 8 6, 7,  
7 1.40 m 1.35 - 6. 6, 7, 
8 
6, 7, 8, 18 
8 48.1 CH 47.8 1.60 m 1.56 7, 9, 10, 19, 
30 
7, 7 7,15, 16, 18, 
19a 
9 21.3 C 21.0 - - - - - 
10 26.2 C 25.9 - - - - - 
11 27.0 CH2 26.7 2.04 m 2.00 - 11, 12 11,  
12 33.0 CH2 32.7 1.67 m 1.62 9, 11, 13,18 11, 11 - 
13 45.6 C 45.3 - - - - - 
14 49.0 C 48.7 - - - - - 
15 35.8 CH2 34.9 1.32 m 1.30 13, 16, 30 16  8 
16 28.4 CH2* 28.1 1.94 m  1.90 - 15, 16, 17 8, 16, 17, 22 
16 1.32 m 1.29 13, 14, 15 16, 17 16, 18, 22 
17 52.5 CH 52.2 1.62 m 1.59 18, 21 16, 16, 
20 
16, 21, 22, 
30 
18 18.3 CH3 18 1.00 s 1.06 s 12, 14, 17  - 7, 8, 16, 20, 
22 
19a 29.8 CH2 29.5 0.79 d J=4.2 Hz 0.80 d J= 4.2Hz 8 19b 8, 19b 
19b 0.58 d J=4.2 Hz 0.60 d J=4.2 Hz 8, 9, 10 19a 1, 2, 11, 19a 
20 36.3 CH 36.0 1.41 m 1.38 - 17, 21, 22 18, 21, 22 
21 18.5 CH3 18.3 0.91 d J=6.1 Hz 0.91 d J=6.3 Hz 17, 20, 22 20 17, 20, 23 
22 35.2 CH2 35.5 1.16 m 1.10 - 22, 23, 
23 
17, 22 
22 1.58 m 1.55 - 20, 22, 
23, 23 
16, 16, 18, 
20, 22, 23 
23 31.5 CH2 31.2 2.13 m 2.10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    - 22, 22,
23 
21, 23 
23 1.90 m 1.85 - 22, 22, 
23 
22, 23 
24 157.1 C 157.5 - - - - - 
25 34.0 CH 33.7 2.24 septet J=6.8 Hz  2.20 26, 27 26, 27 -  
26 22.2 CH3 22.0 1.04 d J= 6.8 Hz 1.02 d J=5.3 Hz  25, 27 25 - 
27 22.1 CH3 21.8 1.03 d J= 6.8 Hz 1.05 d J=5.3 Hz  25, 27 25 - 
28 22.4 CH3 20.7 1.05 s 1.12 s 3, 4, 5, 29 - 5, 6 
29 21.0 CH3 22.1 1.1 s 0.92 s 3, 4, 5, 28 - 2 
30 19.5 CH3 19.3 0.91 s 1.07 s 8, 13, 14, 15, 
17 
- 17 
31a 106.2 CH2 105.9 4.67 brs W½=4.20 Hz 4.64 s 23, 25, - - 
31b 4.72 brs W½=3.78 Hz 4.69 s 23, 25 - - 
*The 13C NMR chemical shifts for C-7 and C-16 reported in the literature have been corrected by using HMBC 
correlations  
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 Structural elucidation of compound TS.3: 23,24,25-trihydroxytirucall-7-en-3-one 
(piscidinol A) (Appendices 268-277) 
 
Figure 4.9: Structure of compound TS.3: 23,24,25-trihydroxytirucall-7-en-3-one 
Compound TS.3 was found to be the known piscidinol A and was isolated as a white solid 
from the dichloromethane extract of the stem bark of T. sinensis.  It has been isolated 
previously from Ailanthus altissima Miller,217 Brucea mollis218 and Castela texana T.&G. 
(Simaroubaceae),219 Cedrela sinensis Juss200 and Trichilia hirta L. (Meliaceae).220 
 
The HRMS showed an ion peak at m/z 497.3594 for [M+Na]+ which indicated a molecular 
formula C30H50O4 for this compound.  A double bond equivalence of six was calculated.  The 
FTIR spectrum for compound TS.3 showed absorption bands at 3400 cm-1 for OH stretch, 
2916 and 2849 cm-1 for C-H stretch and 1708 cm-1 for ketone C=O stretch.77 
 
The 13C NMR spectrum, displayed thirty carbon resonances, including seven fully substituted 
carbons, seven methine, eight methylene and eight methyl group carbon resonances [Figure 
4.9 and Table 4.3].  The seven singlet proton resonances with one doublet proton resonance 
supported a triterpenoid structure. 
 
A ketone group carbon resonance at c 217.2  was assigned as C-3 as it showed correlations 
with the H-1 (H 1.99), H-2 (H 2.24), H-2 (H 2.75), 3H-28 (H 1.05) and 3H-29 (H 
1.12 ) proton resonances in the HMBC spectrum.  The proton resonance at H 5.31 (dd J=6.4, 
3.3 Hz), which corresponded to the carbon resonance at c 118.2, in the alkene region, of the 
HSQC spectrum, was assigned as H-7.  The H-7 resonance showed correlations with the C-5 
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(c 52.5) and C-9 (c 48.7) carbon resonances.  The proton resonance at H 1.50 was assigned 
as H-17 due to the correlations, seen in the HMBC spectrum with two methyl group carbon 
resonances at c 22.3 and 19.1 for C-18 and C-21 respectively, and with one methine group 
carbon resonance at H 33.9 for C-20. 
 
An oxymethine proton resonance at H 4.12 was assigned to H-23 in the side chain as it 
showed a correlation with the C-20 (H 33.9) resonance in the HMBC spectrum, and was seen 
to be coupled, in the COSY spectrum, with the two H-22 (H 1.85 and 1.19) resonances and 
with the other oxymethine proton resonances at H 3.17 which was assigned as H-24.  The 
fully substituted oxygenated carbon resonance at c 74.6 ppm was assigned as C-25 due to 
observed correlation in the HMBC spectrum with the 3H-26 (H1.31) and 3H-27 (H 1.32) 
resonances.  
 
In the NOESY spectrum, the H-5 (H 1.72) resonance showed correlations with the H-9 (H 
2.28) and 3H-28 (H 1.05) resonances.  Moreover, the 3H-18 (H 0.82) resonance showed 
correlations with the H-9 (H 2.28) and H-20 (H 1.41) resonances.  The H-17 (H 1.51), 3H-
19 (H 1.01) and 3H-29 (H 1.12) resonances showed correlation with each other in the 
NOESY spectrum.  The 1H and 13C NMR resonances for this compound piscidinol A were 
same as these of the reported values.219   
 
The NMR data for H/C-23 (H 4.12, m, c 96.6 ) and H/C-24 (H 3.14, brs, W1/2=2.6 Hz), c 
75.2) were similar to those of piscidinol A,219 while in the reported 24-epi piscidinol A, the 
NMR resonances for H/C-23 and H/C-24 were H 3.70 (m), c 73.9 and H 3.09 (d) J=8.0 Hz 
, c 79.3 respectively.219  The C-23 and C-24 were also assigned as R and S respectively as for 
piscidinol A.219   
 
Previous research has shown that piscidinol A possesses moderate cytotoxic activity against 
the Huh-7 human liver cancer cell line, human nasopharynx carcinoma cell line KB, human 
gastric carcinoma cell lines BGC-823 and KE-97, and the Jurkat human T lymphoma cancer 
cell line with IC50 of 40.3, 35.4, 67.5, 70.0 and 25.8 µM respectively.
217  Moreover, it 
exhibited comparable cytotoxicity against P-388 murine leukemia cells, with IC50 values of 
3.3µg/ml,200 and inhibitory activity on NO production induced by LPS in macrophages in 
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vitro at a concentration of 10 µM, with inhibitory ratios of 68.2 ± 4.5%.218  However, it was 
reported that piscidinol A was inactive against the human ovarian carcinoma SKOV-3, 
human breast carcinoma SK-Br-3, human chronic myelogenous leukemia K562, oral human 
epidermoid carcinoma KB cancer cell lines, and for antiprotozoal activity against Crithidia 
fasciculate (ATCC 11745) and Giardia intestinalis (ATCC 30888) at concentrations below 
20 µg /ml.219   
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Table 4.3: NMR data for compound TS.3: 23,24,25-trihydroxytirucall-7-en-3-one in 
CDCl3 compared literature against reference values. 
No. 13C NMR 
(125 
MHz) 
13C NMR  
(75 
MHz)219 
in CDCl3 
1H NMR 
 (500 MHz) 
1H NMR 
 (300 MHz)219 
in CDCl3 
HMBC 
(H      C) 
COSY NOESY 
1 38.8 CH2 33.5 1.99 m 1.96 m 2, 3, 5, 10 1, 2, 2 1, 2, 2, 
11 
1 1.46 m 1.45 m 2, 10 1, 2, 2  1, 2, 2 
2 35.1 CH2 34.9 2.24 dt J=14.5, 
3.5 Hz 
2.20 dt J=14.5, 
3.5 
3, 10 1, 1, 2 1, 1, 2 
2 2.75 dt J=14.4, 
5.6 Hz 
2.74 dt J=14.5, 
5.6 Hz 
1,3 1, 1, 2 1, 1, 2, 
19, 29 
3 217.2 C 217.0 - - - - - 
4 48.1 C 47.8 - - - - - 
5 52.5 CH 52.3 1.72 t J=8.7 Hz 1.71 t J=8.7 Hz 6, 10, 19, 28, 29 6 6, 9, 28 
6 24.6 CH2 24.3 2.10 m 2.05 m 4, 5, 7, 8,10 5, 7 5, 7, 19, 28, 
29 
7 118.2 CH 117.9 5.31 dd J=6.4, 3.3 
Hz 
5.30 dd J=6.1, 
3.1 Hz 
5, 9 6, 6, 15, 29  
8 146.0 C 145.7 - - - - - 
9 48.7 CH 48.4 2.28 m 2.28 m - 11 5, 18 
10 35.2 C 35.0 - - - - - 
11 18.5 CH2 18.3 1.56 m 1.53 m 9, 12 9 1, 12, 19 
12 34.0 CH2 33.8 1.64 m 1.47 m - 12 12, 21 
12 1.83 m 1.47 m 18 12 11, 12, 17, 
21 
13 43.8 C 43.5 - - - - - 
14 51.4 C 51.2 - - - - - 
15 34.2 CH2 34.0 1.49 m 1.47 m 14, 30 16 7, 16, 18 
15 2.34 m 1.47 m - - - 
16 28.7 CH2* 28.4 1.28 m  1.29 m - 16 16 
16 2.00 m 1.99 m - 15, 16 15, 16, 17, 
30 
17 54.0 CH 53.8 1.50 m 1.50 m 18, 20, 21 - 12, 16, 19 
18 22.3 CH3 22.0 0,82 s 0.80 s 12, 13, 1 4, 17  - 9, 15, 20 
19 13.0 CH3 12.8 1.01 s 0.99 s 1, 5, 9, 10  - 2, 6, 11, 17, 
29 
20 33.9 CH 33.7 1.41 m 1.38 m - 21 18, 21, 22, 
24 
21 19.1 CH3 18.9 0.93 d J=6.5 Hz 0.91 d J=6.1 Hz 17, 20, 22 20 12, 12, 20, 
23 
22 40.7 CH2 40.4 1.85 m 1.83 m 23 22, 23 20, 22, 23, 
24, 26 
22 1.19 m  1.20 m 24 22, 23 22, 23 
23 69.9 CH 69.7 4.12 m 4.09 m 20, 22, 24 22, 22, 
24 
21, 22, 22, 
24, 26 
24 75.2 CH 75.0 3.17 brs 
W1/2=2.60 Hz 
3.13 brs 22, 27 23 20, 22, 23, 
26, 27 
25 74.6 C 74.3 - - - - -  
26 26.4 CH3 26.2 1.31 s 1.30 s 24, 25, 27 - 23, 24 
27 27.7 CH3 27.4 1.32 s 1.29 s 24, 25, 26 - 24 
28 24.8 CH3 24.5 1.05 s 1.10 s 3, 4, 5, 29 - 5, 6, 6 
29 21.8 CH3 21.6 1.12 s 0.99 s 3, 4, 5, 28 - 2, 6, 6, 7, 
19 
30 27.6 CH3 27.4 1.00 s 1.00 s 8, 14, 15 - 16 
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 Structural elucidation of compound TS.4: 24-methylenetirucalla-8-en-3-ol, 
euphorbol  (Appendices 278-287) 
 
Figure 4.10: Structure of compound TS.4: 24-methylenetirucalla-8-en-3β-ol 
Compound TS4 was found to be the known compound euphorbol, and was isolated as a white 
solid from the dichloromethane extract of the stem bark of T. sinensis.  It has been isolated 
previously from Cerbera manghas L. (Apocynaceae)221, Euphorbia antiquorum L. 
(Euphorbiaceae)222, the marine fungus Eutypella scoparia FS26223 and the marine endophytic 
fungus Exophiala oligosperma (EN-21).224 
 
The LCMS of this compound gave a [M+Na] + ion peak at m/z 463.3800, calculated for 
[M+Na] + 463.3916 which indicated a molecular formula of C31H52O.  A double bond 
equivalence of six was calculated for this compound.  The FTIR spectrum showed 
absorptions bands at 3350 cm-1 for an OH stretch and 1640 cm-1 for a double bond stretch.77 
 
The 13C NMR spectrum, displayed thirty-one carbon resonances, including seven fully 
substituted carbons, five methine, eleven methylene and eight methyl group resonances, 
typical of a methylated triterpenoid structure [Figure 4.10 and Table 4.4]. 
 
The 1H NMR spectrum showed a proton resonance at H 3.11 which was seen to correspond 
to the carbon resonance at C 76.9 in the HSQC spectrum.  This resonance was assigned to C-
3 as it showed correlation in the HMBC spectrum with the two methyl group proton 
resonance at H 1.00 (3H-28) and 0.99 (3H-29), and with the H-1 (H1.23) and H-5 (H 
0.97) proton resonances.  The observed coupling constants (dd, J=5.0, 10.0 Hz) suggested 
that the configuration of H-3 was  with hydroxyl group in the -position.222 
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The two fully substituted carbon resonances at c 134.9 and 133.8 ppm were assigned as C-8 
and C-9 respectively due to their correlation with the H-5 (H 0.97), 2H-7 (H 2.04) and 2H-
11 (H 2.06) resonances in the HMBC spectrum.  The other alkene carbon resonances at 
c157.2 and 106.2 were assigned as C-24 and C-31 respectively because of their correlations 
with the two H-23 (H 2.12, 1.89), H-25 (H 2.22), 3H-26 (H 1.02, d J=6.8) and 3H-27 (H 
1.03, d J=6.8) proton resonances.  
 
In the NOESY spectrum, the H-3 resonance showed correlations with the 3H-28 and H-5 
resonances, and the H-5 resonance showed a further correlation with the 3H-18 (H 0.71)  
resonance.  All these protons (H-5, H-18 and H-28) were placed in the -orientation on 
biosynthetic grounds.213  The H-17 resonance (H 1.50) showed correlations with the 3H-30 
(H 0.89), which are in the -orientation on biosynthetic grounds.213   
 
The 1H NMR and 13C NMR chemical shifts [Table 4.4] for compound TS.4 were similar to 
those of the known euphorbol 222 except for the C-3, C-5, C-7 and C-19 chemical shifts which 
were at c 76.9, 47.3, 25.8 and 18.4 ppm respectively for compound TS4 and at c 79.0, 51.0, 
27.7 and 20.2 ppm for the reported compound.  A further search in the literature showed that 
euphorbol had chemical shifts at 76.5 and 18.3 ppm for C-3 and C-19 respectively.221  
However, the 1D and 2D-NMR spectrum confirmed that compound TS4 is 24-
methyltirucalla-8,24-dien-3-ol (euphorbol). 
 
Previous research showed that euphorbol had 100% inhibitory effect on the Epstein-Barr 
virus early antigen (EBV-EA ) activation induced by the tumour promoter TPA at 1000 mol 
ratio/TPA, while -carotene showed 8.6% inhibitory effect at the same concentration.222 
Furthermore, it showed 93.6 and 90.3% inhibition rates against the MCF-7 and SF-268 
tumour cell lines respectively at 100 µM and weak cytotoxicity against NCI-H460 cell line at 
the same concentration.223 
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Table 4.4: NMR data for compound TS.4: 24-methyltirucalla-8-en-3β-ol in CDCl3 
compared against literature reference values 
No. 13C NMR 
(125 MHz) 
13C NMR  
(125 MHz)222 
in CDCl3 
13C NMR 
(125 MHz)221   
in CDCl3
 
1H NMR 
 (500 MHz) 
1H NMR 
 (500 MHz)222 in 
CDCl3 
HMBC 
(H      C) 
COSY NOESY 
1 35.2 CH2 35.3 35.0 1.23 m 1.21  3,10, 19  1b, 2a 1, 2, 11 
1 1.78 m 1.77  3, 5, 10 1a 1, 2, 11, 29 
2 28.4 CH2 27.9 27.3 1.95 m  1.67  10 1a, 2b 1, 2 
2 1.33 m 1.57  - 2a 2,19 
3 76.9 CH 79.0 76.5 3.11 dd J=5.0, 10.0 
Hz 
3.24 dd J=4.3, 11.6 
Hz 
- - 5, 28 
4 39.5 C 38.9 39.2      
5 47.3 CH 51.0 50.4 0.98 m 1.12 dd J=1.8, 12.5 
Hz 
3, 6, 9, 
28, 29 
6b  3, 6, 7,18 
6 20.9 CH2 18.9 17.9 1.28 m 1.42  5, 7 5, 6a, 7 6, 7, 5 
6 1.78 m 1.69  5, 10 6b, 7 6, 7, 29 
7 25.8 CH2 27.7 28.2 2.04 m 2.08 6, 8, 9 6a, 6b 5, 6, 6 
8 134.9 C 133.5 133.2 - - - - - 
9 133.8 C 134.1 134.6 - - - - - 
10 36.6 C 36.5* 36.5 - - - - - 
11 22.0 CH2 21.5 20.7 2.06 m 2.06 1.92  8, 9 8, 9 1, 1, 12, 30 
12 31.3 CH2 30.8 25.5 1.72 m 1.72  11, 18 11 11, 21, 30 
13 44.8 C 44.1 44.6 - - - - - 
14 50.1 C 50.0 47.0 - - - - - 
15 29.9CH2 29.8 31.0 1.60 m 1.52 m 14, 16, 
30 
15b, 16a, 
16b 
15 
15 1.18 m 1.18 m - 15a, 16b 15, 16, 30 
16 28.5 CH2 28.1 30.8 1.32 m  1.32 m 13, 15 15a, 16b, 
17 
16 
16 1.95 m 1.94 m 15 15a, 15b, 
16a, 17  
15, 16, 30 
17 50.6 CH 50.1 50.4 1.50 m 1.52 m 13, 18, 
20 
16a, 16b, 
20 
30 
18 16.0 CH3 15.4 15.7 0.71 s 0.76 s 12, 13, 1 
4, 17  
- 5, 20 
19 18.4 CH3 20.2 18.3 0.97 s 0.96 s 5, 9 - 2 
20 36.7 CH 36.3 35.0 1.41 m 1.43 m - 21, 22a  18, 21 
21 18.9 CH3 18.8 19.1 0.93 d J=6.4 Hz 0.93 d J=6.4 Hz 17, 20, 
22 
20 12, 20 
22a 35.2 CH2 35.0 33.8 1.58 m 1.55 m 17 20, 22b, 
23a, 23b 
 22b, 23a, 31a, 
31b 
22b 1.13 m  1.12 m 23 22a, 23a, 
23b 
22a, 23b, 31a 
23a 31.5 CH2 31.3 31.2 2.12 m 2.12 m 24, 31 22a, 22b, 
23b 
22a, 23b 
23b 1.89 m 1.88 m 24, 31 22a, 22b, 
23a 
22b, 23a 
24 157.2 C 156.9 156.9 - - - - - 
25 34.0 CH 33.8 31.3 2.22 septet J=6.6 
Hz 
2.24 septet J=6.7 Hz 24, 26, 
27, 31 
26. 27 26, 27, 31b 
26 22.2 CH3 22.0 21.8 1.02 d J=6.8 Hz 1.02 d J=6.8 Hz 24, 25, 
27 
25 25, 31b 
27 22.1 CH3 21.9 21.9 1.03 d J=6.8 1.03 d J=7.0 Hz 24, 25, 
26 
25 25, 31b 
28 28.8 CH3 28.0 28.1 1.00 s 1.00 s 3, 4, 5 - 3 
29 15.3 CH3 15.5 15.0 0.99 s 0.80 s / 1.04 s* 3, 4, 5, 
28 
- 1, 6 
30 24.7 CH3 24.4 24.4 0.89 s 0.88 s 8, 13, 14, 
15 
- 11, 12, 15, 16, 
17 
31 106.2 CH2 105.9 105.9 4.66 brs W½=4.29 
Hz 
4.66 brs 23, 25 - 22a, 22b 
4.71 brs W½=3.79 
Hz 
4.72 brs 23, 25 - 22a, 25 
*The value was reported in another literature222 
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 Structural elucidation of compound TS.5: -amyrin acetate (Appendices 288-297) 
 
Figure 4.11: Structure of compound TS.5: β-amyrin acetate 
Compound TS5 was obtained from an inseparable mixture from the dichloromethane extract 
of the stem bark of T.sinensis that was acetylated in order to separate the components and 
was isolated as white oil and found to be the known -amyrin acetate.  It has been isolated 
previously from many species such as Forsythia suspense Thunb225, Solidago virga-aurea 
var. gigantea M (Compositae)226and Wrightia tomentosa Roem& Schult (Apocynaceae).227 
 
The LCMS of this compound gave a [M-H]+ ion peak at m/z 467.3903 which indicated a 
molecular formula of C32H52O2 for the compound.  A double bond equivalence of seven was 
calculated for this compound.  The FTIR spectrum showed absorptions bands at 2921 and 
2851 cm-1 for C-H stretches, 1737 cm-1 for the carbonyl stretch of an acetate group, 1636 cm-1 
for a double bond stretch and 1244 cm-1 for a C-O stretch.77 
 
The NMR spectra displayed thirty-two carbon resonances, including nine methyl, ten 
methylene, six methine, and seven fully substituted carbons resonances which indicated that 
this compound was an acetylated pentacyclic triterpenoid derivative [Figure 4.11 and Table 
4.5]. 
 
The 1H NMR spectrum showed a resonance at H 4.50 (dd, J=10.0, 5.9 Hz), which 
corresponded to the carbon resonance at c 81.2 in the HSQC spectrum.  The observed 
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coupling constants suggested that the configuration of H-3 was  with the acetate group in 
the -position.218, 225,226  
 
This proton resonance showed correlations with the two methyl group carbon resonances 3H-
23 (H 0.87, s) and 3H-24 (H 0.86, s), in the HMBC spectrum.  The olefinic proton 
resonance, H-12 (H5.18, t, J=3.7), showed correlations with the C-9 (c 47.8) and C-18 (c 
47.5) carbon resonances in the HMBC spectrum, and it showed further coupling with the H-
11 (H 1.87) resonance in the COSY spectrum.  The correlation between the proton resonance 
at H 1.13 (3H-27) and c145.5 (C-13) in the HMBC spectrum confirmed this placement for 
the alkene group. 
 
In the NOESY spectrum, the H-3 resonance at H 4.50 showed correlations with the H-5 (H 
0.84) and H-9 (H 1.58) resonances.  The H-9 resonance showed also correlations with the H-
5 (H 0.84) and 3H-27 (H 1.13) resonances.  All these protons (H-5, H-9, 3H-27) are in the -
orientation according to the biosynthesis, while the H-18 (H 1.96), 3H-25 (H0.98) and 3H-
26 (H 1.00) resonances, which showed correlations with each other in the NOESY spectrum, 
are in the - orientation.213  The NMR data compared well with literature values.225, 226, 228 
 
Previous research showed that -amyrin acetate reduced the plasma level of low density 
lipoprotein cholesterol (LDL-C) by 36%, total cholesterol (TC) by 37%, triglycerides (TG) 
by 35% and increased the high density lipoprotein cholesterol/total cholesterol (HDL-C/TC) 
ratio by 49% at a 10 mg/kg dose.227 
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Table 4.5: NMR data for compound TS.5: β-amyrin acetate in CDCl3 compared against 
literature reference values 
No. 13C NMR 
(125 MHz) 
13C NMR  
(75 
MHz)225  
in CDCl3 
1H NMR 
 (500 MHz) 
1H NMR 
(90 MHz) 228 
in CDCl3 
HMBC 
(H      C) 
COSY NOESY 
1 38.5 CH2 38.4 1.06 m - -  1, 2 1, 2, 3, 9 
1 1.63 m - 3, 10 1, 2 1, 3, 11, 25 
2 23.76 CH2 23.7 1.63 m - 3, 4, 10 1, 1, 3 1, 3, 25 
3 81.2 CH 81.0 4.5 dd J=10.0, 
5.5 Hz 
4.54 dd J=11.0, 
6.0 Hz 
- 2 1, 1, 2, 5, 9 
4 37.9 C 37.9 - - - - - 
5 55.5 CH 55.4 0.84 m - 7, 10, 23, 24, 25 6, 6  3, 9, 6, 6, 
7 
6 18.5 CH2 18.4 1.55 m - - 5, 6, 7 5, 6, 7, 27 
6 1.40 m - - 5, 6, 7, 7 5, 6 
7 32.8 CH2 32.7 1.50 m - - 6, 7 5, 7, 27 
7 1.34 m - - 6, 6, 7 6, 7, 26 
8 40.0 C 39.9 - - - - - 
9 47.8 CH 47.7 1.58 m - - 11 1, 3, 5, 27 
10 37.1 C 37.0 - - - - - 
11 23.8 CH2 23.7 1.87 m - - 11, 12 1, 12, 25 
12 121.9 CH 121.8 5.18 t J=3.7 Hz 5.21 t J=3.5 Hz 9, 18 11 18, 26 
13 145.5 C 145.3 - - - - - 
14 41.9 C 41.8 - - - - - 
15 26.4 CH2 26.3 1.78 m - - 15, 16, 16 15, 25, 28 
15 0.96 m - 8, 14, 17 15, 16 15, 16, 18 
16 27.2 CH2 27.1 2.0 m  - - 15, 15, 16 16, 27, 28 
16 0.8 m - 14, 17, 28 15, 16 15, 16, 18, 
26 
17 32.7 C 32.6 - - - - - 
18 47.5 CH 47.4 1.96 m - - 19, 19 12, 15, 16, 
19, 26, 28, 
30 
19 47.0 CH2 46.9 1.01 m - 17, 18, 29 18, 19 19, 21 
19 1.66 m - 20, 29, 30 18, 19 18, 19, 21, 
26 
20 31.3 C 31.2 - - - - - 
21 35.0 CH2 34.9 1.34 m - - 21, 22 19, 21, 27 
21 1.10 m - - 21, 22 19, 21, 
22, 28 
22 37.4 CH2 37.3 1.21 m - - 22 22 
22 1.41 m  - - 21, 21, 
22 
21, 22, 28 
23 28.3 CH3 28.2 0.87 s 0.88 s 3, 4, 5, 24 - - 
24 16.9 CH3 16.9 0.86 s 0.88 s 3, 4, 5, 23 - - 
25 15.8 CH3 15.7 0.98 s 0.98 s 1, 5, 9, 10 - 1, 2, 15, 28  
26 17.0 CH3 16.9 1.00 s 0.98 s 7, 8, 9, 14 - 7, 16, 18, 
19, 28  
27 26.2 CH3 26.1 1.13 s 1.14 s 8, 13, 14, 15 - 6, 7, 9, 16 
28 28.6 CH3 28.5 0.83 s 0.84 s 16, 17, 18, 22 - 15, 18, 21, 
22, 25, 26 
29 33.6 CH3 33.5 0.87 s 0.88 s 19, 20, 21, 30 - - 
30 23.9 CH3 23.8 0.87 s 0.88 s 19, 20, 21, 29 - 18 
O-CO-CH3 
 
171.4 C 171.1 - - - - - 
O-CO-CH3 21.5 CH3 21.4 2.05 s 2.07 s O-CO-CH3 
 
-  
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 Structural elucidation of compound TS.6: catechin (Appendices 298-305) 
 
Figure 4.12: Structure of compound TS.6: catechin 
Compound TS.6 was obtained from an inseparable mixture from the methanol extract of the 
stem bark of T.sinensis that was acetylated in order to separate the components and was 
isolated as white solid and found to be the known catechin.  It has been isolated previously 
from many species such as Schinus terebinthifolius Raddi (Anarcardiaceae),229 Salix 
acutifolia Willd (Salicaceae),230 Pavetta owariensis P. Beauv (Rubiaceae)231 and from Toona 
sinensis (Meliaceae).202 
 
The LCMS spectrum of compound TS.6 gave a [M+Na]+ ion at m/z 523.3 which suggested a 
molecular formula of C25H24O11 for the compound.  A double bond equivalence of thirteen 
was calculated for this compound. 
 
The NMR spectra displayed twenty-five carbon resonances, including five methyl, one 
methylene, seven methine, and eleven fully substituted carbons resonances; five of them are 
for carbonyl group carbon resonances and the rest for aromatic carbon resonances [Figure 
4.12 and Table 4.6].   
 
The HMBC spectrum showed correlations between 2H-4 (δH 2.82 and δH 2.72) and two 
oxygenated methine carbon resonance C-2 (δC 79.0) and C-3 (δC 69.7), and three aromatic 
fully substituted carbon resonance C-4a (δC 111.9), C-5 (δC 151.1) and C-8a (δC 155.9).  The 
two aromatic proton resonances at H-6 (δH 6.59) and H-8 (δH 6.69) were assigned at this 
position as they showed correlations with each other and with two fully substituted carbon 
resonances C-4a (δC 111.9) and C-7 (δC 151.5), in the HMBC spectrum.  In addition, H-6 (δH 
6.59) showed a correlation with the C-5 (δC 151.1) carbon resonance, and H-8 (δH 6.69) 
170 
 
showed a correlation with the C-8a (δC 155.9) carbon resonance in the HMBC spectrum.  The 
oxygenated methine proton resonance H-2 (δH 5.25) was assigned due to its correlations, seen 
in the HMBC spectrum, with two aromatic fully substituted carbon resonances C-8a (δC 
155.9) and C-1’ (δC 137.9), two methine aromatic carbon resonances C-2’ (δC 123.0) and C-6’ 
(δC 125.6), and oxygenated methine and methylene carbon resonance C-3 (δC 69.7) and C-4 
(δC 24.8).  The oxygenated methine proton resonance H-3 (δH 5.30) showed correlations with 
the acetyl carbonyl carbon resonance (δC 171.7) and with the C-4a (δC 111.9). 
 
The COSY spectrum showed coupling between 2H-4 (δH 2.82 and δH 2.72) and H-3 (δH 
5.30), and H-3/H-2 which confirmed their assignments.  The NOESY spectrum and coupling 
constant were used to assign the relative configuration of TS.6.  The H-2 (δH 5.25) showed 
correlation with one H-4 (δH 2.72) proton resonance, while H-3 (δH 5.30) showed correlations 
with the another H-4 (δH 2.82) proton resonances.  The big coupling constant between H-2 
(δH 5.25) and H-3 (δH 5.30) of J2,3=6.0 Hz, and between H-4 and H-3 of J4,3=5.0, 6.5, 16.7 Hz 
indicated the trans orientation between H-2 and H-3.229,231,232  While, a cis configuration give 
broad singlet multiplicity of H-2, and coupling constant of J=2.8, 4.8, 16,8 Hz for 2H-4.232,233   
 
Compound TS.6 was found to be an acetylated derivative of catechin.  1H and 13C NMR data 
for this compound have not been reported in the literature.  Due to insufficient material, the 
FTIR and optical rotation were not determined.   
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Table 4.6: NMR data for acetylated derivative of compound TS.6:catechin penta-acetate 
in CD3OD  
No. 13C NMR 
(125 MHz) 
1H NMR 
 (500 MHz) 
HMBC 
(H      C) 
COSY NOESY 
2 79.0 CH 5.25 d J=6.0 Hz 3, 4, 8a, 1’, 2’, 6’ - 4, 6’, 5’ 
3 69.7 CH 5.30 m 4a, 3-O-CO-CH3 4α, 4β 4 
4β 24.8 CH2 2.72 dd J=6.5, 
16.7 Hz 
2, 3, 4a, 5, 8a 3, 4 2 
4α 2.82 dd J=5.0, 
16.7 Hz 
2, 3, 4a, 5, 8a 3, 4 3 
4a 111.9 C - - - - 
5 151.1 C - - - - 
6 110.0 CH 6.59 d J=2.3 Hz 4a, 5, 7, 8 - - 
7 151.5 C - - - - 
8 108.7 CH 6.69 d J=2.3 Hz  4a, 6, 7, 8a - - 
8a 155.9 C - - - - 
1’ 137.9 C - - - - 
2’ 123.0 CH 7.25 s 2, 1’, 3’, 4’, 6’ - - 
3’ 134.7 C - - - - 
4’ 134.7 C - - - - 
5’ 124.8 CH 7.24 d J=8.0 Hz 1’, 3’, 4’, 6’ - 2 
6’ 125.6 CH 7.33 dd J=2.3, 
8.0 Hz 
2, 2’, 4’ - 2 
3-O-CO-CH3 171.7 C - - - - 
3-O-CO-CH3 20.5 CH3 1.97 s -3-O-CO-CH3 - - 
5-CO-CH3 170.7 C* 
 
- - - - 
5-O-CO-CH3 20.9 CH3** 2.28 s** 5-O-CO-CH3 - - 
7-O-CO-CH3 
 
170.2 C* - - - - 
7-O-CO-CH3 20.8 CH3** 2.28 s** 7-O-CO-CH3 - - 
3’-O-CO-CH3 169.9 C* - - - - 
3’-O-CO-CH3 20.4 CH3** 2.28 s** 3’O-CO-CH3 - - 
4’-O-CO-CH3 169.9 C* - - - - 
4’-O-CO-CH3 20.4 CH3** 2.28 s** 4’-O-CO-CH3 - - 
*/** Refers to overlapped proton and carbon resonances 
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 Structural elucidation of compound TS.7: epicatechin (Appendices 306-313) 
 
Figure 4.13: Structure of compound TS.7: epicatechin 
Compound TS.7 was obtained from an inseparable mixture from the methanol extract of the stem 
bark of T.sinensis that was acetylated in order to separate the components and was isolated as 
white solid and found to be the known epicatechin.  It has been isolated previously from many 
species such as Pavetta owariensis P. Beauv (Rubiaceae)231 Polygonum multiflorum Thunb 
(Polygonaceae)234 and Toona sinensis (Meliaceae).202 
 
The LCMS spectrum of compound TS.7 gave a [M+Na]+ ion at m/z 523. 3 which suggested a 
molecular formula of C25H24O11 for the compound.  A double bond equivalence of thirteen 
was calculated for this compound.  The FTIR spectrum showed absorptions bands at 2923 
and 2853 cm-1 for C-H stretches, 2360 cm-1 for C=O stretch.77 
 
The NMR spectra displayed twenty-five carbon resonances, including five methyl, one 
methylene, seven methine, and eleven fully substituted carbons resonances; five of them are 
for carbonyl group carbon resonances and the rest for aromatic carbon resonances [Figure 
4.13 and  
Table 4.7]. 
 
The NMR spectra of compound TS.7 was similar to those of TS.6.  However, the coupling 
constant between H-2 (δH 5.25, J1,2=6.0 Hz) and H-3 (δH 5.47), and H-3 and 2H-4 (δH 2.84, 
dd J=1.9. 17.8 Hz and δH 3.08, dd J=4.5, 17.8 Hz) were different from these in TS.6.  In 
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addition, the NOESY spectrum showed difference in the H-2, H-3 and 2H-4 correlations 
between TS.6 and TS.7.  The H-2 (δH 5.25) showed correlation, in the NOESY spectrum, 
with the H-3 (δH 5.47) proton resonance and one H-4 (δH 3.08) proton resonance, all these 
protons (H-2, H-3 and H-4β) were assigned in same orientation.  The H-3 resonance (δH 5.30) 
showed correlations with the two 2H-4 (δH 2.84, 3.08) proton resonances.  The broad singlet 
proton resonance of H-2 (δH 5.30) and the coupling constant of 2H-4 J=1.9, 4.5, 17.8 Hz 
indicated the cis orientation between H-2 and H-3 proton resonances.232,233  Compound TS.7 
was found to be an acetylated derivative of epicatechin.  1H and 13C NMR data for this 
compound have not been reported in the literature.  The specific optical rotation compound 
TS.7 was determined to be +90.0 in methanol.   
Table 4.7: NMR data for compound TS.7: epicatechin penta-acetate in CD3OD 
No. 13C NMR 
(125 MHz) 
1H NMR 
 (500 MHz) 
HMBC 
(H      C) 
COSY NOESY 
2 78.0 CH 5.30 s 3, 1’, 2’, 6’ - 3, 4β, 2’, 
6’ 
3 68.3 CH 5.47 m - 4α, 4β 2, 4α, 4β, 
6’ 
4α 26.8 CH2 2.84 dd J=1.9, 17.8 Hz 4a 3, 4 3, 4β 
4β 3.08 dd J=4.5, 17.8 Hz 5, 8a 3, 4 3, 2, 4α 
4a 111.9 C - - - - 
5 151.3 C - - - - 
6 110.0 CH 6.58 d J=2.3 Hz 4a, 5, 7, 8 - - 
7 151.4 C - - - - 
8 108.7 CH 6.69 d J=2.3 Hz  4a, 7, 8a - - 
8a 156.4 C - - - - 
1’ 137.9 C - - - - 
2’ 123.1 CH 7.40 s 2, 3’, 4’, 6’ - - 
3’ 134.5 C - - - - 
4’ 134.4 C - - - - 
5’ 124.3 CH 7.24 d J=8.0 Hz 1’, 3’, 4’, 6’ - 2 
6’ 125.6 CH 7.39 dd J=2.3, 8.0 Hz 2, 2’, 4’ - 2, 3 
3-O-CO-CH3 171.8 C -  - - 
3-O-CO-CH3 20.9 CH3 1.88 s 3-O-CO-CH3 - - 
5-CO-CH3 170.3 C* 
 
- - - - 
5-O-CO-CH3 20.6 CH3** 2.27 s 5-O-CO-CH3 - - 
7-O-CO-CH3 
 
170.2 C* - - - - 
7-O-CO-CH3 20.5 CH3** 2.30 s 7-O-CO-CH3 - - 
3’-O-CO-CH3 169.9 C* - - - - 
3’-O-CO-CH3 20.5 CH3** 2.29 s**  3’O-CO-CH3 - - 
4’-O-CO-CH3 169.9 C* - - - - 
4’-O-CO-CH3 20.4 CH3** 2.29 s** J=7.3 4’-O-CO-CH3 - - 
*/** Refers to overlapped proton and carbon resonances 
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 Structural elucidation of compound TS.8: sitosterol, stigmast-5-en-3-ol 
(Appendices 314-318) 
 
 
 
 
 
 
 
 
Figure 4.14: Structure of compound TS.8: sitosterol 
Compound TS.8 was found to be the very common compound sitosterol, and was isolated as 
white crystals from the dichloromethane extract of the stem bark of T. sinensis.  It has been 
isolated previously from many species such as Anoectochilus koshunensis (Orchidaceae)235 
and Trifolium balansae (Leguminosae).236  
 
The LCMS of this compound gave a [M-H]+ ion peak at m/z 413.3733, which indicated a 
molecular formula of C29H50O for the compound.  A double bond equivalence of five was 
calculated for this compound.  The FTIR spectrum showed absorptions bands at 3411 cm-1 for 
OH stretch, 1052 cm-1 for a C-O stretch and 1640 cm-1 for a double bond stretch.77 
 
The 1H NMR spectrum displayed a proton resonance at H 5.35 (m), which corresponded to 
the carbon resonance at c 121.9 in the HSQC spectrum, and was assigned as H-6.  The 
oxymethine proton resonance at H 3.52 (m) was assigned as H-3.  The 1H and 13C NMR 
data of compound TS.8 were compared with literature reference values sitosterol236 and was 
found to be identical [Figure 4.14 and Table 4.8]  
 
Sitosterol did not show significant activity at a concentration less than 64 µg/ml in vitro 
against Mycobacterium tuberculosis, in previous research.237 
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Table 4.8: NMR data for compound TS.8: sitosterol in CDCl3 compared against 
literature reference values 
No. 13C NMR 
(125 MHz) 
13C NMR  
(75 MHz)236  
in CDCl3 
1H NMR 
 (500 MHz) 
1H NMR 
(300 MHz)236  
in CDCl3 
1a 37.5 CH2 37.48 1.85* - 
1b 1.08* - 
2a 31.9 CH2 31.86 1.84 m - 
2b 1.53 m - 
3 72.0 CH 72.05 3.52 m 3.52 m  
4a 42.54 CH2 42.50 2.30 m - 
4b 2.24 m - 
5 141.0 C 140.97 - - 
6 121.9 CH 121.93 5.35 m 5.34 d J=5.5 Hz 
7a 32.1 CH2 32.14 2.00 m - 
7b 1.46 m - 
8 32.1 CH 31.86 1.45 m - 
9 50.4 CH 50.38 0.93 m - 
10 36.7 C 36.73 - - 
11a 21.3 CH2 21.31 1.50 m - 
11b 1.47 m - 
12a 40.0 CH2 40.01 2.01 m - 
12b 1.15 m - 
13 42.6 C 40.01 - - 
14 57.0 CH 57.00 0.99 m - 
15a 24.5 CH2 24.52 1.58m - 
15b 1.08* - 
16a 28.5 CH2 28.45 1.85*  - 
16b 1.25 m - 
17 56.3 CH 56.31 1.10 m - 
18 12.1 CH3 12.07 0.68 s 0.67 s 
19 19.6 CH3 19.26 1.01 s 1.00 s 
20 36.4 CH 36.36 1.37 m - 
21 19.0 CH3 19.00 0.92 d, J=6.5 Hz 0.90 d J=6.5 Hz 
22a 34.2 CH2 34.19 1.33 m - 
22b 1.02 m  - 
23a 26.3 CH2 26.37 1.18 m - 
23b 1.15 m - 
24 46.1 CH 46.09 0.93 m - 
25 29.4 CH 28.46 1.66 m - 
26 20.0 CH3 19.20 0.83* 0.81 d J=6.0 Hz 
27 19.3 CH3 19.60 0.81* 0.81 d J=6.0 Hz 
28a 23.3 CH3 23.31 1.28 m - 
28b 1.22 m - 
29 12.2 CH3 12.43 0.84* 0.84 t J=7.1 Hz 
*Refers to overlapped proton and carbon resonances 
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 Structural elucidation of compound TS.9: sitostenone, stigmast-4-en-3-one 
(Appendices 61-66) (Appendices 319-322) 
 
 
 
 
 
 
 
Figure 4.15: Structure of compound TS.9: sitostenone 
 
Compound TS.9 was found to be the known sitostenone and was isolated as white crystals 
from the dichloromethane extract of the stem bark of T sinensis.  It has been isolated 
previously from many species such as Spilanthes acmella (Compositae).238 
 
The LCMS of this compound gave a [M+H]+ ion peak at m/z 413.3712, calculated for 
[M+H]+ 413.3783 which indicated a molecular formula of C29H48O for the compound.  A 
double bond equivalence of six was calculated for this compound.  The FTIR spectrum 
showed absorptions bands at 2919 and 2869 cm-1 for C-H stretches, 1727 cm-1 for C=O and 
1680 cm-1 for double bond stretches.77 
 
The 1H NMR spectrum displayed a proton resonance at H 5.72 (s), which corresponded to 
the carbon resonance at c 124.0 in the HSQC spectrum, and was assigned as H-4.  The fully 
substituted carbon resonance at c 199.9 was assigned as C-3.  The NMR data of compound 
TS.9 was compared with literature values for sitostenone238,239 and was found to be identical 
[Figure 4.15 and Table 4.9].  
 
Previous research showed that sitostenone has strong antimicrobial activity against 
Corynebacterium diphtheria NCTC 10356 with a MIC of 64-256 µg/mL, but it exhibited 
weak antioxidant activity in the superoxide dismutase (SOD) and 2,2-diphenyl-1-
picrylhydrazyl (DPPH) assays 238 
177 
 
Table 4.9: NMR data for compound TS.9: sitostenone in CDCl3 compared against 
literature reference values 
 
 
 
 
 
 
 
  
No. 13C NMR 
(125 MHz) 
13C NMR  
(100 
MHz)238  
in CDCl3 
1H NMR 
 (500 MHz) 
1H NMR 
(300 MHz)239 
 in CDCl3 
1a 35.9 CH2 36.06 2.01 m 2.00 m 
1b 1.69 m 1.67 m 
2a 34.2 CH2 33.93 2.45 m 2.35 m 
2b 2.31 m 2.23 m 
3 199.9 C 199.58 - - 
4 124.0 CH 123.69 5.72 s 5.70 s 
5 171.9 C 171.64 - - 
6a 33.20 CH2 33.86 2.28 m 2.35 m 
6b 2.25 m 2.23 m 
7a 32.3 CH2 32.91 
 
1.84 m 1.80 m 
7b 1.01 m 1.00 m 
8 35 8 CH 35.60 1.53 m 1.55 m 
9 54.0 CH 53.79 0.91 m 0.90 m 
10 38.8 C 39.59 - - 
11a 21.2 CH2 21.10 1.51 m 1.50 m 
11b 1.44 m 1.34 m 
12a 39.8 CH2 38.57 2.03 m 2.01 m 
12b 1.16 m 1.12 m 
13 42.6 C 42.35 - - 
14 56.1 CH 55.87 1.00 m 1.10 m 
15a 28.4 CH2 24.14 1.86 m 1.08 m 
15b 1.28 m 1.50 m 
16a 24.4 CH2 28.13 1.61 m  2.07 m 
16b 1.11 m 1.43 m 
17 56.2 CH 55.99 1.11 m 1.00 m 
18 12.16 CH3 11.90 0.71 s 0.69 s 
19 17.6 CH3 18.65 1.18 s 1.15 s 
20 36.3 CH 36.07 1.38 m 1.30 m 
21 18.9 CH3 18.98 0.91 d, J=6.3 Hz 0.90 d J=6.5 
22a 34.1 CH2 35.65 1.32 m 1.04 m 
22b 1.02 m  1.32 m 
23a 26.3 CH2 26.08 1.16 m 1.15 m 
24 46.0 CH 45.81 0.92 m 0.94 
25 29.4 CH 29.64 1.67 m 1.65 
26 20.0 CH3 20.99 0.83 d, J=6.8 Hz 0.85 d J=6.8 
27 19.2 CH3 19.75 0.91 d, J=6.8 Hz 0.79 d J=6.8 Hz 
28a 23.3 CH3 23.04 1.27 m 1.24 m 
28b 1.22 m 1.18 m 
29 12.19 CH3 11.14 0.86 t J=7.6 Hz 0.81 t J=7.2 Hz 
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 Conclusion  
Toona sinensis Roem is widely used in traditional medicine, therefore, it has been extensively 
studied by many chemist and pharmacologists.  However, the stem bark of T. sinensis has 
been investigated phytochemically only once.200  The objective of this study was to compare 
the chemical constituents of Toona sinensis, naturally grown in Asia to this grown on the 
University of Surrey campus, Guildford, UK.  24-Methylencycloartan-3-yl acetate (TS.1), 
24-methylencycloartan-3-one (TS.2), piscidinol A (TS.3), 24-methyltirucalla-8-en-3-ol 
(TS.4), -amyrin acetate (TS.5), catechin (TS.6), epicatechin (TS.7), sitosterol (TS.8) and 
sitostenone (TS.9) were isolated from the stem bark of the T. sinensis in this study.  Toona 
genus has been reported to have different types of triterpenoids and TS.1, TS.2 and TS.3 
were reported previously from this genus.  However, the report of TS.4 and TS.5 in this study 
is the first, while TS.6 and TS.7 were reported previously from this species.  In general, 
Toona sinensis grown in the UK yielded compounds (TS.4 and TS.5) have not been isolated 
before from Asia species.   
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 Chapter five: Biological activities of isolated compounds 
From the 250,000-500,000 species of higher plants, only a small percentage have been 
investigated and their phytochemical and medicinal properties described.240  Therefore, there 
is a need to continue research on the safety and efficiency of medicinal plants.241  The 
chemodiversity of natural product compounds has given many anticancer drugs or their 
derivatives [Section 1.1and Table 1.1 ] indicating the important role of natural products in 
the development of anticancer drugs. 
 
In this study, the anti-cancer screening of some compounds isolated in this study was 
performed in two ways, neutral red assay for the estimation of cell cytotoxicity and by 
submitting selected isolated compounds to the Development Therapeutics Program (DTP) of 
the National Cancer Institute (NCI). 
 Cytotoxicity  
Cytotoxicity refers to the ability of a chemical compound or a mediator cell (such as T-cell) 
to destroy living cells.242,243  Cells exposed to a cytotoxic compound can respond in two 
possible cytocidal mechanisms, firstly the lytic mechanism, in which the cytotoxic compound 
secretes lytic molecules into the intercellular space to from pores in the target cell membrane, 
causing breaking down of the cell, secondly the apoptotic mechanism (programmed cell 
death), in which the cytotoxic compound activates caspases, which, in turn, cleave 
intracellular substrates, for example, DNAse leading to cell lysis quickly and neatly.242  This 
process cleans the tissues from harmful and unwanted cells.  Most anti-cancer drugs depend 
on the activation of apoptotic pathways.242,243  Therefore, it will be discussed in this chapter. 
 
In the absence of adequate toxicological data of most existing chemicals, in vitro cytotoxicity 
data, which needs a short time and relatively low cost to perform, can be a vital tool for 
ranking compounds according to their potential toxicity that might pose a health risk to 
humans, and it can be very useful during the development of a new pharmaceutical 
product.244  Therefore, in vitro cytotoxicity tests against a panel of cancer cell lines is the 
most common method of anticancer drug discovery.244 
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 Measuring Cell Cytotoxicity  
There are many different ways to measure in vitro cytotoxicity, firstly by observing 
morphological alterations in the cell by using microscopy techniques, another index of 
toxicity is cell proliferation which can measure, by assay, total cell number, DNA content, 
protein content or enzyme activity in the population.244  Another indicator of in vitro 
cytotoxicity is cell viability, which is based on ATP level, O2 consumption, nucleotide uptake 
activity, enzyme activity, such as lactate dehydrogenase activity, and cell membrane 
permeability that uses vital dyes such as neutral red that is taken up by the live cell, while 
trypan blue is excluded by viable cells.242,244  Many of these methods involve fluorescence, 
colorimetric and luminescence detection.242  As the neutral red assay was used in this study to 
assay the cytotoxicity of isolated compounds, it will be discussed in the next section 
 
 Principle of neutral red assay  
The neutral red assay is one of the most used methods to determine cell viability.245  It is 
based on the binding of neutral red to the lysosomes of live cells.246  Neutral red is a weak 
cationic dye that penetrates cell membranes by non-ionic passive diffusion as the net charge 
of neutral red is about zero.245,247  The pH of lysosomes in the viable cell is lower than the 
cytoplasm due to the production of ATP.  This leads neutral red dye to bind with anionic 
groups of the lysosomal matrix and maintains the neutral red dye charge, so it can retain 
inside lysosomes.245  When the cell dies, cell surface changes and the pH gradient reduces, so 
the dye cannot be taken up or retained.  Therefore, the capacity of taking up the dye can be 
used to distinguish between dead, damaged and viable cells.245  An acidified ethanol solution 
can be used to extract the dye from viable cells, which can be measured by spectrometry at 
540 nm.245,247  The amount of dye taken up is proportional to the number of live cells [Figure 
5.1].245,247   
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Figure 5.1: Example of correlation between lysosomal activity of  Caco-2 cells and 
absorbance of neutral red dye at 24 hours growth247 
 
 Apoptosis mechanism 
Programmed cell death, apoptosis, is a process of all multicellular organisms and it plays an 
important role in cellular processes such as in immune systems and embryogenesis.243  
Apoptosis starts with morphology changes in the cell, including chromatin condensation, 
nuclear fragmentation, blebbing of membrane and shrinkage to forms apoptotic bodies that 
contain portions of nucleus and are surrounded by plasma membranes.242,243  These apoptotic 
bodies will be recognized and ingested by phagocytes or neighbouring cells before spilling 
cell contents onto surrounding cells.242,243  Therefore, apoptosis often occurs without any 
inflammatory response.  This death process is induced by activating caspases.242,243  
 
Caspases are cysteine proteases that degrade proteins and occur in cells as inactive zymogens.  
They can be divided into initiator caspases and effector caspases.  Initiator caspases, such as 
caspase-8, -9 and -10, are activated by binding to an adaptor complex, which causes a 
dimerization and conformational change in the initiator caspases.242,243  This type has a long 
prodomain, while effector caspases, such as caspase-3, -6, -7, have a short prodomain, and 
are activated by initiator caspases.  Effector caspases cleave about 400 substrates, such as 
proteins involved in DNA replication and repair, and signal transduction.  For example, 
caspase-3 cleaves ICAD (inhibitor of caspase-activated DNAase) and liberates the active 
CAD nucleus that forms apoptotic DNA fragments.242,243 
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Cells can undergo apoptosis by two pathways, the intrinsic pathway and extrinsic pathway.  
To stimulate any of the apoptosis pathways (intrinsic and extrinsic) there is a need to activate 
initiator caspases, which, in turn, are responsible to activate executioner caspases.  The 
executioner caspases kill the cells by degrading intracellular substrates.242  The extrinsic 
pathway is usually used in the immune system to keep tissue homeostasis, In this type, the 
extracellular ligands bind with various cell-surface death receptors, which leads to activation 
of initiator procaspases-8, and -10.  These initiator procaspases will activate the executioner 
procaspases-3 and -7.242,243  The intrinsic pathway (mitochondrial dependent pathway), is 
used during intracellular stresses such as DNA damage or increasing of reactive oxygen 
species (ROS).  Mediating these stresses activates mitochondrial-initiator procaspase-9, 
which is responsible for activation of executioner procaspases-3 and -7.  Therefore, both 
ways lead to activation of effector caspases that cleave intracellular substrates at a specific 
amino acid recognition motif.242,243  Both caspases-3 and -7 share 54% of sequence identity 
and both of them cleave many of the same substrates, which is usually a tetrapeptide 
recognition sequence after the last aspartic acid (DEVD).242,243 
 Apoptosis in cancer 
Anti-apoptosis proteins and the caspase inhibitors have been found up regulated in cancer, 
while pro-apoptotic proteins have been found mutated or down regulated.243,248,249  However, 
studies have found that procaspase level is higher in many cancer cells243.  The strategy has 
been used to develop compounds that activate procaspase for cancer cells over non cancer 
cells as an anticancer treatment.242  Compound PAC-1 [Figure 5.2] is the first activator of 
procaspase-3/-7 to be discovered via a high throughput screening campaign.243 
 
Figure 5.2: structure of Compound PAC-1243 
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 Measuring Apoptosis: CellPlayerTM 96-well caspase-3/7 reagent  
The commonly used method to detect apoptosis is by determination of caspase activation, as 
the caspases have a crucial role in apoptotic cell death.242  This method relies on measuring 
the quantity of caspase activation by detecting the cleaved caspase substrate.242 
 
One of these methods that was used in this study is kinetic measurement apoptosis using the 
CellPlayerTM 96-well caspase-3/7 reagent.  This reagent is the caspase-3/-7 recognition motif 
peptide (DEVD) conjugated to a DNA intercalating dye, which is non-fluorescent until 
released from the peptide and bonded to DNA.  When this reagent is added to tissue culture, 
it crosses the cell membrane and is cleaved by activated caspase-3/7.  This leads to release of 
the DNA dye and green fluorescent staining after bonding to nuclear DNA.  The fluorescence 
emission of the dye can be observed using a standard “FITC" filter set.  This method can be 
monitored morphologically using live cell imaging and quantified using the IncuCyte FLR 
object counting algorithm.248  The high definition phase contrast images give qualitative 
information of cell death (caspase activity) by detecting the morphological characteristic 
changes during apoptosis.249,250  While the Incucyte FLR counts cell growth based on area 
(confluence) metrics by isolating fluorescent signal from background, then divide the signal 
into singular objects, and count objects on area for each time point.249,250  
 The cytotoxicity Results  
 Neutral red assay results 
The isolated compound from Croton dichogamus (Euphorbiaceae) and Crinum species 1 
6538 (Amaryllidaceae) that were screened in vitro for cell viability against Caco-2 (Human 
Colorectal Adenocarcinoma) cell lines by using neutral red assay are given in Table 5.1. 
 
All the samples were tested at 100 µM to estimate their cytotoxicity and compared with 
actinomycyin at a concentration of 7.96 µM (10µg/ml) as a positive control as described in 
Materials and Methods, and promising ones were subjected to further testing to estimate their 
IC50’s.  All the compounds tested showed lower potency than actinomycyin, except 
compounds 10-epi maninsigin D (CD.5) and masonine (CF.5) that displayed 32.6% and 
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45.7% cell death [Figure 5.3].  CD.5 and CF.5 were tested at five concentrations 1, 3, 10, 30, 
100 µM to estimate their IC50.  CF.5 did not show inhibition activity at any concentration 
under 100 µM, while CD.5 showed promising activity with an IC50 24.1 µM [Figure 5.4].  
All screened compounds have not been tested for cytotoxicity except the epimer of CD.5, the 
normal enantiomer of CD.6 and CD.8.  Maninsigin D (epimer of CD.5) has been tested 
against HL-60, A-549, SW-480, SMMC-7721 and MCF-7 human cell lines by the MTT 
method with cis-platin as a positive control and it showed IC50 values > 40 µM.  The normal 
enantiomer series of CD.6 showed cytotoxicity against BT-474, KATO-3, CHAGO, SW-620 
and HEP-G2 human cancer cell lines with LC50 values of  3.26, 6.78, 6.67, 4.44 and 6.37 
µg/mL.91  This difference of cytotoxicity of reported and screened compounds can be 
attributed to the differences of stereochemistry and cancer cell line.  CD.8 did not show 
cytotoxic against human premyelocytic leukemia HL-60 and murine leukemia P-388 cell 
lines with an IC50 ≥ 10µM in previous research and in this study.93  
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Table 5.1: Structures of compounds screened for cytotoxicity 
Croton dichogamus (Euphorbiaceae) 
 
Crinum species 1 6538 (Amaryllidaceae) 
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Figure 5.3: Percentage of cell death of actinomycyin at 7.96 µM and screened 
compounds at 100 µM using the neutral red cytotoxicity assay  
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Figure 5.4: Percentage of cell death of compound CD.5 and CF.5 at different 
concxentrations by using neutral red cytotoxicity assay  
 Results of CellPlayerTM 96-well caspase-3/7 reagent 
In this experiment, we could not compare the activity of caspase-3/7 of the screened 
compound 10-epi maninsigin D (CD.5) and the positive and negative controls as there was no 
significant difference between them.  That might be belonging to the reagent used in DNA 
labeling, and during apoptosis, cell undergoes DNA fragmentation, which makes it difficult 
to determine the actual cell number.249,250  As there was no linear correlation between cell 
nuclei and confluence (the percentage of the images full by fluorescents objects),249,250 this 
experiment showed the ability of compound CD.5 at 100 µM to inhibit Caco-2 cell growth 
compared to DMSO and media by measuring the confluence in wells over 48 hours [Figure 
5.5]. 
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Figure 5.5: Percentage of confluences of compound CD.5 compared with positive and 
negative controls over 48 hours. 
 The NCI anticancer drug discovery screen  
Since 1955, the National Cancer Institute (NCI) in the US has made a major contributions by 
preclinical anticancer drug screening by screening over 3 million compounds.251  The 
intention of the NCI was to establish a high-throughput in vitro screen that reduces the 
number of compounds to be chosen for further in vivo assay.252  In 1995, the hollow fiber 
assay was implemented by the NCI to evaluate compounds for secondary in vivo testing.252  
In addition, the NCI has generated mean graphs (fingerprints) of growth inhibition of over 
85,000 compounds using the in vitro NCI 60 cell line panel at five concentrations for each 
compound.252  A programme called COMPARE is used to compare the mean graph pattern 
with compounds with known mode of action and assists in predicting the mode of action.252 
 
Since 1990, the Development Therapeutics Program (DTP) of the NCI has used the 60 
human tumor cell line panel of nine tissue types divided into: six leukemia, nine non-small 
cell lung, seven colon, six central nervous system, nine melanoma, seven ovarian, eight renal, 
two prostate and six breast.253  From 2007, all compounds submitted to the NCI are tested 
against the in vitro NCI 60 cell line panel at one dose of 15 µg/ml.254  If the compound 
satisfies predetermined threshold criteria, then it will progress again against 60 cell lines in a 
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five dose assay with maximum concentration of 150 µg/ml.  The NCI data is reported as a 
percentage growth of a treated cell relative to the no drug control and to the time zero number 
of cells.  That helps to detect growth inhibition values (between 0 and 100) and lethality 
values (less than 0).  For example a value of 0 means no growth, a value of 100 would mean 
no growth inhibition, a value of 30 means 70% growth inhibition.  A value of -30 would 
mean 30% lethality and a value of -100 means all treated cells are dead.  The bar projection 
to the left indicates that the average cell line in the panel is more sensitive than individual cell 
line.  The bar projection to the right means that an individual cell line is more sensitive than 
the average cell line.  
 
 Results of NCI60 human tumor cell line panel screening 
The selected isolated compound from Croton dichogamus (Euphorbiaceae) and Toona 
sinensis (Meliaceae) that were submitted to the NCI60 screen, are given in Table 5.2  All the 
compounds submitted were tested using one dose of 15 µg/ml NCI60 cell line panel.  The 
mean values of growth inhibition of all compounds did not meet the criteria for further testing 
against the five-dose NCI60 cell line panel [Table 5.3].  However, compounds 10-epi 
maninsigin D (CD.5), trans-cascarillone (CD.6) and agbaninol (CD.7) showed some activity 
against one cancer cell line, prostate cancer (PC-3), with growth inhibition percentages of 
31.78%, 31.92% and 41.54% respectively.  Full results are provided in pages 324-336 of 
Appendix. 
 
Previous research showed that piscidinol A (TS.3) possesses moderate to comparable 
cytotoxic activity against different cell lines.217,200  However, it was also reported that TS.3 
was inactive against the human ovarian carcinoma SKOV-3, human breast carcinoma SK-Br-
3, human chronic myelogenous leukemia K562 and oral human epidermoid carcinoma KB 
cancer cell lines under concentration below 20 µg /ml,219 which is in agreement with the 
NCI60 results in this study.  Previous research showed that euphorbol (TS.4) had 93.6 and 
90.3% inhibition rates against the MCF-7 and SF-268 tumour cell lines respectively and weak 
cytotoxicity against the NCI-H460 cell line at a higher concentration (100 µM) than tested by 
NCI60.223   
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Table 5.2: Structures of compounds submitted to NCI 
Croton dichogamus (Euphorbiaceae) 
 
Toona sinensis (Meliaceae) 
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Table 5.3: One dose mean values of isolated compounds submitted to the NCI 
Plant  Compounds Mean % Growth at 
15 µg/ml 
Croton dichogamus CD.4 100.40 
CD.5 97.86 
CD.6 101.45 
CD.7 101.36 
CD.10 99.39 
CD.11 100.36 
CD.13 100.36 
CD.14 99.14 
Toona sinensis 
TS.1 101.91 
TS.2 102.58 
TS.3 93.63 
TS.4 102.10 
TS.5 101.46 
 Conclusion:  
The cytotoxicity of isolated compounds was evaluated by two methods, the neutral red assay, 
and the NCI60 human tumour cell line panel screening.  The compounds, which were tested 
for cytotoxicity by the neutral red assay against Caco-2 cell lines in this study, had not been 
screened before [Table 5.1].  Two compounds 10-epi maninsigin D (CD.5) and masonine 
(CF.5) showed cytotoxicity at 100 µM.  CF.5 did not show any activity under 100 µM, while 
CD.5 showed an IC50 value 24.1 µM.  The CellPlayer
TM 96-well caspase-3/7 reagent assay 
showed the ability of compound CD.5 at 100 µM to inhibit Caco-2 cell growth compared to 
DMSO over 48 hours.   
 
The isolated compounds from Croton dichogamus (Euphorbiaceae) and Toona sinensis 
(Meliaceae) were selected by the Development Therapeutics Program (DTP) of the NCI for 
screening against the NCI60 human tumor cell line panel [Table 5.2].  All tested compounds 
did not show any growth inhibition against NCI60 cell line panel.  However, compounds 10-
epi maninsigin D (CD.5), trans-cascarillone (CD.6) and agbaninol (CD.7) showed some 
activity against prostate cancer (PC-3) cells, with growth inbition percentages of 31.78%, 
31.92% and 41.54% respectively.  The CD.6 also showed cytotoxicity against the Caco-2 cell 
line in the neutral red assay in this study.  
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 Chapter six: General conclusion  
The phytochemistry of five species, Croton dichogamus Pax (Euphorbiaceae family), Crinum 
sp. 6538, Crinum hardyi Lehmiller and Crinum sp. 5629 (Amaryllidaceae family), and Toona 
sinensis M. Roem (Meliaceae family) were investigated in this study.  The genera and 
families investigated have been reported to possess different phytochemical compounds some 
of which have been developed as medicines, such as galanthamine.   
 
The roots of Croton dichogamus yielded fifteen compounds including four known 
sesquiterpenoids (CD.1-CD.4), one new enantiomer of a known sesquiterpenoid (CD.5), four 
known ent-clerodane diterpenoids (CD.6-CD.9), two new ent-halimane diterpenoids (CD.10-
CD.11), one known crotofolane (CD.12) two new crotofolane diterpenoids (CD.13-CD.14) 
and one known triterpenoid (CD.15).  All these compounds have not been isolated previously 
from this species.  However, CD.1, CD.3, CD.6, CD.8, CD.9 and CD.15 have been isolated 
previously from the Croton genus.  In a previous study, two new crotofolanes were isolated 
from the Croton dichogamus.73  In the present study another two new crotofolane and two 
new halimane diterpenoids were isolated from this species.  This shows that this species is 
rich with new secondary metabolites. 
 
The bulbs of Crinum sp. 6538, Crinum hardyi and of Crinum sp. 5629 gave nine compounds: 
one new alkaloid (CF.2), seven known alkaloids (CF.1, CF.3, CF.4, CF.5, CF.6, CH.1 and 
CS.3) along with the alkaloid salt (CF.7).  CF.5 has not been isolated before from this genus.  
The distribution of alkaloids in the three Crinum species showed some variation in their 
chemical constituents. 
 
The stem bark of Toona sinensis that is growning on the University of Surrey campus, 
Guildford, UK, yielded nine compounds: five known triterpenoids (TS.1-TS.5), two known 
flavonoids (TS.6-TS.7) and two common phytosterols (TS.8-TS.9).  Although many 
compounds have been isolated previously from this species, this study found two compounds 
TS.4 and TS.5 that have not been isolated before from this species.  
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The anti-cancer screening of some isolated compounds in this study was performed in two 
ways, using the neutral red assay for the estimation of cell cytotoxicity against Caco-2 
(Human Colorectal Adenocarcinoma) cell lines, and by submitting selected isolated 
compounds to the Development Therapeutics Program (DTP) of the National Cancer Institute 
(NCI).  CD.5 only showed weak activity with an IC50 24.1 µM against Caco-2 cell lines.  In 
addition, the mean values of growth inhibition of all compounds tested against one dose 
NCI60 cell line panel did not meet the criteria for further testing against the five-dose NCI60 
cell line panel.  However, a literature review showed a degree of anticancer activity for some 
of the isolated compounds. 
 
 
 
. 
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 Chapter seven: Materials and Methods 
 Characterisation techniques 
Spectroscopic techniques including NMR, FTIR, MS and measurement of optical rotations, 
were used to identify the chemical constituents of Croton dichogamus (Euphorbiaceae 
family), Crinum species 1 6538, Crinum hardyi Lehmiller, Crinum species 2 6529 
(Amaryllidaceae family) and Toona sinensis [Meliaceae family]. 
 
 Nuclear Magnetic Resonance Spectroscopy (NMR) 
NMR experiments were performed on a 500 MHz Bruker AVANCE NMR spectrometer at 
the Department of Chemistry, Faculty of Engineering and Physical Science (FEPS), 
University of Surrey, UK.  The spectra were recorded in deuterated chloroform (CDCl3) and 
deuterated methanol (CD3OD).  The deuterated chloroform was referenced according to the 
central line at δ 7.26 in the 1H NMR spectrum and at δ 77.23 in the 13C NMR spectrum. The 
deuterated methanol was referenced according to the central line at δ 4.87 in the 1H NMR 
spectrum and at δ 49.15 in the 13C NMR spectrum. 
 
 Fourier Transform Infrared Spectroscopy (FTIR) 
Infrared spectra were recorded using a Perkin-Elmer (2000 FTIR) spectrophotometre at the 
Department of Chemistry, FEPS, University of Surrey, UK.  The samples were dissolved in 
chloroform or methanol depending on the solubility of compounds, and analysed by adding 
two drops onto a KBr plate. 
 
 Mass Spectrometry (MS) 
High-resolution electrospray ionisation mass spectra (HRMS) were recorded at Oxford 
University on a Bruker MicroToF Mass Spectrometer, using an Agilent 1100 HPLC to 
introduce samples.  Low resolution electron impact mass spectra (LCMS) were recorded at 
the Division of Biosciences, Faculty of Health and Medical Sciences, University of Surrey on 
a QTOF Premier–Water Corp and at the Department of Chemistry, FEPS, University of 
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Surrey on a Micromass Quattro Ultima-Waters 2695.  GC-MS analysis was carried out at the 
Department of Chemistry, FEPS, University of Surrey, UK, by using an Agilent 
Technologies 7890A GC system coupled to an Agilent Technologies 5975C inert XL EI / CI 
MSD with triple Axis Detector, using a HP-5MS 5% phenyl methyl silox column (30 m X 
250µm X 0.25 µm).  The oven temperature was set at 50 ºC for 3 min then raised to 10 
ºC/min to 250 ºC for 2 min, the temperature was then held at 250 ºC for the remaining 20 
min. Helium was used as the carrier gas at a flow rate of 1 ml/min. 2 µl of sample was 
injected in the split ratio 50:1 at 250 ºC. 0.1g of each sample was dissolved in 1ml DCM or 
methanol depending on solubility.  Data was run through the NIST library database as an 
additional tool to confirm identity of the compounds. 
 
 Optical rotation measurement  
Optical rotation were measured at room temperturs in either chloroform or methanol using a 
JASCO-P-1020 polarimeter at the Department of Chemistry, FEPS, University of Surrey, 
UK. 
 
 Electronic circular dichroism (ECD) 
The ECD spectra were measured on a Chirsascan CD spectrometer at the Department of 
Chemistry, FEPS, University of Surrey, UK. It were measured using 1 mm cell with 
acetonitrile as a solvent. 
 
 Plant collection, extraction and isolation of compounds  
 Plant Collection 
Plant material of Croton dichogamus Pax was collected and identified by Mr. Patrick Mutiso 
of the University Herbarium, School Biological Studies, University of Nairobi, Kenya. A 
voucher specimem BN 2010/13 was deposited at School Biological Studies, University of 
Nairobi. 
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Crinum species 1 6538, Crinum hardyi Lehmiller, Crinum species 2 6529 were obtained from 
a green house collection at the University Graz, Geaz, Austria from Wolfgang Wetschnig 
from an earlier collection from Madagascar.  A voucher specimems SKA 6538 for Crinum 
species 1 6538, SKA 6481 for Crinum hardyi and SKA 6529 for Crinum species 2 6529 will 
be deposited in the herbarium in Graz (GZU), after flowering [phytosanitary certificate: N° 
1036/13/11-IV/RL/MAG, authorisation to collect:N°-/5/13/MEF/SEG/DGF/DCB.SAP/SCB]. 
 
Plant material of Toona sinensis M. Roem was collected from a specimen growing on the 
University of Surrey campus, Guildford, UK. 
 
     Plant extraction 
The roots of Croton dichogamus were air dried, ground and extracted successively using 
hexane, dichoromethane and methanol by cold percolation at room temperature for 48h.  The 
extracts were filtered and the solvent was evaporated 
 
The bulbs of Crinum sp. 1 6538, Crinum hardyi, Crinum sp. 2 6529 were chopped into small 
pieces.  Then, chopped bulbs were extracted successively using hexane and ethanol by 
shaking at room temperature for 48h.  The extracts were filtered and the solvent was 
evaporated 
 
The stem bark of Toona sinensis was air dried ground and extracted successively using 
dichloromethane and methanol in a Soxhlet apparatus.  The extracts were filtered and the 
solvent was evaporated. 
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  Dry packing of material 
The plant extract was dissolved in a minimum amount of solvent and mixed with silica gel.  
This resulted in a fine, dry powdery material when left for a few days. 
Table 7.1: The plant collections site and the weights of crude plant extracts 
Plant name Weight of plant 
material 
Plant collection site Part Solvent 
 
Weight of 
dried crude 
extract 
Croton dichogamus Pax 1000 g Nairobi Roots DCM 20.0 
Crinum sp. 1 6538 740 g /wet weight West of the Antsiranana 
National Park 
Bulbs Hexane 2.0 g 
Ethanol 23.5 g 
Crinum hardyi Lehmiller 1000 g/wet weight Vicinity of Befandriana Bulbs Hexane 2.6 g 
Ethanol 24.4 g 
Crinum sp. 2 6529 215 g/wet weight East of the Baie de 
Sakalava 
Bulbs Hexane 0.6 g 
Ethanol 9.6 
Toona sinensis M. Roem 500 g University of Surrey 
campus, Guildford, UK 
Stem bark DCM 25.0 g 
Methanol 26.5 g 
 
 Isolation and purification of compounds 
The isolation process employed column chromatography and flash system techniques.  
Different column sizes (3-5 cm diameter) were used to separate the crude extract, depending 
on the amount of sample available.  The separation process was carried out using Merck Art. 
9385 silica gel with a hexane/ dichloromethane step gradient starting with 100% hexane and 
gradually increasing the concentration of dichloromethane to 100%, then dichloromethane 
/methanol from last concentration (100% DCM) to 50% methanol.  Flash chromatography 
was carried out using three solvent systems hexane/dichloromethane/methanol step gradients 
starting with 100% hexane to 66% methanol/ dichloromethane and compounds were detected 
using three wavelengths 320, 280 and 254 nm. 
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Subsequent purifications employed column, preparative thin layer and high-speed counter 
current chromatographic techniques.  Column chromatography was carried out using a 1 cm 
diameter column, which was packed with silica gel (Merck Art. 9385) in DCM or Sephadex 
(LH 20) in methanol/DCM.  Preparative thin layer chromatography (PTLC) was also 
employed for further purification; the samples were lined 1 cm from the bottom of the TLC 
plate.  The plates were then placed in chromatographic tanks and left to develop in the 
selected solvent system.  The developed plates were viewed under UV light and marked.  The 
marked portion of the TLC plates were then scraped off the plate and dissolved in a similar 
solvent to that in which the plate was run.  The solvent was then filtered and dried.  High-
speed counter current chromatography (HSCCC) was also used in subsequent purifications, 
using a 95% dichloromethane/ ethyl acetate solvent mixture. 
 
Throughout all these stages thin layer chromatography (0.2 mm silica gel, aluminium-backed 
plates, Merck Art. 5554) was used to monitor the fractions that had the same retention value 
on TLC, and to choose the best solvent system to be used in the chromatography.  The 
compounds on TLC were first detected using a UV-lamp at 254 and 365 nm, then they were 
also developed using anisaldehyde spray reagent (1% p-anisaldehyde: 2% sulphuric acid: 97 
% cold methanol) with subsequent heating.  For further details of isolation and purification 
compounds are given in the section 7.6 [Scheme 7.1- Scheme 7.5].  
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 Chemical analysis  
 Acetylation of hydroxylated compounds 
Pyridine (1 ml) and acetic anhydride (1 ml) were added to the sample in a round bottomed 
flask. The reaction was left to stand for 24 hours. MeOH (5 ml) was added to the sample to 
remove the excess acetic anhydride.  Toluene (4 x 10 ml) was added successively and 
evaporated en vacuo to remove the pyridine.  Finally, methanol (5 x 10 ml) was added to 
remove the toluene.  The sample was spotted on a T.L.C. plate to check the reaction had gone 
to completion or not. 
 
 Base treatment 
The ammonium salts that isolated from Crinum species, were treated with base to yield the 
free bases alkaloids.  The compound was dissolved in methanol then few drops of 4M NaOH 
was added.  The sample was left at room temperature till all the solvent was evaporated.   
 
 Cytotoxicity assay 
 Neutral red assay 
Approximately 5x104 Caco-2 cells/ml were seeded into 96-well plates and incubated at 
adequate conditions (CO2, temperature and humidified atmosphere) for 48h.  After 
incubation, the growth of cells was checked by microscope.  100 mM of every compound 
was prepared as a stock solution by dissolving the material in sterile DMSO, then five 
concentrations were prepared for every compound, 1, 3, 10, 30, 100 µM, by dilution of the 
stock solution in medium (Minium Essential Media Eagel M2279).  The culture medium 
from the plates was removed by pipette, and 200 µl of each prepared concentration was 
added in three replicates to the wells.  In addition, 200 µl of medium without chemicals and 
200 µl of medium with equivalent amounts of solvent that were used to prepare stock 
solution (1µl DMSO/ml medium) were added in three replicates to the wells plate as negative 
control.  Actinomycin D was used as a positive control in this experiment at a concentration 
of 10 µg/ml medium, and was added in three replicates to the well.  The plates were 
incubated at appropriate conditions for 48h.  Meanwhile, 40 µg/ml of neutral red working 
199 
 
solution was prepared and incubated overnight under the same conditions as the plates.  
Later, the plates were examined under microscope, and the neutral red solution was 
centrifuged for 10 min.  100 µl of neutral red medium was added to each well of the plates 
after removing all medium from the wells.  Then the plates were incubated at appropriate 
culture conditions for 2h, and then checked under the microscope.  The neutral red medium 
was removed and the cells were washed with 150 µl PBS (Phosphate Buffer Saline) per well.  
Then the PBS was removed and 150 µl of neutral red distain solution was added per well.  
The plates were shacken on a microtiter plate shaker for about 10 min.  Finally the OD of the 
neutral red extract was measured by a microtiter plate reader spectrofluorimeter at 540 nm.  
The experiment was repeated three different times.  The percentage of cell death for each 
concentration of the tested compounds was calculated with the formula 100-[(Abs540 treated 
sample/ Abs540 untreated sample) x 100].  The IC50 (the concentration producing 50% 
inhibition of Neutral Red uptake) was calculated for promising compounds by using the 
Graphepad software programme.   
 
 Measuring Apoptosis: CellPlayerTM 96-well caspase-3/7 reagent 
 
Caspase-3/7 reagent was prepared to a final concentration of 5 µM in the desired medium 
formulation.  The 96-well plates of culture cells were prepared by the Neutral red assay 
method, followed by the same steps of preparing and adding the positive and negative 
control, and 100 µM of tested compound.  Before incubating the plates, 1 µl of caspase-3/7 
reagent was added to each well of the plates.  Then, the plates were incubated within a 
microplate tray into the IncuCyte FLR 
 Methodology of the NCI 60 cancer screening 
The NCI used the method on following website for cancer screening 
https://dtp.cancer.gov/branches/btb/ivclsp.html  
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 Summary of physical data 
 Constituents of Croton dichogamus 
7.5.1.1 Physical data for compound CD.1 
Name: 4-patchoulene (cyperene) 
Yield: 5.2 mg (0.026%) 
Physical descsription: white oil 
Mass spectrum: [M]+ m/z 204.3 [C15H24], calculated for [C15H24] 204.1878 
Infrared spectrum: 2923 and 2853 cm-1 (C-H stretches) 
1H, 13C NMR and 2D NMR data presented in Table 2.8 
 
7.5.1.2 Physical data for compound CD.2 
Name: 4-patchoulen-3-one (cyperotundone) 
Yield: 1.7 mg (0.009%) 
Physical description: white oil 
Mass spectrum: due to decompose the compound the mass could be found, calculated m/z 
value for [C15H22O] 218.1671 
Infrared spectrum: 2925 and 2861 cm-1 (C-H stretches) and 1710 cm-1 (C=O stretch) 
1H, 13C NMR and 2D NMR data presented in Table 2.9 
 
7.5.1.3 Physical data for compound CD.3 
Name: cadin-1(6),2,4,7,9-penta-ene (cadalene) 
Yield: 7.1 mg (0.036%) 
Physical description: white oil 
Mass spectrum: [M]+ m/z 198.2 [C15H18], calculated for [C15H18] value 198.1409 
Infrared spectrum: 2925 and 2854 cm-1 (C-H stretches) and 1601 cm-1 (C=C stretch) 
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1H, 13C NMR and 2D NMR data presented in Table 2.10 
 
7.5.1.4 Physical data for compound CD.4 
Name: 1(6),7,9-cadinatriene-4α,5β-diol (trans-4,5-dihydroxycorocalane; 4α,5β-
corocalanediol)   
Yield: 3.0 mg (0.015%) 
Physical description: white oil 
Mass spectrum: [M]+ m/z 234.2 [C15H22O2], calculated for [C15H22O2] value 234.1620 
Infrared spectrum: 3414 cm-1 (O-H stretches), 2920 and 2857 cm-1 (C-H stretches) and 
1631 cm-1 (C=C stretch) 
[α]23 D =  -10.0 (c= 0.01 g/ml, methanol)  
1H, 13C NMR and 2D NMR data presented in Table 2.11 
 
7.5.1.5 Physical data for compound CD.5 
Name: 1,3,5-cadinatriene-7R,10S-diol (10-epi maninsigin D) 
Yield: 1.5 mg (0.008%) 
Physical description: yellow oil 
Mass spectrum: [M-H]+ m/z 233.1550 [C15H22O2] calculated for [C15H22O2-H] 234.1620 
Infrared spectrum: 3485 cm-1 (O-H stretches), 2926 and 2857 cm-1 (C-H stretches) and 
1601 cm-1 (C=C stretch) 
[α]23 D =  -96.0 (c= 0.002 g/ml, methanol)  
1H, 13C NMR and 2D NMR data presented in Table 2.12 
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7.5.1.6 Physical data for compound CD.6  
Name: 15,16-epoxy-13(16), 14-ent-clerodadien-3-one (trans-cascarillone) 
Yield: 7.5 mg (0.038%) 
Physical description: yellow oil  
Mass spectrum: [M]+ m/z 302.3 [C20H30O2], calculated for value[C20H30O2] 302.2246 
Infrared spectrum: 2926 cm-1 (C-H stretches) and 1740 cm-1 (C=O stretch) 
[α]23 D =  -+66.1 (c= 0.001 g/ml, methanol)  
1H, 13C NMR and 2D NMR data presented in Table 2.13 
 
7.5.1.7 Physical data for compound CD.7 
Name: 15,16-epoxy-4(18),13(16),14-ent-clerodatrien-3-ol (agbaninol) 
Yield: 1.6 mg (0.008%) 
Physical description: white oil 
Mass spectrum: [M]+ m/z 302.1 [C20H30O2], calculated for [C20H30O2] value 302.2246 
Infrared spectrum: 3419 cm-1 (O-H stretch) and 2916 cm-1 (C-H stretches) 
1H, 13C NMR and 2D NMR data presented in Table 2.14 
 
7.5.1.8 Physical data for compound CD.8 
Name: 15,16-epoxy-3-keto-3(16),14-ent-clerodadien-17, 12S-olide (crotonolide E.) 
Yield: 10.2 mg (0.051%) 
Physical description: yellow oil  
Mass spectrum: [M+H]+ m/z 331.1 [C20H26O4], calculated for [C20H26O4+H] value 330.1831 
Infrared spectrum: 2925 and 2852cm-1 (C-H stretches) and 1739 and 1710 cm-1 (C=O 
stretch) 
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[α]23 D = + 84.5 (c= 0.01g/ml, methanol) 
1H, 13C NMR and 2D NMR data presented in Table 2.15 
 
7.5.1.9 Physical data for compound CD.9  
Name: 15,16-epoxy-3,4-dihydroxy-3(16),14-ent-clerodadien-17,12S-olide (furocrotinsulolide 
A) 
Yield: 15.4 mg (0.077%) 
Physical description: yellow oil 
Mass spectrum: [M + Na]+ m/z 371.1831 [C20H28O5], calculated for [C20H28O5+Na] value 
348.1937 
Infrared spectrum: 3448 cm-1 (O-H), 2932 and 2870 cm-1 (C-H stretches) and 1718 cm-1 
(C=O stretch) 
[α]23 D = + 6.0 (c= 0.012g/ml, methanol) 
1H, 13C NMR and 2D NMR data presented in Table 2.16 
 
7.5.1.10  Physical data for compound CD.10 
Name: 15, 16-epoxy-5,13(16),14-ent-halimatriene-3-ol. 
Yield: 1.8 mg (0.009%) 
Physical description: yellow oil 
Mass spectrum: [M+Na]+ m/z 325.2138 [C20H30O2], calculated for[C20H30O2+Na] value 
302.2246 
Infrared spectrum: 3424 cm-1 (O-H stretch), 2922 and 2852 cm-1 (C-H stretches)  
1H, 13C NMR and 2D NMR data presented in Table 2.17 
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7.5.1.11  Physical data for compound CD.11 
Name: 15,16-epoxy-3-hydroxy-5(10), 13(16), 14-ent-halimatriene-17, 12S-olide  
Yield: 3.2 mg (0.016%) 
Physical description: white solid  
Mass spectrum: [M]+ m/z 330.1830 [C20H26O4], calculated for [C20H26O4] value 330.1831 
Infrared spectrum: 3436 cm-1 (O-H stretch), 2936 and 2876 cm-1 (C-H stretches) and 1731 
cm-1 (C=O stretch) 
[α]23 D = + 56.0 (c= 0.036 g/ml, methanol ) 
1H, 13C NMR and 2D NMR data presented in Table 2.18 
 
7.5.1.12  Physical data for compound CD.12 
Name: crotohaumanoxide 
Yield: 4.3 mg (0.021%) 
Physical description: yellow oil 
Mass spectrum: due to the decomposed compound the Mass and FTIR experiments were not 
done. [C22H26O2], calculated m/z value 370.1780 
1H, 13C NMR and 2D NMR data presented in Table 2.19 
 
7.5.1.13  Physical data for compound CD.13 
Name: crotodichogamoin A 
Yield: 20 mg (0.1%) 
Physical description: yellow gum  
Mass spectrum: [M+H]+ m/z 327.1590 [C20H22O4], calculated for value [C20H22O4+H] 
326.1518 
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Infrared spectrum: 2917 and 2848 cm-1 (C-H stretches) 1747 (C=O stretch) and 1649 cm-1 
(C=C stretch) 
[α]23 D = + 11.3 (c= 0.023g/ml, chloroform) 
1H, 13C NMR and 2D NMR data presented in Table 2.20 
 
7.5.1.14  Physical data for compound CD.14 
Name: crotodichogamoin B 
Yield: 2.9 mg (0.015%) 
Physical description: yellow oil 
Mass spectrum: [M+H]+ m/z 295.16945 [C20H22O2], calculated for [C20H22O2+H] value 
294.1620 
Infrared spectrum: 2928 and 2856 cm-1 (C-H stretches), 1730 cm-1 (C=O stretch) and 1594 
cm-1 (C=C stretch) 
[α]23 D = + 111.1 (c= 0.0013 g/ml, chloroform) 
1H, 13C NMR and 2D NMR data presented in Table 2.21 
 
7.5.1.15  Physical data for compound CD.15 
Name: acetyl aleuritolic acid 
Yield: 3.3 mg (0.017%) 
Physical description: white crystal  
Mass spectrum: [M-H]+ m/z 497.3829 [C32H50O4], calculated for [C32H50O4+H]value 
498.3709 
Infrared spectrum: 2934 and 2861 cm-1 (C-H stretches), 1732 and 1686 cm-1 (C=O stretch)  
[α]23 D = 16.2 (c= 0.01g/ml, chloroform) 
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1H, 13C NMR and 2D NMR data presented in Table 2.22 
 
 Constituents of Crinum sp. 6538 
7.5.2.1 Physical data for compound CF.1 
Name: lycorine 
Yield: 15.4 mg (0.062%) 
Physical description: white crystalline  
Mass spectrum: [M+H]+ m/z 288.2 [C16H17NO4], calculated for [C16H17NO4+H] value 
287.1158 
Infrared spectrum: 3432 cm-1 (O-H stretch), 2921 and 2850 cm-1 (C-H stretches),  
[α]23 D = + 50.0 (c= 0.02g/ml, ethanol) 
1H, 13C NMR and 2D NMR data presented in Table 3.2 
 
7.5.2.2 Physical data for compound CF.2  
Name: 6,7,11b,11c-didehydrolycorinium salt 
Yield: 2.7 mg (0.011%) 
Physical description: yellow solid 
Mass spectrum: [M]+ m/z 284.0911 [C16H14NO4], calculated for [C16H14NO4] value 
284.0917 
Infrared spectrum: 3343 cm-1 (O-H stretch), 2920 cm-1 (C-H stretches) and 1609 cm-1 (C=C 
stretch) 
[α]23 D = +20.0 (c= 0.01 g/ml, methanol) 
1H, 13C NMR and 2D NMR data presented in Table 3.3 
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7.5.2.3 Physical data for compound CF.3 
Name: hippadine 
Yield: 3.4 mg (0.014%) 
Physical description: yellow solid 
Mass spectrum: [M+H]+ m/z 264.4 [C16H9NO3], calculated for [C16H9NO3+H]  value 
263.0582 
Infrared spectrum: 2918 and 2849 cm-1 (C-H stretches), 1738 cm-1 (C=O stretch) and 1675 
cm-1 (C=C stretch) 
1H, 13C NMR and 2D NMR data presented in Table 3.4 
 
7.5.2.4 Physical data for compound CF.4 
Name: hippeastrine.  
Yield: 6.3 mg (0.027%) 
Physical description: white crystalline  
Mass spectrum: [M+H]+ m/z 316.3 [C17H17NO5], calculated for [C17H17NO5+H]  value 
315.1107 
Infrared spectrum: 3468 cm-1 (O-H stretch), 2922 and 2852 cm-1 (C-H stretches), 1726 cm-1 
(C=O stretch) and 1614 cm-1 (C=C stretch) 
[α]23 D =  +140.0 (c= 0.002g/ml, chloroform) 
1H, 13C NMR and 2D NMR data presented in Table 3.5 
 
7.5.2.5 Physical data for compound CF.5 
Name: masonine 
Yield: 1.2 mg (0.006%) 
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Physical description: yellow crystalline 
Mass spectrum: [M+H]+ m/z 300.3 [C17H17NO4], calculated for [C17H17NO4+H] value 
299.1158 
Infrared spectrum: 3437 cm-1 (O-H stretch), 2919 and 2850 cm-1 (C-H stretches) and 1717 
cm-1 (C=O stretch)  
[α]23 D = +50.0 (c=0.0005 g/ml, methanol) 
1H, 13C NMR and 2D NMR data presented in Table 3.6 
 
7.5.2.6 Physical data for compound CF.6 
Name: crinine 
Yield: 6.7 mg (0.029%) 
Physical description: white solid  
Mass spectrum: [M+H]+ m/z 272.5 [C16H17NO3], calculated for [C16H17NO3+H]  value 
271.1208 
Infrared spectrum: 3435 cm-1 (O-H stretch) and 2921 and 2851 cm-1 (C-H stretches) 
[α]23 D = -12.0 (c= 0.0005g/ml, methanol) 
1H, 13C NMR and 2D NMR data presented in Table 3.7 
 
7.5.2.7 Physical data for compound CF.7 
Name: the ammonium salt of crinine 
Yield: 4.6 mg (0.019%) 
Physical description: yellow powder 
Mass spectrum: [M]+ m/z 272.3 [C16H18NO3
+], calculated for [C16H18NO3
+] value 272.1281 
 [α]23 D = -15.7 (c= 0.0004g/ml, methanol) 
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1H, 13C NMR and 2D NMR data presented in Table 3.8 
 
 Constituents of Crinum hardyi 
7.5.3.1 Physical data for compound CH.1 
Name: 6-hydroxycrinamine 
Yield: 3.8 mg (0.016%) 
Physical description: white crystalline  
Mass spectrum: [M]+ m/z 317.4 [C17H19NO5], calculated for [C17H19NO5]  value 317.3410 
Infrared spectrum: 3397 cm-1 (O-H) and 2923 cm-1 (C-H stretches)  
[α]23 D = +45.0 (c= 0.005g/ml, chloroform+methanol) 
1H, 13C NMR and 2D NMR data presented in Table 3.9 
 
7.5.3.2 Physical data for compound CH.2 
Name: Crinine 
Yield: 1.9 mg (0.008%) 
Physical description: white solid 
Mass spectrum: [M+H]+ m/z 272.5 [C16H17NO3], calculated for [C16H17NO3+H]  value 
271.1208 
[α]23 D = -12.0 (c= 0.0005g/ml, methanol) 
1H, 13C NMR and 2D NMR data presented Table 3.7 
 
7.5.3.3 Physical data for compound CH.3 
Name: the ammonium salt of crinine 
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Yield: 2.1 mg (0.009%) 
Physical description: yellow solid 
.Mass spectrum: [M]+ m/z 272.3 [C16H18NO3
+], calculated for [C16H18NO3
+] value 272.1281 
 [α]23 D = -15.7 (c= 0.0004g/ml, methanol) 
1H, 13C NMR and 2D NMR data presented in Table 3.8 
 
7.5.3.4 Physical data for compound CH.4 
Name: lycorine  
Yield: 1.8 mg (0.007%) 
Physical description: white crystalline 
Mass spectrum: [M+H]+ m/z 288.2 [C16H17NO4], calculated for [C16H17NO4+H] value 
287.1158 
Infrared spectrum: 3432 cm-1 (O-H stretch), 2921 and 2850 cm-1 (C-H stretches),  
[α]23 D = + 50.0 (c= 0.02g/ml, ethanol) 
1H, 13C NMR and 2D NMR data presented in Table 3.2 
 
7.5.3.5 Physical data for compound CH.5 
Name: 6,7,11b,11c-didehydrolycorinium salt 
Yield: 3.6 mg (0.015%) 
Physical description: yellow solid  
Mass spectrum: [M]+ m/z 284.5 [C16H14NO4] calculated for [C16H14NO4] value 284.0917 
Infrared spectrum: 3343 cm-1 (O-H stretch), 2920 cm-1 and 2850 cm-1 (C-H stretches) and 
1609 cm-1 (C=C) 
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[α]23 D =+20.0 (c= 0.01 g/ml, methanol) 
1H, 13C NMR and 2D NMR data presented Table 3.10 
 
 Constituents of Crinum species 5629 
7.5.4.1 Physical data for compound CS.1 
Name: 6α,11exo-diacetoxy crinamine 
Yield: 3.1 mg (0.322%) 
Physical description: white solid 
Mass spectrum: [M-OAc]+ m/z 342.6 [C21H23NO7], calculated for [C21H23NO7-OAc]value 
401.1475 
[α]23 D +130 (c=0,.01g/ml, chloroform) 
1H, 13C NMR and 2D NMR data presented Table 3.11. 
 
7.5.4.2 Physical data for compound CS.2 
Name: lycorine 
Yield: 1.1 mg (0.011%) 
Physical description: white crystalline 
Mass spectrum: [M+H]+ m/z 288.2 [C16H17NO4], calculated for[C16H17NO4+H]  value 
287.1158 
Infrared spectrum: 3432 cm-1 (O-H stretch), 2921 and 2850 cm-1 (C-H stretches),  
[α]23 D = + 50.0 (c= 0.02g/ml, ethanol) 
1H, 13C NMR and 2D NMR data presented in Table 3.2 
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7.5.4.3 Physical data for compound CS.3  
Name: pseudolycorine 
Yield: 4.7 mg (0.048%) 
Physical description: yellow solid 
Mass spectrum: [M+H]+ m/z 290.1387 [C16H19NO4], calculated for [C16H19NO4+H]value 
289.1314 
Infrared spectrum: 3391 cm-1 (O-H stretch), 2922 and 2850 cm-1 (C-H stretches),  
 [α]23 D -66.5 (c= 0.001 g/ml, ethanol) 
1H, 13C NMR and 2D NMR data presented Table 3.12 
 
 Constituents of Toona sinensis  
7.5.5.1 Physical data for compound TS.1  
Name: 24-Methylencycloartan-3-yl acetate 
Yield: 6.6 mg (0.246%) 
Mass spectrum: [M+H]+ m/z 483.3768 [C33H55O2] calculated for [C33H55O2+H] value 
482.4124 
Infrared spectrum: 2940 and 2868 cm-1 (C-H stretches), 1734 cm-1 (C=O stretch) and 1636 
cm-1 (C=C stretch)  
1H, 13C NMR and 2D NMR data presented in Table 4.1 
 
7.5.5.2 Physical data for compound TS.2  
Name: 24-Methylencycloartan-3-one 
Yield: 1.8 mg (0.007%) 
Mass spectrum: [M+H]+ m/z 439.3615 [C31H51O], calculated for [C31H51O+H] value 
438.3862 
Infrared spectrum: 2919 and 2849 cm-1 (C-H stretches) and 1708 cm-1 (C=O stretch)  
1H, 13C NMR and 2D NMR data presented in Table 4.2 
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7.5.5.3 Physical data for compound TS.3  
Name: 23,24,25-Trihydroxytirucall-7-en-3-one (piscidinol A) 
Yield: 4.3 mg (0.017%) 
Mass spectrum: [M+Na]+ m/z 497.3594 [C30H50O4Na], calculated for [C30H50O4Na+Na] 
value 474.3709 
Infrared spectrum: 3400 cm-1 (OH stretch), 2916 and 2849 cm-1 (C-H stretch) and 1708 cm-
1 (C=O stretch) 
1H, 13C NMR and 2D NMR data presented in Table 4.3 
 
7.5.5.4 Physical data for compound TS.4  
Name: 24-Methyltirucalla-8,24-dien-3-ol, Euphorbol 
Yield: 4.5 mg (0.02%) 
Mass spectrum: [M+Na]+ m/z 463.3800 [C31H52ONa], calculated for [C31H52Ona+Na] value 
440.4018 
Infrared spectrum: 3350 cm-1 (OH stretch) and 1640 cm-1 (C=C stretch) 
1H, 13C NMR and 2D NMR data presented in Table 4.4 
 
7.5.5.5 Physical data for compound TS.5  
Name: -Amyrin acetate 
Yield: 1.7 mg (0.007%) 
Mass spectrum: [M-H]+ ion m/z 467.3837 [C32H51O2], calculated for [C32H51O2-H] value 
468.3967 
Infrared spectrum: 2921 and 2851 cm-1 (C-H stretches), 1737 cm-1 (C=O) and 1636 cm-1 
(C=C)  
1H, 13C NMR and 2D NMR data presented in Table 4.5 
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7.5.5.6 Physical data for compound TS.6 
Name: catechin  
Yield: 1.4 mg (0.005%) 
Physical description: white solid 
Mass spectrum: [M+Na]+ m/z 523.3 [C25H24O11Na], calculated for [C25H24O11Na+Na] value 
500.1319 
1H, 13C NMR and 2D NMR data presented Table 4.6 
 
7.5.5.7 Physical data for compound TS.7 
Name: epicatechin  
Yield: 1.7 mg (0.006%) 
Physical description: white solid 
Mass spectrum: [M+Na]+ m/z 523.3 [C25H24O11Na], calculated for [C25H24O11Na+Na]  value 
500.1319 
Infrared spectrum: 2923 and 2853 cm-1 (C-H stretches), 2360 cm-1 (C=O) 
1H, 13C NMR and 2D NMR data presented Table 4.7 
 
Physical data for compound TS.8  
Name: sitosterol 
Yield: 2.8 mg (0.011%) 
Mass spectrum: [M-H]+ m/z 413.3733 [C29H29O], calculated for [C29H29O-H] value
 
414.3862 
Infrared spectrum: 3411 cm-1 (OH stretch), 2919 cm-1, (C-O stretch) and 1640 cm-1 (C=C 
stretch). 
1H, 13C NMR and 2D NMR data presented in Table 4.8 
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Physical data for compound TS.9  
Name: Sitostenone 
Yield: 5.9 mg (0.024%) 
Mass spectrum: [M+H] + m/z 413.3712 [C29H49O], calculated for [C29H49O+H] value
 
412.3705 
Infrared spectrum: 2919 and 2869 cm-1 (C-H stretches), 1727 cm-1 (C=O) and 1680 cm-1 
(C=C stretches). 
1H, 13C NMR and 2D NMR data presented in Table 4.9 
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 Flow charts of isolated compounds  
 
Scheme 7.1:A flow chart of the compounds isolated from the dichloromethane extract of 
the roots of Croton dichogamus 
 
Roots of Croton 
dichogamus
Dichloromethane extraction 
for 48 hrs by agitation
Flash System silica 
(SiO2CC), for 34.9 
min and 20 ml 
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min 
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Small column sphedex 
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100% DCM
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7.1 mg
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100% DCM
PTLC 2X (100% DCM))
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24:1 DCM:EtOAc
Small column (SiO2CC)
F 38-42
24:1 DCM:EtOAc
Compound CD.10
1.8 mg
Fr 88-90
24:1 DCM:EtOAc
Small column (SiO2CC)
F 51-53
29:1 DCM:EtOAc
Compound CD.7
1.6 mg
Fr 98-100
24:1 DCM:EtOAc
Small column (SiO2CC)
F 87-89
37:1 DCM:EtOAc
Compound CD.15
3.3 mg
Fr 112-116
24:1 DCM:EtOAc
Small column sphedex 
Fr 28-32
100% DCM
PTLC 3X
(39:1 DCM:EtOAc)
Compound CD.14
2.9 mg
Fr 125-126
23.5:1.5 DCM:EtOAc
PTLC 2X
(39:1 DCM:EtOAc)
Compound CD.8
10.2 mg
Fr 140
23:3 DCM:EtOAc
Compound CD.11
3.2 mg
Fr 149
21:4 DCM:EtOAc
Compound CD.4 
3.0 mg
Fr 160
13:12  DCM:EtOAc
Compound CD.9 
15.4 mg
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Scheme 7.2: A flow chart of the compounds isolated from the ethanol extract of the bulbs of Crinum sp. 1 6538 
 
Compound CF.2 
2.7 mg 
Small column (SiO2CC) 
 
Bulbs of Crinum species 1 6538 
Hexane extraction for 48 hrs by agitation (740 g-wet weight)  
Ethanol extraction for 48 hrs by agitation  
Large column silica (SiO2CC), 75 ml fractions collected 
Fr 119-128 
1:1 Hexane:Ether 
Fr 89-92 
20:4 DCM:Hexane 
Compound CF.3  
3.4 mg 
Fr 195-206 
18:7 DCM:MeOH 
Large column silica (SiO2CC), 75 ml fractions collected 
Compound CF.5 
1.2 mg 
Compound CF.7 
4.6 mg 
Compound CF.4 
6.3 mg 
Compound CF.1 
15.4 mg 
 
F192  
1:1 Ether:EtOAc 
F201  
18:2 DCM:MeOH 
F215 
18:2 DCM:MeOH 
F236 
18:2 DCM:MeOH 
Small column (SiO2CC) 
F34-37 
44:1 DCM:Ether 
Small column (SiO2CC) 
 
F85-90 
17:3 DCM:MeOH 
140-143 
17:3 DCM:MeOH 
Compound CF.6 
6.7 mg 
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 Scheme 7.3: A flow chart of the compounds isolated from the ethanol extract of the bulbs of Crinum hardyi 6481 
 
Bulbs of Crinum hardyi 6481 
Hexane extraction for 48 hrs by agitation (1000 g-wet weight)  
Ethanol extraction for 48 hrs by agitation  
Large column silica (SiO2CC), 75 ml fractions collected 
Fr 94-99 
20:5 DCM: MeOH 
Fr 102-108 
20:5 DCM:MeOH 
Compound CH.4 
1.8 mg 
 
Fr 132-135 
22:3 DCM:MeOH 
Small column sphedex  
Fr 43-46 
22:3 DCM:MeOH 
Compound CH.5 
3.6 mg Fr 34-37 
PTLC (21:4 DCM:MeOH) 
Compound CH.1 
3.8 mg 
Fr 38-41 
PTLC (21:4 DCM:MeOH) 
Compound CH.2 
1.9 mg 
Small column sphedex  
Fr 38-41 
20:5 DCM:MeOH 
Fr 121-124 
18:7 DCM:MeOH 
Compound CH.3 
2.1 mg 
Small column sphedex  
Fr 37 
20:5 DCM:MeOH 
Small column sphedex  
21:4 DCM:MeOH 
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Scheme 7.4:A flow chart of the compounds isolated from the ethanol extract of the bulbs of Crinum species 2 6529 
 
Bulbs of Crinum species 2 6529  
Hexane extraction for 48 hrs by agitation (215 g-wet weight)  
Ethanol extraction for 48 hrs by agitation  
Flash System silica (SiO2CC), for 34.9 min and 20 ml fractions 
collected with flow rate 36 ml/ min  
Fr 72-73 
19:6 DCM: EtOAc 
Small column sphedex  
Fr 55-60 
17:3 DCM:MeOH 
Fr 85 
17:3 DCM:MeOH 
Acetylation, 
PTLC (1:1 DCM:EtOAc)  
Compound CS.1 
3.1 mg 
PTLC (17:3 DCM:MeOH) 
Compound CS.2 
1.1 mg 
Fr 90-92 
17:3 DCM:MeOH 
Small column sphedex  
Fr 43-46 
17:3 DCM:MeOH 
PTLC (17:3 DCM:MeOH) 
Compound CS.3 
7.4 mg 
220 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 7.5: A flow chart of the compounds isolated from the bark of T.sinensis 
 
Stem bark of T.sinensis 
Dichoremethane extraction by soxhlet 
Large column silica (SiO2CC), 75 ml fractions collected 
Fr 55 
30:70 
DCM: H 
Small column 
(SiO2CC), Fr 7-11 
50:50 DCM: H 
 
Small column sphedex,  
Fr 15 
50:50 DCM: MeOH 
 
PTLC 3 X (50:50 DCM: H) 
Fr 204-206 
99:1 DCM: 
MeOH 
Small column 
(SiO2CC),  
Fr 21-32 
60:40 DCM: EtOAC 
 
Small column 
(SiO2CC), Fr 33-34  
96:4 DCM: Ether 
 
Fr 74-75 
40:60 
DCM: H 
Small column 
(SiO2CC), Fr 49-56  
100% DCM 
 
Fr 90-99 
60:40 
DCM: H 
Fr 66-69 
40:60 
DCM: H 
Small column 
(SiO2CC), Fr 11-27  
70:30 DCM:H 
 
HSCC 95:5 
DCM:EtoAC 
 
Acetylation, 
PTLC 4X (25:75 
DCM:H)  
 
Spot 1  
Small column sphedex,  
Fr 19-21 
50:50 DCM: MeOH 
 
pTLC 2 X (50:50 DCM: 
H) 
Spot 2 
 Compound TS.1  
6.6 mg 
 
Fr 30 
Compound 
TS.9  
5.9 mg 
Fr 42-47 
Compound 
TS.8  
2.8 mg 
Compound 
TS.2  
1.8 mg 
 Compound TS.5  
1.7 mg 
 
Compound TS.4  
4.5 mg 
Compound TS.3  
4.3 mg 
 
Methanol extraction by soxhlet 
Flash System silica (SiO2CC), for 34.9 min and 20 ml 
fractions collected with flow rate 36 ml/ min  
Fr 66-70 
3:1 DCM: EtOAc 
Small column sphedex,  
Fr 20-23 
2:1 DCM: EtOAc 
 
Acetylatio
n 
Small column 
(SiO2CC), Fr 7  
25:1 DCM: EtOAc 
 
PTLC 3 (25:1 DCM: 
EtOAc) 
) 
Compound TS.6  
1.4 mg 
 
Compound TS.7 
1.7 mg 
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